Refine
Year of publication
Document Type
- Article (787)
- Doctoral Thesis (280)
- Postprint (106)
- Conference Proceeding (38)
- Review (34)
- Other (32)
- Monograph/Edited Volume (9)
- Habilitation Thesis (5)
- Preprint (2)
- Master's Thesis (1)
Keywords
- inflammation (24)
- obesity (18)
- oxidative stress (15)
- insulin (14)
- type 2 diabetes (14)
- Biomarker (13)
- LC-MS/MS (13)
- insulin resistance (13)
- cancer (12)
- carotenoids (12)
- Adipositas (10)
- FGF21 (10)
- selenium (10)
- sphingolipids (10)
- Insulin resistance (9)
- acid sphingomyelinase (9)
- ceramide (9)
- cytokines (9)
- metabolic syndrome (9)
- α-amylase/trypsin inhibitors (9)
- Caenorhabditis elegans (8)
- Manganese (8)
- Selen (8)
- protein (8)
- Oxidative stress (7)
- adipose tissue (7)
- mass spectrometry (7)
- metabolism (7)
- pregnancy (7)
- retinol (7)
- C. elegans (6)
- Geschmack (6)
- Mitochondria (6)
- NASH (6)
- Obesity (6)
- Pregnancy (6)
- Prunus avium L. (6)
- SDS-PAGE (6)
- Solanaceae (6)
- Vitamin A (6)
- aging (6)
- cholesterol (6)
- diabetes (6)
- diet (6)
- disease (6)
- epigenetics (6)
- polyphenols (6)
- probiotics (6)
- retinol-binding protein 4 (6)
- taste (6)
- vitamin A (6)
- zinc (6)
- Aging (5)
- Arsenolipids (5)
- DNA damage (5)
- DNA methylation (5)
- Dexamethasone (5)
- Energiestoffwechsel (5)
- Entzündung (5)
- Epigenetics (5)
- Fetal programming (5)
- HPLC (5)
- Inflammation (5)
- Insulin (5)
- LC–MS/MS (5)
- NAFLD (5)
- Sphingolipids (5)
- Sphingosine 1-phosphate (5)
- Type 2 diabetes (5)
- adiponectin (5)
- biomarker (5)
- cardiovascular disease (5)
- coffee by-products (5)
- genes (5)
- linagliptin (5)
- liver (5)
- manganese (5)
- mitochondria (5)
- plasma (5)
- protein modification (5)
- type 2 diabetes mellitus (5)
- wheat (5)
- Adipose tissue (4)
- Arsenic-containing fatty acids (4)
- Arsenic-containing hydrocarbons (4)
- C-reactive protein (4)
- Cardiovascular diseases (4)
- Carotenoids (4)
- Diabetes (4)
- Emulsion (4)
- Endothelin (4)
- Flower buds (4)
- GDF15 (4)
- Hypertension (4)
- Mass spectrometry (4)
- Metabolisches Syndrom (4)
- PUFA (4)
- Placenta (4)
- SDS PAGE (4)
- Sphingosine-1-phosphate (4)
- Typ-2-Diabetes (4)
- Vitamin E (4)
- Zinc (4)
- adipogenesis (4)
- brain (4)
- cell-based assay (4)
- cells (4)
- chronic kidney disease (4)
- copper (4)
- database (4)
- electrochemistry (4)
- epidemiology (4)
- glutathione peroxidase (4)
- gut microbiota (4)
- lipid metabolism (4)
- lutein (4)
- macrophages (4)
- malnutrition (4)
- metabolomics (4)
- micronutrients (4)
- neurodegeneration (4)
- neurotoxicity (4)
- non-alcoholic fatty liver disease (4)
- proteinuria (4)
- refinement (4)
- resistin (4)
- transcriptomics (4)
- weight loss (4)
- Abscisic acid (3)
- Acid sphingomyelinase (3)
- African indigenous vegetables (3)
- Alterung (3)
- Arabica coffee beans (3)
- BMI (3)
- Bilophila wadsworthia (3)
- Bioavailability (3)
- Bittergeschmack (3)
- Boron exposure (3)
- Diabetic nephropathy (3)
- Doehlert design (3)
- Dormancy (3)
- Drug delivery (3)
- Ernährung (3)
- Fettstoffwechsel (3)
- GCN2 (3)
- Glucagon (3)
- Glucosinolates (3)
- Hepatocytes (3)
- Insulinresistenz (3)
- Kidney (3)
- MALDI-TOF-MS (3)
- Mendelian randomization (3)
- Meta-analysis (3)
- Methylmercury (3)
- Mitochondrien (3)
- NZO (3)
- Neurotoxicity (3)
- Nrf2 (3)
- Nutrition (3)
- Proteom (3)
- Selenium (3)
- Skeletal muscle (3)
- Sphingosine kinase (3)
- Stability (3)
- TEM (3)
- Toxicity (3)
- Verhalten (3)
- acid ceramidase (3)
- activated carbon (3)
- adiposity (3)
- age (3)
- ageing (3)
- antioxidants (3)
- beta-cell (3)
- bioavailability (3)
- biofortification (3)
- bitter taste (3)
- chronic diseases (3)
- coffee processing (3)
- colorectal cancer (3)
- diabetic nephropathy (3)
- differentiation (3)
- elevated plus-maze (3)
- energy metabolism (3)
- fatty acid metabolism (3)
- fatty acids (3)
- fibrosis (3)
- food choice (3)
- gallbladder cancer (3)
- glucocorticoid receptor (3)
- goblet cells (3)
- heart (3)
- high-sodium (3)
- homeostasis (3)
- iCheck (3)
- infection (3)
- kidney transplantation (3)
- lifestyle (3)
- lipidomics (3)
- liver metabolism (3)
- mitochondrial dysfunction (3)
- model (3)
- mortality (3)
- neurodegenerative diseases (3)
- nutrition (3)
- omega-3 fatty acids (3)
- open-field (3)
- overweight (3)
- p53 (3)
- plant volatiles (3)
- polymorphism (3)
- post-natal (3)
- pre-natal (3)
- prevention (3)
- prostaglandin E2 (3)
- proteasome (3)
- protein restriction (3)
- proteome (3)
- proteostasis (3)
- red meat (3)
- redox state (3)
- saliva (3)
- sample preparation (3)
- sarcopenia (3)
- selenoprotein P (3)
- sphingomyelin (3)
- sphingosine (3)
- sphingosine-1-phosphate (3)
- sulfotransferase (3)
- survival (3)
- tocopherols (3)
- transformation products (3)
- transthyretin (3)
- type 2 (3)
- vascular calcification (3)
- vegetables (3)
- 1-Hydroxymethylpyren (2)
- 1-aminodecylidene bis-phosphonic acid (2)
- AMD (2)
- Ageing (2)
- Akt pathway (2)
- Amino acids (2)
- Amylase (2)
- Anemia (2)
- Apoptosis (2)
- Arabica coffee (2)
- Arabidopsis (2)
- Arsenic (2)
- BMI change (2)
- Beer (2)
- Birth weight (2)
- Blood (2)
- Blood pressure (2)
- BoNT (2)
- BoNT/B uptake (2)
- Boric acid (2)
- Botulinum neurotoxin (2)
- COVID 19 (2)
- CRISPR editing validation (2)
- CVD (2)
- Caco-2 (2)
- Caco-2 intestinal barrier model (2)
- Caco-2/HT-29-MTX-model (2)
- Caenorhabitis elegans (2)
- Camellia sinensis (2)
- Carotenoid (2)
- Carotinoide (2)
- Cattle (2)
- Ceramide (2)
- Ceramides (2)
- Cereals (2)
- Christentum (2)
- Chrysopidae (2)
- Circadian rhythm (2)
- Clinical (2)
- Cohort studies (2)
- Copper (2)
- Cow-side assay (2)
- Curcumin (2)
- Cytotoxicity (2)
- DNA adducts (2)
- DNA damage response (2)
- DNA repair (2)
- DPP-4 inhibitors (2)
- Development (2)
- Differenzierung (2)
- Donors (2)
- Dopamine (2)
- E-2 (2)
- ET-1 (2)
- Endothelial cells (2)
- Endothelin-1 (2)
- Energy metabolism (2)
- Epidemiologie (2)
- Ernährungsfaktoren (2)
- Ernährungsgewohnheit (2)
- Ethanol (2)
- FTY720 (2)
- Ferritin (2)
- Fettgewebe (2)
- Fettsäuren (2)
- Flavonoid (2)
- Fluorescence (2)
- Food labeling (2)
- Foxp3 (2)
- GI-GPx (2)
- GPx activity (2)
- Genotoxicity (2)
- Genregulation (2)
- Gestational diabetes (2)
- Gestational diabetes mellitus (2)
- Global DNA methylation (2)
- Glucose homeostasis (2)
- Glutathionperoxidase (2)
- HEK293 (2)
- HRMS (2)
- Hemoglobin (2)
- HepG2 (2)
- Hypermethylation (2)
- IGF-1 (2)
- IL-8 transcription (2)
- In vitro blood-brain barrier model (2)
- Inflammatory bowel disease (2)
- Insulin secretion (2)
- Intuitives Essen (2)
- Iron deficiency anemia (2)
- Islam (2)
- Isoflavone (2)
- Judentum (2)
- Jurkat cells (2)
- Kaffee (2)
- Körperzusammensetzung (2)
- LC-MRM-MS (2)
- LC/HRMS (2)
- Labile zinc (2)
- Lebensstil (2)
- Leber (2)
- Linagliptin (2)
- Lipid metabolism (2)
- Lipidomics (2)
- Lymphocytes (2)
- M1/M2 differentiation (2)
- MALDI-TOF/MS (2)
- MRSA (2)
- Makrophagen (2)
- Maus (2)
- Meat (2)
- Mediterranean diet (2)
- Mercaptursäure (2)
- Mercuric mercury (2)
- Metabolomics (2)
- Method comparison (2)
- Microarray (2)
- Modified mycotoxins (2)
- Mortality (2)
- Mycotoxins (2)
- NAFLD/MAFLD (2)
- Nahrungssulfonate (2)
- Neutrophils (2)
- Nitric oxide (2)
- Nährstoffe (2)
- PTH (2)
- PXR (2)
- Pak choi (2)
- Palmitate (2)
- Parkinson disease (2)
- Pesticides (2)
- Phenole (2)
- Phenological modelling (2)
- Phenylpropanoids (2)
- Plackett–Burman design (2)
- Polymorphismus (2)
- Polyphenole (2)
- Post mortem chemistry (2)
- Prediabetes (2)
- Prevention (2)
- Prostaglandin E2 (2)
- Proteasome (2)
- Protein oxidation (2)
- Protein restriction (2)
- RBP4 (2)
- RNAseq (2)
- RRR (2)
- Rats (2)
- Redoxregulation (2)
- Religiöses Leben (2)
- Renal failure (2)
- Reticulocytes (2)
- Review (2)
- S-XRF (2)
- SCFA (2)
- SFA (2)
- SIMS techniques (2)
- Sarcopenia (2)
- Se (2)
- Selenoproteine (2)
- Skeletal muscle cells (2)
- Skin nanocarrier (2)
- Skin penetration (2)
- Small for gestational age (2)
- Smpd1 (2)
- Solanum lycopersicum (2)
- Speisegebot (2)
- Stoffwechsel (2)
- Stress response (2)
- Sulforaphan (2)
- Sulfotransferase (2)
- TAS2R (2)
- TLR signaling (2)
- Tandem mass spectrometry (2)
- Technical enzymes (2)
- Tenebrio molitor larvae (2)
- Thiomersal (2)
- Thioredoxin (2)
- Tight Junction (2)
- Trace elements (2)
- Typ-2-Diabetes mellitus (2)
- VGCC (2)
- Vitamin K (2)
- Vollkorn (2)
- Whey protein (2)
- Xylanase (2)
- Zinc homeostasis (2)
- accumulation (2)
- activation (2)
- acute kidney injury (2)
- adipose tissue dysregulation (2)
- aflatoxin B1 (2)
- albuminuria (2)
- alkylierte polyzyklische aromatische Kohlenwasserstoffe (2)
- all-cause mortality (2)
- angiotensin receptor blockers (2)
- animal welfare (2)
- anorexia (2)
- anthropometric measures (2)
- anti-genotoxicity (2)
- anti-inflammatory nutrition (2)
- anti-oxidant activity (2)
- anti-oxidative capacity (2)
- anxiety-like behavior (2)
- apoptosis (2)
- appetite (2)
- ascorbate (2)
- atherosclerosis (2)
- autophagy (2)
- base excision repair (incision activity) (2)
- batch process (2)
- behavior (2)
- benzylic alcohol (2)
- benzylischer Alkohol (2)
- binding (2)
- biological pest control (2)
- birth weight (2)
- bisphosphonates (2)
- bitter (2)
- bitter taste receptors (2)
- blood pressure (2)
- body weight gain (2)
- botulinum toxin (2)
- bound phenolic compounds (2)
- brain insulin signaling (2)
- c. elegans (2)
- calcination (2)
- calcium (2)
- cancer cachexia (2)
- cancer chemoprevention (2)
- cancer epidemiology (2)
- cardiovascular diseases (2)
- carotenoid (2)
- carotenoid biosynthesis (2)
- cellular bioimaging (2)
- cerami-des (2)
- ceramides (2)
- cereal meals (2)
- chaperones (2)
- chronic fatigue (2)
- chronic psychosocial stress (2)
- chronic subordinate colony housing (CSC) (2)
- chronisch-entzündliche Darmerkrankungen (2)
- circadian clock (2)
- clusterin (2)
- coenzyme-a (2)
- coffee (2)
- colon carcinogenesis (2)
- continuous process (2)
- copper-related disorders (2)
- copy number analyses (2)
- coronary heart disease (2)
- cortisol (2)
- cyclooxygenase (2)
- cysteine alkylation (2)
- cytokine (2)
- depressive-like behavior (2)
- design of experiment (2)
- determinants (2)
- diabetes mellitus (2)
- dietary patterns (2)
- dietary restriction (2)
- digestive enzymes quantification (2)
- dogs (2)
- dormancy (2)
- drug delivery (2)
- eNOS (2)
- eicosanoids (2)
- endothelin (2)
- endurance exercise (2)
- energy homeostasis (2)
- energy-metabolism (2)
- enzymology (2)
- equine (2)
- erythropoiesis (2)
- ethanol (2)
- exercise (2)
- exposome (2)
- exposome‐ wide association study (2)
- expression (2)
- extraction (2)
- fatigue reduction diet (2)
- fatty liver (2)
- feeding (2)
- fermentation (2)
- fetal origins hypothesis (2)
- fetal programming (2)
- flavonoid (2)
- flavonoids (2)
- flower buds (2)
- food frequency questionnaire (2)
- force-field (2)
- forebrain (2)
- fractionation (2)
- fruit (2)
- functional inhibitors of acid sphin-gomyelinase (2)
- gene expression (2)
- genetically modified BoNT (2)
- glomerular filtration rate (2)
- glucagon (2)
- glucose (2)
- glucose intolerance (2)
- glucosinolates (2)
- glutathione (2)
- glycaemic control (2)
- growth behavior (2)
- growth restriction (2)
- gwas (2)
- hallervorden-spatz-syndrome (2)
- halophytes (2)
- hepatic steatosis (2)
- high protein diet (2)
- homologous recombination deficiency (2)
- homology-directed repair (2)
- hsp-70 (2)
- human excised skin (2)
- hydrolysis (2)
- hypertension (2)
- immunology (2)
- in vitro intestinal model (2)
- insulin signaling (2)
- insulin-resistance (2)
- interleukin-8 (2)
- intestinal microbiota (2)
- intestinal mucins (2)
- intestinal zinc resorption (2)
- ion-exchange chromatography (2)
- keratinocytes (2)
- kidney (2)
- kupffer cells (2)
- laboratory mice (2)
- laminitis (2)
- later health (2)
- legumes (2)
- leptin (2)
- life-span (2)
- lipid peroxidation (2)
- liver fibrosis (2)
- loci (2)
- low birth weight (2)
- lung infection (2)
- lymphoma (2)
- lysosomal hydrolases (2)
- lysosome (2)
- maintenance of genomic integrity (2)
- mass index (2)
- meal timing (2)
- melatonin (2)
- membrane fusion (2)
- menadione (2)
- mercapturic acid (2)
- meta-analysis (2)
- metabolic cage (2)
- metabolic disorders (2)
- metabolic stress (2)
- metabolic syndrom (2)
- method comparison (2)
- methylmercury (2)
- mice lacking (2)
- microarray (2)
- microcomputed tomography (2)
- microvascular complications (2)
- microwave assisted digestion (2)
- middle adulthood (2)
- mitochondria homeostasis (2)
- mitochondrial function (2)
- mobility-mass spectrometry (2)
- monensin (2)
- monitoring (2)
- mouse (2)
- mucus layer (2)
- multiple-pest infestation (2)
- muscarinic acetylcholine receptor (2)
- myalgic encephalomyelitis (2)
- myocardial infarction (2)
- myopathy (2)
- n-acetyl-cysteine (2)
- nanogels (2)
- nanoparticles (2)
- nanotoxicology (2)
- native American ancestry (2)
- neurotoxins (2)
- nitric oxide (2)
- non-alcoholic fatty liver disease (NAFLD) (2)
- nonalcoholic steatohepatthis (2)
- nut allergenic proteins (2)
- nutrient transport (2)
- nutrients (2)
- nutritional characteristics (2)
- nuts (2)
- odd chain fatty acids (2)
- offspring (2)
- older persons (2)
- organic compounds adsorption (2)
- parchment (2)
- particle characterization (2)
- patterns (2)
- pea (2)
- peptide biomarkers (2)
- peptides markers (2)
- phagocytosis (2)
- phenolics (2)
- physical activity (2)
- pink1 (2)
- plasma measurements (2)
- platelets (2)
- pneumonia (2)
- poly(ADP-ribosyl)ation (2)
- polyenoic fatty acids (2)
- population-specific risk marker (2)
- prediction (2)
- proliferation (2)
- prospective study (2)
- prostaglandins (2)
- protein extraction (2)
- proteomic analysis (2)
- proteomics (2)
- provitamin A (2)
- purification (2)
- rapid test kit (2)
- rat (2)
- rat hepatocytes (2)
- redox regulation (2)
- redox-metabolites (2)
- reducing agents (2)
- relative quantification (2)
- reliability (2)
- renal disease (2)
- repetitive elements (2)
- replacement (2)
- reversed-phase chromatography (2)
- risk (2)
- rotes Fleisch (2)
- s-glutathionylation (2)
- saline agriculture (2)
- salt (2)
- secondary plant metabolites (2)
- seeds (2)
- selenite (2)
- selenoneine (2)
- selenoproteins (2)
- serine palmitoyltransferase (2)
- serum (2)
- sex (2)
- signal transduction (2)
- size (2)
- skeletal muscle (2)
- skin penetration (2)
- sorghum (2)
- soy protein (2)
- spent coffee grounds (2)
- sphingolipid de novo synthesis (2)
- sphingolipid metabolism (2)
- sphingosine kinase (2)
- stable-isotope labeling (2)
- status markers (2)
- stroke (2)
- suppress VLDL secretion (2)
- tacrolimus formulation (2)
- targeted proteomics (2)
- tetanus toxin (2)
- tight junction (2)
- tritrophic system (2)
- tryptic digestion (2)
- ultra-high performance liquid chromatography-mass spectrometry (UHPLC-MS) (2)
- ungeradkettige Fettsäuren (2)
- validity (2)
- valorization (2)
- variants (2)
- veterinary drugs (2)
- vicious cycle (2)
- visfatin (2)
- voltage-dependent calcium channels (2)
- weight gain (2)
- wheat cultivars (2)
- zinc binding (2)
- (2E)-Hexadecenal (1)
- (2E)-hexadecenal (1)
- (2E)-hexadecenoic acid (1)
- (9Z)-neoxanthin (1)
- 1-Methoxy-3-indolylmethyl glucosinolate (1)
- 1-Phenylethanol (1)
- 1-hydroxy methyl pyrene (1)
- 1-hydroxymethylpyrene (1)
- 1-phosphate (1)
- 11 beta-hydroxysteroid dehydrogenase 2 (1)
- 2-Phenylethanol (1)
- 20S (1)
- 20S proteasome (1)
- 25-OH vitamin D (1)
- 2D-LC-MS/MS (1)
- 2k1c renovascular hypertension (1)
- 3,4-didehydroretinol (1)
- 3,5-Dimethoxytoluene (1)
- 3-Methylhistidin (1)
- 3-methylhistidine (1)
- 3D breast cell model (1)
- 3D tissue model (1)
- 4-HNE (1)
- 5-gliadin (1)
- 5/6 nephrectomy (1)
- 6-Shogaol (1)
- 6-shogaol (1)
- 7 macrophages (1)
- ACE I/D polymorphism (1)
- ACE inhibitors (1)
- ADPKD (1)
- AGE (1)
- AMPK (1)
- AOAC (1)
- APC (1)
- APOM protein (1)
- ARB (1)
- ARPE-19 cells (1)
- ASI-3 (1)
- Abrus precatorius (1)
- Acute coronary syndrome (1)
- Acute renal failure (1)
- Adioponectin (1)
- Adipocytes (1)
- Adipozyt (1)
- Adult height (1)
- Advanced fetal programming hypothesis (1)
- Advanced glycation end products (1)
- Advanced glycation end-products (1)
- Advanced glycation endproducts (1)
- Aflatoxin B1 (1)
- Age (1)
- Agonisteninteraktion (1)
- Akkermansia muciniphila (1)
- Akt (1)
- Akt signaling (1)
- Akt/PKB (1)
- Aktivkohle (1)
- Alcohol dependence (1)
- Aldehyddehydrogenase (1)
- Alkohol (1)
- Alkoholdehydrogenase (1)
- Alkoholkonsum (1)
- Allantoin (1)
- Allergenic food (1)
- Allicin (1)
- Alltagsbedingungen (1)
- Allyl isothiocyanate (1)
- Alpine metamorphism (1)
- Alter (1)
- Alternative to animal testing (1)
- Alternativmethoden (1)
- Alveolar epithelial cells (1)
- Amaranth (1)
- Amaranthaceae (1)
- Anaphylatoxin (1)
- Anaphylaxie (1)
- Anatomy (1)
- Angiotensin converting enzyme inhibitor (1)
- Animal (1)
- Ankle-brachial index (1)
- Anorexia (1)
- Antibacterial (1)
- Antibeschlag-Additive (1)
- Antibiotics (1)
- Antibiotikaresistenz (1)
- Antifouling (1)
- Antimicrobial drugs (1)
- Antioxidant capacity (1)
- Antioxidants (1)
- Anxiety (1)
- Anxiety Sensitivity Index (1)
- Aortic valve (1)
- Apgar score (1)
- Apple polyphenoloxidase (1)
- Arabica Kaffeebohnen (1)
- Arbuscularmycorrhizal fungi (1)
- Arsenic speciation (1)
- Arsenite (1)
- Arsenolipid (1)
- Arsenosugar (1)
- Aryl-hydrocarbon receptor (1)
- Asian subjects (1)
- Aspergillus (1)
- Aspirin (1)
- Assay High-resolution mass spectrometry (1)
- Assay hochauflösende Massenspektrometrie (1)
- Assays (1)
- Astrocytes (1)
- Astrozyten (1)
- Atemwegserkrankungen (1)
- Atherosclerosis (1)
- Athletes (1)
- Augmentation (1)
- Ausdauerleistung (1)
- Autophagie Lysosomale System (1)
- Autotaxin (1)
- B cells (1)
- B-phycoerythrin (1)
- BALB/c-3T3 cells (1)
- BBsome (1)
- BIOCROSS (1)
- BMP4 (1)
- BPA (1)
- BRAF (1)
- Baked products (1)
- Ballaststoffe (1)
- Barriere (1)
- Bbs4 (1)
- Be-10 dating (1)
- Beef (1)
- Benzylisothiocyanat (1)
- Beryllium (1)
- Beta-Oxidation (1)
- Beta-Oxydation (1)
- Beta-Zelle (1)
- Beta-amylase (1)
- Beta-lactoglobulin (1)
- BfR MEAL Study (1)
- Bifidobacterium (1)
- Bile Acids (1)
- Bioaktivität (1)
- Biochemical analysis (1)
- Biocompatibility (1)
- Biological Assay (1)
- Biomarkers (1)
- Bioreactor (1)
- Biotransformation (1)
- Bioverfügbarkeit (1)
- Biparietal diameter (1)
- Birds of prey (1)
- Bisphenol A (1)
- Bitter (1)
- Bittergeschmacksrezeptoren (1)
- Bitterrezeptoren (1)
- Blood flow resistance (1)
- Blood platelets (1)
- Blood protein adducts (1)
- Blood-cerebrospinal fluid barrier (1)
- Blood-liquor barrier (1)
- Blut-Hirn-Schranke (1)
- Body composition (1)
- Body weight (1)
- Body-Mass-Index (1)
- Botulinumtoxine (1)
- Brain development (1)
- Brassica (1)
- Brassica carinata (1)
- Brassica oleracea var. sabellica (1)
- Brassica rapa ssp. chinensis (1)
- Brassica vegetables (1)
- Brassicaceae (1)
- Breast cancer (1)
- Brood size (1)
- Brown adipose tissue (1)
- Brustkrebs (1)
- CAR (1)
- CD, DLS (1)
- CEHC (1)
- CKD (1)
- CLEM (1)
- COPD (1)
- CRC (1)
- CRISPR/Cas9 (1)
- CXCL10 (1)
- CXCR2 (1)
- CYP3A4 (1)
- Cachexia (1)
- Calculated free 25-hydroxyvitamin D (1)
- Calorimetry (1)
- Cameroon (1)
- Cancer prevention (1)
- Cannabidiol (CBD) (1)
- Cardiac function (1)
- Cardiac ischemia/reperfusion (1)
- Cardiac rehabilitation (1)
- Cardiovascular (1)
- Cardiovascular effects (1)
- Carobballaststoff (1)
- Carotene supplementation (1)
- Case-control study (1)
- Casein (1)
- Catabolism (1)
- Catechin (1)
- Catechins (1)
- Catecholamine (1)
- Cell culture materials (1)
- Cell proliferation (1)
- Cellular bioavailability (1)
- Cellular damage response (1)
- Cellular uptake (1)
- Cellulose acetate phthalate (1)
- Cerebellum (1)
- Chad (1)
- Chaperone (1)
- Chemerin (1)
- Chemotherapy resistance (1)
- Childhood nephrotic syndrome (1)
- Chlorogensäure (1)
- Chlorophyllide a oxygenase (1)
- Chlorophylls (1)
- Chloroplast (1)
- Cholesterol (1)
- Chronic diseases (1)
- Chronic kidney disease (1)
- Chylomicron (1)
- Claudin-4 (1)
- Clinical study (1)
- Clinical trials (1)
- Clostridium difficile (1)
- Coagulation (1)
- Cognition (1)
- Colitis (1)
- Colitis ulcerosa (1)
- Collagen (1)
- Colon cancer (1)
- Colonic microbiota (1)
- Colonkanzerogenese (1)
- Colorectal cancer (1)
- Colorectal carcinomas (1)
- Comet assay (1)
- Complement system (1)
- Complications in diabetes (1)
- Confluence (1)
- Connective tissue growth factor (1)
- Contaminants (1)
- Contamination (1)
- Contrast induced acute kidney injury (1)
- Control region (1)
- Core-multishell nanocarriers (1)
- Coronary angiography (1)
- Corticotropin-Releasing Factor Receptor Type 1 (1)
- Corticotropin-Releasing Factor Rezeptor Typ 1 (1)
- Cortisol Maternal cortisol (1)
- Cortisol vertical bar metabolism (1)
- Costs (1)
- Covalent modification (1)
- Coxsackie and Adenovirus Receptor (1)
- Coxsackie- und Adenovirus Rezeptor (1)
- Crop quality (1)
- Cross-sectional studies (1)
- Cu NP-incorporated MI-dPG coating (1)
- CuNPs (1)
- Cyp2b1 (1)
- Cyp3a11 (1)
- CypP450 (1)
- Cystic fibrosis (1)
- Cytokines (1)
- D3 cells (1)
- D3-Zellen (1)
- DAF-16 (1)
- DAF-16 transcription factor (1)
- DAIH (1)
- DASH study (1)
- DASH-Studie (1)
- DDP-4 inhibition (1)
- DNA integrity (1)
- DNA-Addukte (1)
- DNA-Reparatur (1)
- DNMT inhibitor (1)
- DNMT1 (1)
- DPP-4 inhibition (1)
- DPP-4 inhibitor (1)
- DPP-IV inhibitor (1)
- DPP4 (1)
- DPP4 inhibition (1)
- DPP4 inhibitor (1)
- Dairy biomarkers (1)
- Darmbakterien (1)
- Darmbakterium (1)
- Darmerkrankung (1)
- Darmkrebs (1)
- Darmkrebsdiagnostik (1)
- Darmlänge (1)
- Daucus (1)
- Decontamination (1)
- Delinquency (1)
- Demographic transitions (1)
- Dendritic cells (1)
- Dendritic core-multishell nanocarriers (1)
- Dengue (1)
- Depression (1)
- Derivatisation (1)
- Derivatization (1)
- Dermal delivery (1)
- Dermal drug delivery (1)
- Desensibilisierung (1)
- Determinants (1)
- Developmental programming (1)
- Diabetes incidence (1)
- Diabetes mellitus Typ 2 (1)
- Diabetes-related vascular complications (1)
- Diabetic cardiomyopathy (1)
- Diacylglycerol (DAG) (1)
- Diagnostic (1)
- Diallyl disulfide (1)
- Diarrhoea (1)
- Dichlorofluorescein assay (1)
- Dickdarmkanzerogenese (1)
- Dickdarmkrebs (1)
- Dietary Fibre (1)
- Dietary compliance (1)
- Dietary fat composition (1)
- Dietary fat replacement (1)
- Dietary sulfonates (1)
- Differential Gene Expression (1)
- Differenzierungsassay (1)
- Dipeptidyl peptidase 4 inhibitor (1)
- Dipeptidyl peptidase IV (1)
- Dipeptidyl peptidase-4 inhibition (1)
- Dipeptidylpeptidase-4 (1)
- Disease (1)
- Distal tubules (1)
- Diät (1)
- Dog growth (1)
- Dogs (1)
- Dolichol lipids (1)
- Domestic cat (1)
- Domestic cooking (1)
- Dopaminergic neurons (1)
- Dopaminergic system (1)
- Drug delivery systems (1)
- Drug metabolism (1)
- E. coli (1)
- EBI3 (1)
- EDC (1)
- ENaC (1)
- EPIC-Potsdam study (1)
- ER stress (1)
- ER-stress (1)
- EST (1)
- ETA (1)
- ETB (1)
- ETB receptor-deficient mouse (1)
- Edible insects (1)
- Eicosanoid (1)
- Electrochemistry (1)
- Electron paramagnetic resonance spectroscopy (1)
- Elektrochemie (1)
- Elemental blood serum concentration (1)
- Ellagsäure (1)
- Embryonaler Stammzelltest (EST) (1)
- Emulsifying properties (1)
- Enantio-selective reduction (1)
- Endocannabinoide (1)
- Endocrine disruption (1)
- Endodormancy (1)
- Endosomal sorting (1)
- Endothelfunktion (1)
- Endothelial dysfunction (1)
- Endothelial nitric oxide synthase (1)
- Endothelin receptor antagonists (1)
- Endothelin-1 transgenic mice (1)
- Endothelzelle (1)
- Energiehaushalt (1)
- Energy expenditure (1)
- Energy intake (1)
- Energy requirement (1)
- Enteric polymer (1)
- Enterolignanen (1)
- Enterolignans (1)
- Environmental (1)
- Enzyme (1)
- Epigallocatechingallat (1)
- Epigenetic (1)
- Epigenetik (1)
- Epstein-Barr Virus-induziertes Gen 3 (1)
- Equine metabolic syndrome (1)
- Equines (1)
- Equol (1)
- Erdnussallergie (1)
- Ernährungsmuster (1)
- Erosion kinetics (1)
- Escherichia coli (1)
- Et-1 (1)
- Ethyl cellulose (1)
- Eudragit (R) (1)
- Eudragit (R) RS (1)
- Eudragit L 100 (1)
- Euphorbia mauritanica (1)
- Euphorbiaceae (1)
- Europe (1)
- Evaluation tool (1)
- Evidence-based guideline (1)
- Excretion (1)
- Exercise tests (1)
- Experimental autoimmune encephalomyelitis (EAE) (1)
- Experimental study (1)
- Exploration (1)
- Extraction (1)
- Extrudate (1)
- FASN (1)
- FISH (1)
- FOXO1 (1)
- FVB/NJ Maus (1)
- FVB/NJ mouse (1)
- Fabaceae (1)
- Factor-Xa (1)
- Faecal bacteria (1)
- Farber disease (1)
- Fast and slow fibers (1)
- Fat infiltration in muscle (1)
- Fat-free mass (1)
- Fattening pigs (1)
- Fatty acid hydroperoxides (1)
- Fetal development (1)
- Fettinfiltration im Muskel (1)
- Fettleibigkeit (1)
- Fettsucht (1)
- Fettwahrnehmung (1)
- Fettzelle (1)
- Fetuin-A (1)
- Fibroblast growth factor 21 (1)
- Fibrosis (1)
- Fingolimod (1)
- Firefly luciferase inhibition (1)
- First trimester (1)
- Flavonoid glycosides (1)
- Flavonoide (1)
- Flavonoids (1)
- Floral scent compound (1)
- Flowering (1)
- Fluorescence lifetime imaging microscopy (1)
- Fluorescence screening (1)
- Foal (1)
- Foaming properties (1)
- Folientunnel (1)
- Food (1)
- Food Chain (1)
- Food analysis (1)
- Food authentication (1)
- Food choice (1)
- Food composition (1)
- Food labelling (1)
- Food safety (1)
- Food-exchange model (1)
- Forensic science (1)
- Formyl-Peptid Rezeptor 2 (1)
- Forster resonance energy transfer (FRET) (1)
- Frailty (1)
- Frailty criteria (1)
- Frataxin (1)
- Free radicals (1)
- Free vitamin D (1)
- Freeze-fracturing (1)
- Fremdstoffmetabolismus (1)
- Fruits (1)
- Functionality (1)
- Furosemide (1)
- G protein-coupled receptors (1)
- G-Protein gekoppelte Rezeptoren (1)
- G-Protein-gekoppelte Rezeptoren (1)
- G-protein coupled receptors (1)
- GADD45A and GADD45G (1)
- GC gene (1)
- GC-MS (1)
- GC-globulin (1)
- GLP-1 (1)
- GLUT1 XbaI gene polymorphism (1)
- GLUT8 (1)
- GOAT (1)
- GPCR (1)
- GPX (1)
- GPx2 (1)
- Gallensäuren (1)
- Gallensäurenbindung (1)
- Garlic (1)
- Gastrointestinal tract (1)
- Gehirn (1)
- Gene Array (1)
- Gene Chip (1)
- Gene expression (1)
- Gene polymorphism (1)
- Genetics (1)
- Genetik (1)
- Genexpression (1)
- Genexpressionsanalysen (qRT-PCR) (1)
- Geriatric patients (1)
- Gerontologie (1)
- Geschlecht (1)
- Geschmacksrezeptor (1)
- Getränkeauswahl (1)
- Getränkeautomat (1)
- Gewicht (1)
- Gewichtserhalt (1)
- Gewichtsreduktion (1)
- Gewichtsverlust (1)
- Ghrelin (1)
- Gliadin and glutenin fractions (1)
- Global (1)
- Glp1r(-/-) mice (1)
- Glucocorticoid receptor (1)
- Glucose intolerance (1)
- Glucose metabolism disorders (1)
- Glucose tolerance (1)
- Glucosehomöostase (1)
- Glucosetransport (1)
- Glucosinolate breakdown product (1)
- Glukoseintoleranz (1)
- Glukosestoffwechselstörungen (1)
- Glukosinolaten (1)
- Glutathion-Peroxidase (1)
- Glutathione (1)
- Gluten (1)
- Glycation (1)
- Glycemia (1)
- Glycerophospholipids (1)
- Grave’s orbitopathy (1)
- Grüner Tee (1)
- Gut microbiota (1)
- HAMP (1)
- HNRNPA1 (1)
- HOG (1)
- HOMA (1)
- HPLC-ESI-QTOF (1)
- HPLC/HR-ESMS (1)
- HPLC/ICPMS (1)
- HPMCP (1)
- HSD11B2[CA]n polymorphism (1)
- HSP70 (1)
- HaCaT cells (1)
- Hafer (1)
- Halophyten (1)
- Hautmodell (1)
- Head circumference (1)
- Health care expenditure (1)
- Health-promoting compounds (1)
- Heart failure (1)
- Heart weight (1)
- Heat aggregation (1)
- Heat shock protein 90 (1)
- Heat shock proteins (1)
- Heavy metals (1)
- Heme (1)
- Hepatic artery (1)
- Hepatic glucose balance (1)
- Hepatic hemodynamics (1)
- Hepatic insulin resistance (1)
- Hepatic lactate balance (1)
- Hepatic nerve (1)
- Hepatic stellate cells (1)
- Hepatocyte (rat) (1)
- Hepatotoxicity (1)
- Hepatotoxizität (1)
- Herd size (1)
- Herd type (1)
- Heritabilität (1)
- Herzinfarkt (1)
- Herzkreislauferkrankungen (1)
- Heterocyclic aromatic amines (1)
- Heterogeneity (1)
- High pressure - low temperature treatments (1)
- High resolution microscopy (1)
- High-resolution mass spectrometry (1)
- High-salt diet (1)
- Histologie (1)
- Hoch-Protein Diät (1)
- Hochfettdiät (1)
- Homocystein (1)
- Homologiemodellierung (1)
- Honey (1)
- Honeydew honey (1)
- Hormone (1)
- Hormonersatztherapie (1)
- Hormones (1)
- Horse (1)
- Host-plant suitability (1)
- Human (1)
- Human differentiated neurons (1)
- Human nutritional intervention (1)
- Hungerhormon (1)
- Hydroxycinnamic acids (1)
- Hydroxymethylfurfural (1)
- Hydroxymethylpyren (1)
- Hyperglycaemia (1)
- Hypertonie (1)
- Hyphenated techniques (1)
- Hypoxia (1)
- IBD (1)
- ICP-MS (1)
- ICP-QQQ-MS (1)
- IDH1 (1)
- IRAK (1)
- IgE (1)
- Imiquimod (1)
- Immediate-early-Gen (1)
- Immunhistochemie (1)
- Inactivation (1)
- Indigenous African leafy vegetables (1)
- Indole (1)
- Indoor farming (1)
- Induced pluripotent stem cells (1)
- Inductively (1)
- Inductively coupled plasma mass spectrometry (1)
- Infarct size (1)
- Inflammaging (1)
- Inflammatory skin disease (1)
- Influenza virus (1)
- Inhalation (1)
- Inorganic mercury (1)
- Insulin sensitivity (1)
- Insulin signaling (1)
- Insulin signalling (1)
- Insulin-induzierte Hypoglykämie (1)
- Insulinsekretion (1)
- Insulinsensitivität (1)
- Interactome (1)
- Intergenerational effects (1)
- Interleukin-1 (1)
- Intestinal absorption (1)
- Intimahyperplasie (1)
- Intimal Hyperplasia (1)
- Intraperitoneal administration (1)
- Iodization (1)
- Ischemia/reperfusion (1)
- Isoprostane (1)
- Isotope ratios (1)
- Isotope-dilution (1)
- Isotope-dilution analysis (1)
- Ivy (1)
- IκB (1)
- Jod (1)
- K-RAS (1)
- K-ras (1)
- Kachexie (1)
- Kaede (1)
- Kaffeenebenprodukte (1)
- Kaffeeproteine (1)
- Kaffeeverarbeitung (1)
- Kalorienrestriktion (1)
- Kalzium (1)
- Kanzerogenese (1)
- Kardiovaskuläre Erkrankungen (1)
- Kardiovaskuläre Krankheit (1)
- Katalase (1)
- Kernrezeptor (1)
- Kidney weight (1)
- Kinetik (1)
- Knock-out (1)
- Kokultur (1)
- Kolokalisation (1)
- Kolonkrebs (1)
- Konsum (1)
- Kontaktallergie (1)
- Kontrollierte klinische Studie (1)
- Kopfsalat (1)
- Kosakonia radicincitans (1)
- Krebs (1)
- Kunststoff-Additive (1)
- Kupfer (1)
- Kupfferzellen (1)
- Kurzkettige Fettsäuren (1)
- Kynurenine (1)
- Körperfett (1)
- Körpergewichsterhalt (1)
- Körpergewicht (1)
- Körpergewichtsregulation (1)
- Körpergewichtsverlust (1)
- Körpermasse (1)
- LC (1)
- LC-MS (1)
- LC-MS-MS (1)
- LC/MS/MS (1)
- LC/MS/MS; Quantification of allergenic plant traces (1)
- LEDs (1)
- LNA- clamp-PCR (1)
- LNA-clamp-PCR (1)
- LPA(3) receptor subtype (1)
- LRP8 (1)
- Labormäuse (1)
- Langerhans Zellen (1)
- Langerhans cells (1)
- Lebensmittelkette (1)
- Leg length (1)
- Legume (1)
- Lemna paucicostata (1)
- Life science (1)
- Light quality (1)
- Lignan-converting bacteria (1)
- Lignan-umwandelnde Bakterien (1)
- Lipase (1)
- Lipasen (1)
- Lipid (1)
- Lipid droplet proteome (1)
- Lipidstoffwechsel (1)
- Lipolysis (1)
- Liquid chromatography-tandem mass spectrometry (1)
- Liquid-liquid extraction (1)
- Lithiumion battery (LIB) (1)
- Liver fat (1)
- Liver fibrosis (1)
- Liver injury (1)
- Long term health (1)
- Long-term cellular toxicity (1)
- Loop diuretics (1)
- Low birth weight (1)
- Low lean mass (1)
- Low muscle mass (1)
- Lu-Hf geochronology (1)
- Lupin (1)
- Lutein (1)
- Lutein ester (1)
- Luteinester (1)
- Lysophosphatidic acid (1)
- Lysophosphatidylcholines (1)
- MCHR-1 (1)
- MCT oil (1)
- MMF (1)
- MS quantification of leguminous additives (1)
- MSCs (1)
- MUFA (1)
- Macrovascular (1)
- Major adverse kidney event (1)
- Major royal jelly proteins (1)
- Mangan (1)
- Manganese . C. elegans (1)
- Manganism (1)
- Marker (1)
- Marker peptides (1)
- Massenspektrometrie (1)
- Mauritanicain (1)
- Measured free 25-hydroxyvitamin D (1)
- Meat peptide biomarker (1)
- Mediationsanalyse (1)
- Mediterranean Diet (1)
- Medizinprodukt (1)
- Membrane (1)
- Menderes Massif (1)
- Mesoangioblasts (1)
- Meta-analyses (1)
- Metabolically benign (1)
- Metabolism (1)
- Metabolismus (1)
- Metabolom (1)
- Metabolome analysis (1)
- Metals (1)
- Methicillin resistant Staphylococcus aureus (1)
- Method (1)
- Methylation (1)
- Methylglyoxal (1)
- MiSpEx* (1)
- Mice (1)
- Micellar caseins (1)
- MicroRNA (1)
- MicroRNAs (1)
- Microbial degradation (1)
- Microbiome (1)
- Microdialysis (1)
- Microelements (1)
- Microsatellite instability (1)
- Microsomal (1)
- Microvascular complications (1)
- Migration (1)
- Mikrobiologie (1)
- Mikrobiota (1)
- Mikronährstoffe (1)
- Mikrosomal (1)
- Milcheinnahme (1)
- Mitochondrial respiration (1)
- Mitohormesis (1)
- Mixed lymphocyte culture (MLC) (1)
- Model (1)
- Modell (1)
- Modelling (1)
- Molecular cloning and expression (1)
- Molecular structure (1)
- Molkenproteine (1)
- Monocyte (1)
- Moringa oleifera (1)
- Morphogenesis (1)
- Mortalität (1)
- Motor coordination (1)
- Motor neurons (1)
- Motorneurone (1)
- Multi-Methods (1)
- Multi-method (1)
- Multi-mycotoxin analysis (1)
- Multi-resistant bacteria (1)
- Multiple herbivory (1)
- Multiple sclerosis (1)
- Multiplex platforms (1)
- Muskelproteinumsatz (1)
- Muskelschwund (1)
- Mussel-inspired coating (1)
- Mycobacterium tuberculosis (1)
- Myoblasts (1)
- Myocardial infarction (1)
- Myocardial ischemia (1)
- Myofibroblasten (1)
- Myogenic differentiation (1)
- Myoglobin (1)
- Myrrhe (1)
- Myzus persicae (1)
- NAD booster; (1)
- NAD+ (1)
- NF-?B (1)
- NF-kB (1)
- NF-kappa B (1)
- NF-κB (1)
- NF1 (1)
- NMR-based metabolomics (1)
- NR3C1 gene (1)
- Nachkommen (1)
- Nahrung der Zukunft (1)
- Nahrungsbestandteile (1)
- Nahrungsfette (1)
- Nahrungsmittelallergie (1)
- Nahrunsgergänzungsmittel (1)
- Nanoparticle uptake (1)
- Nanoparticles (1)
- Nanotoxicology (1)
- Natriuretic peptides (1)
- Neisseria gonorrhoeae (1)
- Neoglucobrassicin (1)
- Neointima (1)
- Nephropathie (1)
- Nephropathy (1)
- Netzwerke (1)
- Neurodegeneration (1)
- Neurodevelopmental toxicity (1)
- Neurone (1)
- Neuronen (1)
- Neurons (1)
- Neuropathie (1)
- Neuropathy (1)
- Neuropeptides (1)
- Neutral lipids (1)
- New World camelids (1)
- Nif2 (1)
- Non-esterified fatty acids (NEFA) (1)
- Nordic diet (1)
- Novelose (1)
- Nuclear receptor (1)
- Nucleus tractus solitarii (1)
- Nukleosidaddukt (1)
- NutriAct family study (1)
- Nutrient stress (1)
- Nutrition-related diseases (1)
- Nutritional counseling (1)
- OCFA (1)
- Oats (1)
- Occurrence data (1)
- Ocular delivery (1)
- Odorant compounds (1)
- Offending (1)
- Offspring (1)
- Oligomere (1)
- Olivenöl (1)
- Omega-3 Fettsäuren (1)
- Omega-Hydroxylation (1)
- Omega-Hydroxylierung (1)
- Oncogenes (1)
- Ontogenetic development (1)
- Ontogeny (1)
- Optogenetik (1)
- Organic and conventional type of production (1)
- Organic arsenic (1)
- Organic carbonates (1)
- Organic mercury (1)
- Osteogenesis (1)
- Other livestock (1)
- Outcome (1)
- Oxidativer Stress (1)
- Oxidized proteins (1)
- OxyR (1)
- Oxylipin (1)
- Oxylipins (1)
- PARP (1)
- PBCEC (1)
- PBPK (1)
- PBTK (1)
- PCR-DHPLC (1)
- PCaaC38:6 (1)
- PGC1 alpha (1)
- PGC1a (1)
- PHGPx (1)
- PKM2 (1)
- PPARalpha (1)
- PRM/Alf Maus (1)
- PRM/Alf mouse (1)
- PTEN (1)
- Pancreatic cells (1)
- Pannexin 1 (1)
- Parenthood (1)
- Paternal exposure (1)
- Paternal programming; (1)
- Paternal, maternal, sex differences (1)
- Pea flour (1)
- Pea protein isolate (1)
- Peptides (1)
- Perfusion (1)
- Permeability (1)
- Peroxidatic and resolving cysteine (1)
- Peroxiredoxin (1)
- Peroxynitrite (1)
- Personalised medicine (1)
- Pest infestation (1)
- Pest-pest interaction (1)
- Pflanzliches Lignan (1)
- PhIP (1)
- Pharbitis nil cv. Violet (1)
- Pharmacokinetics (1)
- Phase II Enzyme (1)
- Phenol-amino-adducts (1)
- Phosphatidylcholines (1)
- Phosphatidylinositols (1)
- Phosphoenolpyruvate carboxykinase (1)
- Phospholipids (1)
- Photosynthesis (1)
- Physical activity (1)
- Physicochemical properties (1)
- Physiologie (1)
- Pig (1)
- Pilot-Studie (1)
- PlGF (1)
- Plant allergen (soy, sesame, lupine) (1)
- Plant authentication (1)
- Plant growth promoting bacteria (1)
- Plant lignan (1)
- Plasma (1)
- Plasma concentration (1)
- Plasmalogens (1)
- Platelets (1)
- Polyamine (1)
- Polymeric nanoparticle (1)
- Polymeric nanoparticles (1)
- Polyphenols (1)
- Polyubiquitination (1)
- Ponderostat (1)
- Pooling analysis (1)
- Portal vein (1)
- Post-translational modifications (1)
- Post-translational protein modification (1)
- Postharvest processing (1)
- Preadipozyt (1)
- Precision medicine (1)
- Precision prognostics (1)
- Preeclampsia (1)
- Pregnane X Receptor (1)
- Preinterventional biomarker (1)
- Presystemic metabolism (1)
- Preterm birth (1)
- Preterm delivery (1)
- Primary care (1)
- Principal component analysis (1)
- Probiotika (1)
- Procyanidins (1)
- Proliferation (1)
- Prostaglandin (1)
- Prostaglandin E₂ (1)
- Prostaglandin receptor (1)
- Prostaglandin receptor EP4 (1)
- Prostaglandine (1)
- Proteasomal system (1)
- Proteasome and lysosome (1)
- Protein (1)
- Protein Modifizierung (1)
- Protein aggregates (1)
- Protein functionality and modification (1)
- Protein intake (1)
- Protein-Wechselwirkungen (1)
- Proteine (1)
- Proteinmodifizierung (1)
- Proteolysis (1)
- Proteome (1)
- Proteostase (1)
- Proteostasis (1)
- Prävention (1)
- Pseudomonas aeruginosa (1)
- Psoriasis (1)
- Pulmonary arterial hypertension (1)
- Pulse wave velocity (1)
- Punktmutation (1)
- Purification (1)
- Pyrrolizidine alkaloids (1)
- QSAR (1)
- QTL (1)
- Quality appraisal (1)
- Quantification of peptides (1)
- Quercetin (1)
- RAW 264 (1)
- RBP (1)
- RNA Sequencing (1)
- RNA Sequenzierung (1)
- ROS (1)
- Radiocontrast media-induced nephropathy (1)
- Raman spectroscopy (1)
- Rat (1)
- Ratte (1)
- Rauchen (1)
- Reactive Oxygen Species (1)
- Reaktive Sauerstoffspezies (1)
- Recycling (1)
- Redox (1)
- Redox control (1)
- Redox homeostasis (1)
- Redox regulation (1)
- Reduktase (1)
- Reference intervals (1)
- Refinement (1)
- Regionality (1)
- Regulatory T cells (Treg) (1)
- Reh (1)
- Relaxin (1)
- Reliability (1)
- Renin-angiotensin system (1)
- Renin-angiotensin-aldosterone system (1)
- Reportergen-Assay (1)
- Resistance (1)
- Resistant starch (1)
- Retinoblastoma (1)
- Retinol (1)
- Retinol-Bindungsprotein 4 (1)
- Retinol-binding protein 4 (1)
- Retinopathie (1)
- Rezeptoren (1)
- Rezeptorscreening (1)
- Rheologie (1)
- Risikobewertungen (1)
- Risikoeinschätzung (1)
- Risk (1)
- Risk factor (1)
- Risk prediction (1)
- Risk prediction model (1)
- Risk score (1)
- Root exudates (1)
- Rosa x level (1)
- Rye (1)
- S1P receptors (1)
- S1P(3) receptor (1)
- SARS CoV-2 host factors (1)
- SCID mice (1)
- SEC-HPLC (1)
- SELENOH (1)
- SEM (1)
- SGK-1 (1)
- SGLT2 blocker (1)
- SNARE proteins (1)
- SREBP-1c (1)
- SSCP (1)
- ST-1071 (1)
- ST-1893 (1)
- ST-1894 (1)
- ST-968 (1)
- STED (1)
- SU5416 (1)
- SULT1A1 (1)
- SULT1A2 (1)
- SVM (1)
- Saccharomyces boulardii (1)
- Safety (1)
- Salicin (1)
- Saline Landwirtschaft (1)
- Salzgeschmack (1)
- Sarkopenie (1)
- Schilddrüse (1)
- Schilddrüsenautoimmunerkrankungen (1)
- Schlaganfall (1)
- Schwerkraft (1)
- Se-methylselenoneine (1)
- Seafood (1)
- Seasonality (1)
- Secondary metabolites (1)
- Selenonein (1)
- Selenoneine (1)
- Selenoprotein (1)
- Selenosugar 1 (1)
- Senescence (1)
- Sensorik (1)
- Serine and trypsin protease (1)
- Serotonin (1)
- Set-Point (1)
- Sex ratio at birth (1)
- Sexual dimorphism (1)
- Shan He Jian Fei Granules (SHJFG) (1)
- Short chain dehydrogenase (1)
- Short stature (1)
- Side effects (1)
- Signal transduction (1)
- Signaling pathways (1)
- Signalübertragung (1)
- Single nucleotide polymorphism (1)
- Skelettmuskel (1)
- Skelettmuskelalterung (1)
- Skin (1)
- Skin barrier disruption (1)
- Skin model (1)
- Slatted floor (1)
- Small molecules (1)
- Small selenium species (1)
- Smooth muscle cells (1)
- Sojabohne (1)
- Solanum scabrum (1)
- Speciation (1)
- Species differences (1)
- Spectrophotometry (1)
- Speichel (1)
- Spelt (1)
- Spermienmotilität (1)
- Sphingomyelin (1)
- Sphingosine 1-phosphate (S1P) (1)
- Sphingosine 1phosphate (1)
- Sphingosine kinase-1 (1)
- Sphingosine-1-phosphate lyase (1)
- Spirulina (1)
- Sport (1)
- Spurenelement (1)
- Spurenelemente (1)
- Stammzelle (1)
- Starvation (1)
- Stereotypien (1)
- Stickstoffmonoxid (1)
- Stillbirth (1)
- Stoffwechselhormone (1)
- Stoffwechselkäfig (1)
- Stroke (1)
- Stromal cell-derived factor-1 (1)
- Structural changes (1)
- Study protocol (1)
- Styrol (1)
- Substratverwertung (1)
- Sucrose (1)
- Sulfid (1)
- Sulfonate (1)
- Sulfoquinovose (1)
- Superoxiddismutase (1)
- Susceptibility-genes (1)
- Suszeptibilitätsgene (1)
- Swine (1)
- Synbiotika (1)
- Synthesis (1)
- Säugetiere ; Fettgewebe ; Zelldifferenzierung ; Genexpression (1)
- Säuglingsnahrung (1)
- Süßgeschmack (1)
- Süßrezeptor (1)
- Süßstoff (1)
- T helper 17 cells (1)
- T2D (1)
- TAVI (1)
- TEAC (1)
- TET (1)
- TFA (1)
- TGF-beta (1)
- TGF-beta 1 (1)
- TNF alpha (1)
- TRPV5 (1)
- TRPV6 (1)
- TTC (1)
- TTR (1)
- Tagetes (1)
- Tas1r1 (1)
- Tas2r (1)
- Tas2rs (1)
- Taurocholate (1)
- Tea leaves (1)
- Technique (1)
- Technofunctional properties (1)
- Teecatechin (1)
- Testicle (1)
- Tetranychus urticae (1)
- Th17 (1)
- Thai population (1)
- Thermal and nonthermal treatment (1)
- Thermal processing (1)
- Thin layer chromatography (1)
- Thio-arsenosugar-glycerol (1)
- Thio-dimethylarsinic acid (1)
- Thiol (1)
- Thiol-dependent peroxidase (1)
- Thiolmodifikation (1)
- Thioredoxin reductase (1)
- Three phase partitioning (1)
- Thrifty phenotype (1)
- Thyroid hormone (1)
- Tierarzneimittel (1)
- Tierschutz (1)
- Tight Junctions (1)
- ToF-SIMS (1)
- ToF-SIMS imaging (1)
- Tocopherol (1)
- Tocotrienol (1)
- Tocotrienols (1)
- Total arsenic (1)
- Total diet study (1)
- Toxicokinetics (1)
- Toxikokinetik (1)
- TraceAge (1)
- Trans-Fettsäuren (1)
- Trans-epoxy-fatty acid (1)
- Transactivation assay (1)
- Transcatheter Aortic Valve Implantation (1)
- Transcriptomics (1)
- Transformation product (1)
- Transformationsprodukt (1)
- Transforming Growth Factor beta (1)
- Transforming growth factor beta (1)
- Transkriptionsfaktor (1)
- Transkriptom (1)
- Transmembrane asymmetry (1)
- Transmission (1)
- Transplantation (1)
- Triglyceride secretion (1)
- Trunk length (1)
- Tumor (1)
- Tumor necrosis factor alpha (1)
- Tumour suppressor genes (1)
- Tween40 micelles (1)
- Twister (TM) (1)
- Twister TM (1)
- Typ 2 Diabetes (1)
- Type-2-diabetes (1)
- UDP-glucuronosyltransferase (1)
- UV light (1)
- Ubiquitin Proteasom System (1)
- Ulcerative colitis (1)
- Umbilical artery Doppler (1)
- Umbrella review (1)
- Uncoupling proteins (1)
- Unprepared and (1)
- Urate (1)
- Urinary ET-1 (1)
- Urine excretion (1)
- Uruguay River (1)
- VCAM-1 (1)
- VOC (1)
- Validation (1)
- Vascular stiffness (1)
- Vegan (1)
- Verhaltensstudien (1)
- Versuchstierkunde (1)
- Very low birth weight infant (1)
- Veterinary drugs (1)
- Vineatrol (R) 30 (1)
- Vitamin A supplementation (1)
- Vitamin C (1)
- Vitamin D (1)
- Vitamin D binding protein (1)
- Vitamin D deficiency (1)
- Vitamin D insufficiency (1)
- Vitamin D-binding protein (1)
- Vitellogenin (1)
- Volatile compound (1)
- WAT (1)
- WHO (1)
- Warburg effect (1)
- Water and salt retention (1)
- Weight change (1)
- Wheat (1)
- Whey proteins (1)
- Wiederkäuer (1)
- Wnt pathway (1)
- Wnt-Signalweg (1)
- World Cancer Research Fund/American Institute for Cancer Research Recommendations (1)
- Xenobesity (1)
- Y:X chromosome ratio (1)
- YB-1 (1)
- Yolk (1)
- Zellkulturen (1)
- Zelllinien (1)
- Zellproliferation (1)
- Zink (1)
- Zinypr-1 (1)
- Zirkadianer Rhythmus (1)
- Zoonoses (1)
- Zwillingsstudie (1)
- Zytokine (1)
- Zytotoxizitätsassay (1)
- [N-15]Anthranilic acid (1)
- [N-15]Indole (1)
- a-tocopherol (1)
- absorption (1)
- accretionary wedge (1)
- acetate (1)
- activity-regulated cytoskeleton-associated protein (1)
- acute inflammation (1)
- ad libitum consumption (1)
- ad libitum-Verzehr (1)
- adduct formation (1)
- adenylate-cyclase (1)
- adipocyte (1)
- advanced glycation endproducts (1)
- aggregated immunoglobulin-g (1)
- agonists interaction (1)
- air pollution (1)
- air-dried (1)
- air-fried (1)
- akute Entzündung (1)
- alcohol (1)
- alcohol dehydrogenase (1)
- alcohol intake (1)
- alcylated polycyclic aromatic hydrocarbons (1)
- aldehyde dehydrogenase (1)
- alkylated polycyclic aromatic hydrocarbons (1)
- alkylating agents (1)
- allometric model (1)
- alpha-Catenin (1)
- alpha-SMA (1)
- alpha-Tocopherol (1)
- alpha-tocopherol (1)
- alpha-tocopherol transfer protein (Ttpa) (1)
- alternative splicing (1)
- alternative zu Tierversuchen (1)
- amaranth (1)
- amino acid score (1)
- amino acids (1)
- amitriptyline (1)
- amylase activity (1)
- analytical methods (1)
- anaphylaxis (1)
- and nutrition (1)
- angiotensin (1-7) (1)
- angiotensin II (1)
- anti-inflammatory therapy (1)
- antibacterial aerosol (1)
- antibacterial effect (1)
- antibakterielles Aerosol (1)
- anticancer (1)
- antidiabetic drug (1)
- antifogging additives (1)
- antioxidant activity (1)
- antioxidant defense systems (1)
- antioxidant potential (1)
- antioxidative capacity (1)
- antioxidative phenolic ingredients (1)
- anxiety sensitivity (1)
- aphids (1)
- appetite regulation (1)
- arabinoxylan (1)
- arachidonic-acid (1)
- aroma quality (1)
- aromatic amines; sulfotransferases; mutagenicity; bioactivation (1)
- aromatische Amine; Sulfotransferasen; Mutagenität; Bioaktivierung (1)
- arsenic (1)
- arsenolipids (1)
- artificial (1)
- astrocytes (1)
- asymmetric dimethylarginine (1)
- asymmetric dimethylarginine (ADMA) (1)
- asymmetrisches Dimethylarginin (1)
- atmospheric deposition (1)
- auditory neurons (1)
- autofluorescence (1)
- autoimmunity (1)
- autophagy flux (1)
- autophagy lysosomal system (1)
- b-Catenin (1)
- barrier (1)
- behavioral experiments (1)
- behaviour (1)
- benzylic sulfate (1)
- benzylic sulfuric acid ester (1)
- benzylischer Schwefelsäureester (1)
- benzylisches Sulfat (1)
- benzylisothiocyanate (1)
- beta-Lactoglobulin (1)
- beta-carotene (1)
- beta-carotene hydroxylase (1)
- beta-cell loss (1)
- beta-cells (1)
- beverage (1)
- bifidobacterium (1)
- bile acids (1)
- bioactive peptides (1)
- bioactivity (1)
- biomarkers (1)
- biomarkers of renal failure (1)
- biotransformation (1)
- birds of prey (1)
- birthweight (1)
- bladder cancer cells (1)
- blood banking (1)
- blood biomarker (1)
- blood-brain barrier (1)
- blood– brain barrier (1)
- blood– cerebrospinal fluid barrier (1)
- body composition (1)
- body mass (1)
- body weight (1)
- body weight loss (1)
- body weight maintenance (1)
- bone (1)
- bone mineral density (1)
- bovine milk (1)
- brain-gut axis (1)
- branched chain amino acids (1)
- braunes Fettgewebe (1)
- breast cancer (1)
- broiler chicks (1)
- brown adipose tissue (1)
- browning (1)
- burn injury (1)
- c-Fos (1)
- cachexia (1)
- caenorhabditis elegans (1)
- caffeic acid derivatives (1)
- calbindin D9k (1)
- calcitriol (1)
- calcium imaging (1)
- calcium transport (1)
- caloric restriction (1)
- cancer cells (1)
- cancer stem cells (1)
- canine osteoarthritis (1)
- cannabidiol (CBD) (1)
- capillary blood (1)
- caquexia (1)
- carbon sequestration (1)
- carcinogenesis (1)
- cardiac inflammaging (1)
- cardiac progenitor migration and differentiation (1)
- cardiokine (1)
- cardiometabolic diseases (1)
- cardiovascular risk (1)
- carob fibre (1)
- carota L (1)
- carotene (1)
- carotenoids bioavailability (1)
- catFISH (1)
- catalase (1)
- cell cuture (1)
- cell cycle (1)
- cell line (1)
- cell migration (1)
- cell transformation assay (1)
- cell wall deficient mutant (1)
- cell-based in vitro assay (1)
- cell-death (1)
- cellular uptake (1)
- central nervous system (1)
- cerebellum (1)
- chemokines (1)
- chick embryo (1)
- children (1)
- chimpanzee (1)
- chlorbenzol (1)
- chlorogenic acid (1)
- chlorophylls (1)
- chronic and acute inflammation (1)
- chronic disease (1)
- chronic renal failure (1)
- chronic renal failure in children (1)
- cilium (1)
- circulation (1)
- classification (1)
- claudin-4 (1)
- click chemistry (1)
- clinical prediction rule (1)
- clinical sample (1)
- clinical studies (1)
- clinical trial (1)
- cocoa processing (1)
- cocoa proteins (1)
- coffee proteins (1)
- cold atmospheric pressure plasma (1)
- collagen I (1)
- colocalisation study (1)
- colon cancer (1)
- colon cancer diagnosis (1)
- color (1)
- color preference (1)
- color vision (1)
- colorectal carcinoma (1)
- colorectal neoplasm (1)
- colostrum (1)
- colour (1)
- commensal (1)
- comparison (1)
- complement (1)
- complication (1)
- complications (1)
- constitutive androstane receptor (1)
- construct validity (1)
- contrast-induced nephropathy (1)
- core (1)
- core-multishell (CMS) nanocarriers (1)
- cost-effectiveness analysis (1)
- coupled plasma mass spectrometry (1)
- cow's milk (1)
- cow-side assay (1)
- crop (1)
- curcumin (1)
- cystic fibrosis (1)
- cytotoxicity (1)
- cytotoxicity assay (1)
- d-Loop (1)
- dairy intake (1)
- decision tree (1)
- decitabine (1)
- deep-fried (1)
- dendritic cell (1)
- dendritic polyglycerol (1)
- depression (1)
- dermal drug administration (1)
- desensitization (1)
- diatoms (1)
- dichlorbenzol (1)
- dichlorobenzene (1)
- diet quality (1)
- diet score (1)
- diet selection (1)
- diet-disease association (1)
- dietary antioxidants (1)
- dietary choices (1)
- dietary citric acid (1)
- dietary factors (1)
- dietary fibre (1)
- dietary guidelines (1)
- dietary lipids (1)
- dietary sulfonates (1)
- dietary supplements (1)
- differentiation assay (1)
- disproportional intrauterine growth retardation (1)
- distal convoluted tubule (1)
- distress (1)
- diurnal rhythm (1)
- diätetische Antioxidantien (1)
- dog (1)
- domestic cooking (1)
- dosage recommendation (1)
- drug delivery systems (1)
- drug design (1)
- drug metabolism (1)
- drug-resistant bacteria (1)
- dysfunction (1)
- e-Zigarette (1)
- e-cigarette (1)
- eating (1)
- eating disorder symptoms (1)
- echocardiography (1)
- egg yolk (1)
- electron microscopy (1)
- electronic drug delivery system (EDDS) (1)
- electronic nicotin delivery system (ENDS) (1)
- ellagic acid (1)
- embryonic stem cell test (EST) (1)
- emotionality (1)
- emulsion (1)
- endocannabinoids (1)
- endocrine disruption (1)
- endocytosis (1)
- endothelabhängige flussinduzierte Vasodilatation (1)
- endothelial cell (1)
- endothelial function (1)
- endothelin-converting enzyme (1)
- energy (1)
- energy expenditure (1)
- energy harvest (1)
- environmental DNA (1)
- environmental impact (1)
- enzyme assays (1)
- enzyme induction (1)
- enzymes (1)
- epigallocatechin gallate (1)
- epigenetic (1)
- equol (1)
- essential oils (1)
- etanercept (1)
- etiology (1)
- exercise performance (1)
- experimental antigen-induced encephalomyelitis (1)
- exposure (1)
- expression analysis (1)
- extinction (1)
- extra-cellular matrix (1)
- extracellular matrix (1)
- extraction and characterization methods (1)
- extrazelluläre Matrix (1)
- factor structure (1)
- failure (1)
- fasting blood glucose (1)
- fat metabolism (1)
- fat perception (1)
- fat-soluble vitamin (1)
- fatigue (1)
- fatty acid profile (1)
- fatty acid synthesis (1)
- fatty pancreas (1)
- female (1)
- fermentation-related enzymes (1)
- fetal programing (1)
- fetal sex (1)
- fiber (1)
- filter paper (1)
- fingolimod (1)
- first trimester (1)
- flow (1)
- fluorescent probe (1)
- fluvial terraces (1)
- foal (1)
- food (1)
- food allergy (1)
- food group consumption (1)
- food groups (1)
- food safety (1)
- foot and mouth disease (HFMD) (1)
- formyl peptide receptor 2 (1)
- fortification (1)
- frailty (1)
- frataxin (1)
- free radicals (1)
- free zinc (1)
- fruit metabolites (1)
- functional diversity (1)
- functional properties (1)
- funktionelle Variabilität (1)
- future food (1)
- fígado (1)
- garnet (1)
- gender (1)
- gene (1)
- gene expression analysis (qRT-PCR) (1)
- gene regulation (1)
- gene-lifestyle interaction (1)
- genetic variants (1)
- genetics (1)
- genomic instability (1)
- genomics (1)
- genomische Instabilität (1)
- gerontology (1)
- geschützter Anbau (1)
- gestational diabetes mellitus (1)
- gestational diabetes mellitus (GDM) (1)
- girths and breadths (1)
- glasswort (1)
- gliptins (1)
- glomerular arterioles (1)
- glucose homeostasis (1)
- glucose transport (1)
- glycation (1)
- glycemic control (1)
- glycemic control during pregnancy (1)
- glycogen synthase kinase-3 (1)
- glycosylation (1)
- gold nanostars (1)
- grafische Modelle (1)
- graphical models (1)
- gravity (1)
- green tea (1)
- green tea phenols (1)
- greenhouse gas emissions (1)
- groEL (1)
- growth (1)
- gut length (1)
- hTAS2R10 (1)
- haemodialysis (1)
- hand (1)
- haplotype (1)
- health (1)
- health risks (1)
- health span (1)
- healthy subjects (1)
- heart tube (1)
- heart-type fatty acid binding protein (1)
- heat shock proteins (1)
- heath potentials (1)
- heme (1)
- hemodialysis (1)
- hepatic impairment (1)
- hepatocellular carcinoma (1)
- hepatotoxicity (1)
- heptadecanoic acid (C17:0) (1)
- heritability (1)
- heterocyclic aromatic amine (1)
- heterocyclic aromatic amines (1)
- heterocyclisches aromatisches Amin (1)
- heterologe Expression (1)
- heterologous expression (1)
- heterozyklische aromatische Amine (1)
- high fat diet (1)
- high salt (1)
- high-density lipoprotein (HDL) (1)
- high-fat diet (1)
- high-resolution imaging (1)
- hippocampus (1)
- homocysteine (1)
- homology modelling (1)
- hormones (1)
- human body composition (1)
- human diet (1)
- human follicular fluid (1)
- human health (1)
- human liver microsomes (1)
- human milk (1)
- human nutrition (1)
- hunger hormone (1)
- hydroxymethylfurfural (1)
- hydroxymethylpyrene (1)
- hyperglycemia (1)
- hypotension (1)
- hypoxic pulmonary vasoconstriction (1)
- hypoxische pulmonale Vasokonstriktion (1)
- immediate early gene (1)
- immune (1)
- immune response (1)
- immune system (1)
- immune-inflammatory biomarkers (1)
- immunoblot (1)
- immunohistochemistry (1)
- immunomodulator (1)
- impaired glucose tolerance (1)
- in silico (1)
- in situ chemical reduction (1)
- in vitro blood-brain barrier model (1)
- in vivo (1)
- incident type 2 diabetes (1)
- increases (1)
- index (1)
- indigenous leafy vegetables (1)
- indoor farming (1)
- induced pluripotent stem cells (1)
- induction (1)
- induzierte pluripotente Stammzellen (1)
- inflamação (1)
- inflammatory bowel disease (1)
- inhalative Applikation (1)
- inhibitory cytokines (1)
- inorganic mercury (1)
- insect proteins (1)
- insulin signalling (1)
- insulin-induced hypoglycemia (1)
- insulina (1)
- insulinresistance (1)
- integrated stress response (1)
- integrins (1)
- intercellular communication (1)
- intercropping (1)
- interleukin-1 (1)
- interleukin-35 (1)
- interventions (1)
- intesinal disease (1)
- intestinal (1)
- intestinal epithelial cells (1)
- intestinal inflammation (1)
- intestinal model (1)
- intestinale Epithelzellen (1)
- intestinale Mikrobiota (1)
- intrauterine (1)
- intrauterine fetal growth (1)
- inulin (1)
- invasion (1)
- involuntary weight loss (1)
- iodine (1)
- ion chromatography (1)
- ion quantification (1)
- ionophore antibiotics (1)
- iron (1)
- ischemia reperfusion injury (1)
- isoflavones (1)
- isothiocyanate (1)
- kale (1)
- kappa-casein (1)
- kardiovaskuläres Risiko (1)
- ki-ras (1)
- kidney dysfunction (1)
- kidney injury molecule 1 (1)
- kinetics (1)
- knock-out (1)
- kolorektales Karzinom (1)
- kurzkettige Fettsäuren (1)
- körperliche Aktivität (1)
- laboratory animal sciences (1)
- lactate output (1)
- lactobacillus (1)
- lake sediments (1)
- land use (1)
- land-based aquaculture (1)
- langsame und schnelle Fasertypen (1)
- large for gestational age fetus (LGA) (1)
- large population (1)
- large sample size studies (1)
- latex (1)
- lettuce (1)
- leucine (1)
- leukocyte-endothelial interaction (1)
- life cycle toxicities (1)
- life style (1)
- lifestyle risk reduction (1)
- limb lengths (1)
- lineage commitment (1)
- linear gemischte Modelle (1)
- linear mixed models (1)
- lipases (1)
- lipid (1)
- lipid analysis (1)
- lipid droplets (1)
- lipids (1)
- lipophagy (1)
- liposomes (1)
- litter decomposition (1)
- liver disease (1)
- liver regeneration (1)
- liver toxicity (1)
- locus of control (1)
- long chain base (1)
- long-chain polyunsaturated fatty acids (1)
- longevity (1)
- longitudinal analysis (1)
- low birth weight (LBW) (1)
- low molecular weight selenium species (1)
- low temperature (1)
- low-grade inflammation (1)
- lower nephron (1)
- lower respiratory tract infections (LRTIs) (1)
- lung cancer (1)
- lung inflammation (1)
- lupin (1)
- lutein ester (1)
- lutein esters (1)
- lycopene (1)
- lymphopenia (1)
- lysosomal storage disorders (1)
- lysozyme (1)
- lysozyme activity (1)
- mPGES (1)
- mRNA degradation (1)
- machine learning (1)
- macroarray (1)
- macrophage (1)
- macrovascular complications (1)
- macrófagos (1)
- macular pigment density (1)
- makrovaskuläre Komplikationen (1)
- male (1)
- malignant transformation (1)
- maligne Transformation (1)
- mare (1)
- mastery (1)
- maternal diet (1)
- maternale Ernährung (1)
- matrix metalloproteinases (1)
- maturity (1)
- mealworm (1)
- measles virus (1)
- mediation analysis (1)
- mediterrane Ernährung (1)
- membrane analysis (1)
- membrane lipids (1)
- membrane-lipid therapy (1)
- menschliche Ernährung (1)
- mercuric mercury (1)
- metablism (1)
- metabolic response (1)
- metabolischer Stress (1)
- metabolisches Syndrom (1)
- methionine restriction (1)
- method development (1)
- method validation (1)
- methyl jasmonate (1)
- miRNAs (1)
- microRNAs (1)
- microbial mining (1)
- microbiology (1)
- microbiome (1)
- microbiomics (1)
- microbiota (1)
- microgreen (1)
- micronutrient (1)
- micronutrient deficiencies (1)
- microorganisms (1)
- microparticle (1)
- microplastics (1)
- microscope (1)
- microwave-assisted extraction (1)
- migration (1)
- mikrovaskuläre Komplikationen (1)
- mitochondria, (1)
- mitochondrial homeostasis (1)
- mixtures (1)
- molecular dynamics (1)
- molecular modeling (1)
- molecular pathways (1)
- monochlorobenzene (1)
- morpholino analogues of fingolimod (1)
- motor neurons (1)
- mouse models (1)
- moxidectin (1)
- mtDNA (1)
- mucus (1)
- multiple sclerosis (1)
- muscle (1)
- muscle atrophy (1)
- muscle fibre composition (1)
- muscle fibre type (1)
- muscle mass (1)
- muscle metabolism (1)
- muscle protein turnover (1)
- muscle wasting (1)
- mustard agents (1)
- mustards (1)
- myofibroblast (1)
- myoglobin (1)
- myokine (1)
- myrrh (1)
- n-3 fatty acid (1)
- n-6 fatty acid (1)
- n-oxPTH (1)
- narrow-banded UVB (1)
- natural compounds (1)
- nephrin (1)
- nephropathy (1)
- network (1)
- networks (1)
- neurofibromatosis (1)
- neuron (1)
- neurons (1)
- neuropathy (1)
- neuropeptides (1)
- neutral endopeptidase (1)
- neutrophil chemotaxis (1)
- neutrophil gelatinase-associated lipocalin (1)
- new analysis method (1)
- nicotinamide adenine dinucleotide (1)
- nicotinamide riboside (1)
- nomadic pastoralist (1)
- non-alcoholic steatohepatitis (1)
- nonlinear microscopy (1)
- nuclear receptor (1)
- nucleosidadduct (1)
- nucleus of the solitary tract (1)
- nukleärer Rezeptor (1)
- nutrient bioavailability (1)
- nutrition security (1)
- nutritional factors (1)
- nutritional supplements (1)
- old adults (1)
- oligomers (1)
- omega-3 fatty acid (1)
- one dot two development signals (ODTDS) dot blot (1)
- ontogeny (1)
- operant behavior (1)
- optimization (1)
- optogenetic (1)
- oral immunotherapy (1)
- orale Immuntherapie (1)
- orangutan (1)
- organ failure (1)
- organic mercury (1)
- orphan crops (1)
- osteoblast (1)
- osteopontin (1)
- osteoporosis (1)
- osterix (1)
- outcome (1)
- ovarian cancer (1)
- oxidation (1)
- oxidativer Stress (1)
- p-AKT (1)
- p-mTOR (1)
- p53 signaling (1)
- p53 targets (1)
- pH-sensitive nanoparticle (1)
- pH-sensitive nanoparticles (1)
- palm oil (1)
- paternal programming (1)
- pathogen (1)
- peanut allergy (1)
- penetration enhancement (1)
- pentadecanoic acid (C15:0) (1)
- peptide (1)
- performance (1)
- perfused-rat-liver (1)
- peripheral nervous system (1)
- peripheres Nervensystem (1)
- perturbation (1)
- pflanzliche Sekundär Metabolite (1)
- phase II enzymes (1)
- phenol nitration (1)
- phenol oxidation (1)
- phenols (1)
- phosphorus (1)
- phosphorylation (1)
- photochemistry (1)
- photosynthesis (1)
- photothermal therapy (1)
- phthalates (1)
- physiology (1)
- phytochemicals (1)
- pilot study (1)
- placenta (1)
- plant drinks (1)
- plant growth-promoting bacteria (1)
- plant phenolic compounds (1)
- plant protease (1)
- plant secondary metabolites (1)
- plant-based diets (1)
- plasma membrane (1)
- plasma process indicators (1)
- plastic additives (1)
- point mutation (1)
- pollution (1)
- poly ungesättigte Fettsäuren (1)
- poly(ADP-ribose) polymerase-1 (1)
- poly(ADP-ribosylation) (1)
- polyamines (1)
- polycystic kidney disease (1)
- polycystic ovary syndrome (1)
- polytunnel (1)
- polyunsaturated fatty acids (1)
- ponderostat (1)
- porphyridium purpureum (1)
- positional cloning (1)
- post-hospital syndrome (1)
- post-menopausal Thai women (1)
- post-translational modifications (1)
- postmenopausal (1)
- postprandial response (1)
- postprandial study (1)
- potassium iodate (1)
- potency assessment (1)
- preadipocyte (1)
- prebiotics (1)
- pregnancy induced diabetes (1)
- pregnane X-receptor (1)
- prepared foods (1)
- presystemic metabolism (1)
- preterm delivery (1)
- preterm infant (1)
- preventive measures (1)
- primary immunodeficiencies (1)
- priming effect (1)
- principal component analysis (1)
- proinsulin (1)
- proline rich proteins (1)
- prolinreiche Proteine (1)
- propionate (1)
- prostaglandin receptor (1)
- prostaglandin-f2-alpha (1)
- prostaglandine (1)
- prostate cancer (1)
- protected cultivation (1)
- protein derivatization (1)
- protein digestibility (1)
- protein interactions (1)
- protein microheterogeneity (1)
- protein pattern (1)
- protein quantification (1)
- protein-phenol binding (1)
- protein-phenol interactions (1)
- proteomix analysis (1)
- pulmonalarterielle glatte Muskelzellen (1)
- pulmonary artery smooth muscle cells (1)
- qPCR-based gene expression screening (1)
- quality control (1)
- quantitativ (1)
- quantitative (1)
- quercetin (1)
- ramipril (1)
- randomisierte Studie (1)
- randomized controlled intervention study (1)
- randomized controlled trial (1)
- rapeseed protein (1)
- rapid detection method (1)
- reactive oxygen and nitrogen species (1)
- reactive oxygen species (1)
- real life context (1)
- receptor (1)
- red wine (1)
- redox (1)
- redox homeostasis (1)
- reductase (1)
- reflection spectroscopy (1)
- regional diets (1)
- regulatory T cells (1)
- regulatory monitoring (1)
- relative dose response test (1)
- reliability; (1)
- renal dysfunction (1)
- renal function (1)
- renal haemodynamics (1)
- repair (1)
- repeated measures design (1)
- replication (1)
- reporter gene assay (1)
- reproducibility (1)
- resistência à insulina (1)
- respiratory diseases (1)
- resveratrol (1)
- resveratrol oligomers (1)
- retinoic acid (1)
- retinol (ROH) (1)
- retinol binding protein 4 (1)
- retinol-binding protein (1)
- retinopathy (1)
- retinyl esters (1)
- retinyl palmitate (1)
- risk assessment (1)
- risk factors (1)
- risk score (1)
- risk scores (1)
- roe deer (1)
- ruminant (1)
- ruminants (1)
- sFlt-1 (1)
- safety efficacy (1)
- salinomycin (1)
- saliva proteins (1)
- salivary proteins (1)
- salmon fish (1)
- salt composition (1)
- salt taste perception (1)
- scores (1)
- screening (1)
- scrub typhus (1)
- seawater (1)
- sekundäre Pflanzenstoffe (1)
- selenium transport (1)
- selenoprotein (1)
- sensory analysis (1)
- sepsis (1)
- serine protease (1)
- serum amyloid A (SAA) (1)
- serum retinol binding protein (RBP4) (1)
- set-point (1)
- short chain fatty acids (1)
- shortening rate (1)
- single nucleotide polymorphism (1)
- single-cell analysis (1)
- situation (1)
- skeletal muscle aging (1)
- skeletal-muscle (1)
- skin (1)
- skin equivalents (1)
- slow and fast fiber types (1)
- smartphone (1)
- smoking (1)
- snacking (1)
- sodium (1)
- soy (1)
- soy isoflavones (1)
- spectrophotometry (1)
- sperm motility (1)
- spermatogenesis (1)
- sphingomyelin phosphodiesterase 1 (1)
- sphingosine kinase-1 (1)
- sphingosine kinases (1)
- sphingosine-1-phosphate (S1P) (1)
- spider mites (1)
- starter formula (1)
- stem cell (1)
- stereotypy (1)
- stomach model (1)
- storage (1)
- styrene (1)
- suPAR (1)
- substrate utilisation (1)
- succession (1)
- sudden death (1)
- sulfide (1)
- sulforaphan (1)
- sulforaphane (1)
- sulfur mustard (1)
- superoxide dismutase (1)
- suppressor of cytokine signaling (SOCS) (1)
- sweet taste (1)
- sweet taste receptor (1)
- sweetener (1)
- synbiotics (1)
- synovial fluid (1)
- systematischer Review (1)
- systemic response (1)
- systolic function (1)
- síndrome metabólica (1)
- tacrolimus (1)
- tannin binding salivary proteins (1)
- tannin-protein interaction (1)
- tanninbindende Speichelproteine (1)
- targeted metabolomics (1)
- taste receptor (1)
- taste receptor screening (1)
- tea catechin (1)
- tea processing (1)
- telbivudine (1)
- telmisartan (1)
- terpenoids (1)
- therapy (1)
- thermal processing (1)
- thermal processing of food (1)
- thermogenesis (1)
- thermoresponsive-nanogel (1)
- thimerosal (1)
- thiol modification (1)
- thiomersal (1)
- thioredoxin-interacting protein (1)
- thymosin beta 4 (1)
- tight junctions (1)
- tissue inhibitior of metalloproteinases 1 (1)
- tocopherol (1)
- topical (1)
- topical drug delivery (1)
- total body fat (1)
- total glycated hemoglobin (1)
- total glycosylated hemoglobin (1)
- total phenol content (1)
- toxicology (1)
- trace element (1)
- trace elements (1)
- training intervention (1)
- trans fatty acids (1)
- trans-Golgi (1)
- trans-migration (1)
- transcription factor (1)
- transformation product (1)
- transforming growth factor beta (1)
- transfusion-related acute lung injury (1)
- transgenerational effects (1)
- transgenes Mausmodell (1)
- transgenic mousemodel (1)
- transient receptor potential (1)
- transmission of hepatitis B virus (HBV) (1)
- transport proteins (1)
- transthyretin (TTR) (1)
- triazole fungicides (1)
- trypsin inhibitors (1)
- tryptophan quenching (1)
- tumor (1)
- tumor-metastasis (1)
- twin study (1)
- type 2 diabetes (T2DM) (1)
- type II diabetes (T2DM) (1)
- type-2-diabetes (1)
- ubiquitin proteasomal system (1)
- ultra heat treatment (1)
- ultrasound (1)
- umami (1)
- underutilized species (1)
- universal coating (1)
- urban (1)
- urinary biomarker (1)
- urine (1)
- valine (1)
- vascular disease; (1)
- vascular senescence (1)
- vascular smooth muscle cells (1)
- vegan diet (1)
- vending machine (1)
- verzweigtkettige Aminosäuren (1)
- vesicular trafficking (1)
- vesicular transport (1)
- vesikulärer Transport (1)
- veterinary drug (1)
- vitamin (1)
- vitamin A deficiency (1)
- vitamin D binding protein (1)
- vitamin D-binding protein (1)
- vitamin E (1)
- vitamins (1)
- volatile compounds (1)
- weight loss intervention (1)
- weight maintenance (1)
- weight reduction (1)
- weight regulation (1)
- weight status (1)
- western blot (1)
- whey proteins (1)
- white adipose tissue (1)
- whole grains (1)
- whole-grain (1)
- yield enhancement (1)
- yolk (1)
- zeaxanthin (1)
- zentrales Nervensystem (1)
- zinc/iron supplementation (1)
- Östrogene (1)
- Übergewicht (1)
- Übertragung (1)
- ß-Glucan (1)
- ätherische Öle (1)
- α-Tocopheroltransferprotein (Ttpa) (1)
- α-amylase (1)
- α-tocophero (1)
Institute
- Institut für Ernährungswissenschaft (1294) (remove)
Intensive Forschung hat in den vergangenen Jahrzehnten zu einer sehr detaillierten Charakterisierung des Geschmackssystems der Säugetiere geführt. Dennoch sind mit den bislang eingesetzten Methoden wichtige Fragestellungen unbeantwortet geblieben. Eine dieser Fragen gilt der Unterscheidung von Bitterstoffen. Die Zahl der Substanzen, die für den Menschen bitter schmecken und in Tieren angeborenes Aversionsverhalten auslösen, geht in die Tausende. Diese Substanzen sind sowohl von der chemischen Struktur als auch von ihrer Wirkung auf den Organismus sehr verschieden. Während viele Bitterstoffe potente Gifte darstellen, sind andere in den Mengen, die mit der Nahrung aufgenommen werden, harmlos oder haben sogar positive Effekte auf den Körper. Zwischen diesen Gruppen unterscheiden zu können, wäre für ein Tier von Vorteil. Ein solcher Mechanismus ist jedoch bei Säugetieren nicht bekannt. Das Ziel dieser Arbeit war die Untersuchung der Verarbeitung von Geschmacksinformation in der ersten Station der Geschmacksbahn im Mausgehirn, dem Nucleus tractus solitarii (NTS), mit besonderem Augenmerk auf der Frage nach der Diskriminierung verschiedener Bitterstoffe. Zu diesem Zweck wurde eine neue Untersuchungsmethode für das Geschmackssystem etabliert, die die Nachteile bereits verfügbarer Methoden umgeht und ihre Vorteile kombiniert. Die Arc-catFISH-Methode (cellular compartment analysis of temporal activity by fluorescent in situ hybridization), die die Charakterisierung der Antwort großer Neuronengruppen auf zwei Stimuli erlaubt, wurde zur Untersuchung geschmacksverarbeitender Zellen im NTS angewandt. Im Zuge dieses Projekts wurde erstmals eine stimulusinduzierte Arc-Expression im NTS gezeigt. Die ersten Ergebnisse offenbarten, dass die Arc-Expression im NTS spezifisch nach Stimulation mit Bitterstoffen auftritt und sich die Arc exprimierenden Neurone vornehmlich im gustatorischen Teil des NTS befinden. Dies weist darauf hin, dass Arc-Expression ein Marker für bitterverarbeitende gustatorische Neurone im NTS ist. Nach zweimaliger Stimulation mit Bittersubstanzen konnten überlappende, aber verschiedene Populationen von Neuronen beobachtet werden, die unterschiedlich auf die drei verwendeten Bittersubstanzen Cycloheximid, Chininhydrochlorid und Cucurbitacin I reagierten. Diese Neurone sind vermutlich an der Steuerung von Abwehrreflexen beteiligt und könnten so die Grundlage für divergentes Verhalten gegenüber verschiedenen Bitterstoffen bilden.
While the underlying mechanisms of Parkinson’s disease (PD) are still insufficiently studied, a complex interaction between genetic and environmental factors is emphasized. Nevertheless, the role of the essential trace element zinc (Zn) in this regard remains controversial. In this study we altered Zn balance within PD models of the versatile model organism Caenorhabditis elegans (C. elegans) in order to examine whether a genetic predisposition in selected genes with relevance for PD affects Zn homeostasis. Protein-bound and labile Zn species act in various areas, such as enzymatic catalysis, protein stabilization pathways and cell signaling. Therefore, total Zn and labile Zn were quantitatively determined in living nematodes as individual biomarkers of Zn uptake and bioavailability with inductively coupled plasma tandem mass spectrometry (ICP-MS/MS) or a multi-well method using the fluorescent probe ZinPyr-1. Young and middle-aged deletion mutants of catp-6 and pdr-1, which are orthologues of mammalian ATP13A2 (PARK9) and parkin (PARK2), showed altered Zn homeostasis following Zn exposure compared to wildtype worms. Furthermore, age-specific differences in Zn uptake were observed in wildtype worms for total as well as labile Zn species. These data emphasize the importance of differentiation between Zn species as meaningful biomarkers of Zn uptake as well as the need for further studies investigating the role of dysregulated Zn homeostasis in the etiology of PD.
Background
Coronavirus disease (COVID-19) has a severe impact on all aspects of patient care. Among the numerous biomarkers of potential validity for diagnostic and clinical management of COVID-19 are biomarkers at the interface of iron metabolism and inflammation.
Methods
The follow-up study included 54 hospitalized patients with laboratory-confirmed COVID-19 with a moderate and severe/critical form of the disease. Iron deficiency specific biomarkers such as iron, ferritin, transferrin receptor, hepcidin, and zinc protoporphyrin (ZnPP) as well as relevant markers of inflammation were evaluated twice: in the first five days when the patient was admitted to the hospital and during five to 15 days; and their validity to diagnose iron deficiency was further assessed. The regression and Receiver Operating Characteristics (ROC) analyses were performed to evaluate the prognosis and determine the probability for predicting the severity of the disease in the first five days of COVID-19.
Results
Based on hemoglobin values, anemia was observed in 21 of 54 patients. Of all iron deficiency anemia-related markers, only ZnPP was significantly elevated (P<0.001) in the anemic group. When patients were grouped according to the severity of disease, slight differences in hemoglobin or other anemia-related parameters could be observed. However, the levels of ZnPP were significantly increased in the severely ill group of patients. The ratio of ZnPP to lymphocyte count (ZnPP/L) had a discrimination power stronger than the neutrophil to lymphocyte count ratio (N/L) to determine disease severity. Additionally, only two markers were independently associated with the severity of COVID-19 in logistic regression analysis; D-dimer (OR (5.606)(95% CI 1.019–30.867)) and ZnPP/L ratio (OR (74.313) (95% CI 1.081–5108.103)).
Conclusions
For the first time ZnPP in COVID-19 patients were reported in this study. Among all iron-related markers tested, ZnPP was the only one that was associated with anemia as based on hemoglobin. The increase in ZnPP might indicate that the underlying cause of anemia in COVID-19 patients is not only due to the inflammation but also of nutritional origin. Additionally, the ZnPP/L ratio might be a valid prognostic marker for the severity of COVID-19.
Background
Coronavirus disease (COVID-19) has a severe impact on all aspects of patient care. Among the numerous biomarkers of potential validity for diagnostic and clinical management of COVID-19 are biomarkers at the interface of iron metabolism and inflammation.
Methods
The follow-up study included 54 hospitalized patients with laboratory-confirmed COVID-19 with a moderate and severe/critical form of the disease. Iron deficiency specific biomarkers such as iron, ferritin, transferrin receptor, hepcidin, and zinc protoporphyrin (ZnPP) as well as relevant markers of inflammation were evaluated twice: in the first five days when the patient was admitted to the hospital and during five to 15 days; and their validity to diagnose iron deficiency was further assessed. The regression and Receiver Operating Characteristics (ROC) analyses were performed to evaluate the prognosis and determine the probability for predicting the severity of the disease in the first five days of COVID-19.
Results
Based on hemoglobin values, anemia was observed in 21 of 54 patients. Of all iron deficiency anemia-related markers, only ZnPP was significantly elevated (P<0.001) in the anemic group. When patients were grouped according to the severity of disease, slight differences in hemoglobin or other anemia-related parameters could be observed. However, the levels of ZnPP were significantly increased in the severely ill group of patients. The ratio of ZnPP to lymphocyte count (ZnPP/L) had a discrimination power stronger than the neutrophil to lymphocyte count ratio (N/L) to determine disease severity. Additionally, only two markers were independently associated with the severity of COVID-19 in logistic regression analysis; D-dimer (OR (5.606)(95% CI 1.019–30.867)) and ZnPP/L ratio (OR (74.313) (95% CI 1.081–5108.103)).
Conclusions
For the first time ZnPP in COVID-19 patients were reported in this study. Among all iron-related markers tested, ZnPP was the only one that was associated with anemia as based on hemoglobin. The increase in ZnPP might indicate that the underlying cause of anemia in COVID-19 patients is not only due to the inflammation but also of nutritional origin. Additionally, the ZnPP/L ratio might be a valid prognostic marker for the severity of COVID-19.
Die gesundheitsfördernden Eigenschaften von grünem Tee sind weitgehend akzeptiert. Den Teecatechinen, insbesondere dem Epigallocatechin-3-gallat (EGCG), werden zahlreiche positive Effekte zugesprochen (z. B. antioxidativ, antikanzerogen, antiinflammatorisch, Blutdruck und Cholesterinspiegel senkend). Die Mechanismen, die zu einer Reduktion der in Tierversuchen beschriebenen Körper- und Fettmasse führen, sind nicht ausreichend geklärt. Ziel dieser Arbeit bestand darin, die kurz- und mittelfristigen Wirkungen einer TEAVIGO®-Applikation (mind. 94 % EGCG) am Mausmodell im Hinblick auf den Energie- und Fettstoffwechsel sowie die Expression daran beteiligter Gene in wichtigen Organen und Geweben zu untersuchen. In verschiedenen Tierversuchen wurde männlichen C57BL/6-Mäusen eine Hochfettdiät (HFD) mit und ohne Supplementation (oral, diätetisch) des entkoffeinierten Grüntee-Extraktes TEAVIGO® in unterschiedlichen Dosierungen gefüttert. Es wurden sowohl kurz- als auch mittelfristige Wirkungen des EGCG auf die Energiebilanz (u. a. indirekte Tierkalorimetrie) und Körperzusammensetzung (NMR) sowie die exogene Substratoxidation (Stabilisotopentechnik: Atemtests, Inkorporation natürlicher 13C-angereicherter Triglyceride aus Maiskeimöl in diverse Organe/Gewebe) und Gen-expression (quantitative real-time PCR) untersucht. Die Applikationsform und ihre Dauer riefen unterschiedliche Wirkungen hervor. Mäuse mit diätetischer Supplementation zeigten bereits nach kurzer Zeit eine verminderte Körperfettmasse, die bei weiterer Verabreichung auch zu einer Reduktion der Körpermasse führte. Beide Applikationsformen resultieren, unabhängig von der Dauer der Intervention, in einer erhöhten Energieausscheidung, während die Futter- und Energieaufnahme durch EGCG nicht beeinflusst wurden. Der Energieverlust war von einer erhöhten Fett- und Stickstoffausscheidung begleitet, deren Ursache die in der Literatur beschriebene Interaktion und Hemmung digestiver Enzyme sein könnte. Besonders unter postprandialen Bedingungen wiesen EGCG-Mäuse erniedrigte Triglycerid- und Glycogengehalte in der Leber auf, was auf eine eingeschränkte intestinale Absorption der Nährstoffe hindeutet. Transkriptanalysen ergaben im Darm eine verminderte Expression von Fettsäuretransportern, während die Expression von Glucosetransportern durch EGCG erhöht wurde. Weiterhin reduzierte EGCG, nach Umstellung von Standard- auf eine maiskeimölhaltige Hochfettdiät, die Inkorporation natürlicher 13C-angereicherter Triglyceride in diverse Organe und Gewebe – insbesondere Leber, viszerales und braunes Fettgewebe sowie Skelettmuskel. Die Analyse der 13C-Anreicherung im Atem der Mäuse und die Energieumsatzmessungen ergaben nach kurzer Applikation eine erhöhte Fettoxidation, die im weiteren Verlauf der Intervention auf eine erhöhte Kohlenhydratoxidation umgeschaltet wurde. Weiterhin war die orale Applikation von EGCG bei gleichzeitiger Fütterung einer Hochfettdiät von makroskopischen und mikroskopischen degenerativen Veränderungen der Leber begleitet. Diese Effekte wurden nach diätetischer Supplementation der Hochfettdiät mit EGCG nicht beobachtet. Zusammenfassend zeigen die Ergebnisse, dass die Körpergewichts- und Fettgewebs-abnahme durch diätetisches EGCG sich durch eine herabgesetzte Verdaulichkeit der Nahrung erklären lässt. Dies führte zu verschiedenen kurz- und mittelfristigen Veränderungen in der Fettverteilung und im Fettmetabolismus.
BackgroundWheat is one of the most common food allergens in early childhood. In contrast to other food allergies, wheat-specific IgE correlates badly with clinical symptoms and relevant components have been identified mostly for wheat-depended exercise-induced anaphylaxis. Moreover, a high percentage of patients present with immediate type symptoms but wheat-specific IgE cannot be detected with commercial available systems. ObjectiveWe addressed the question whether the IgE recognition pattern between wheat allergic (WA) and clinically tolerant (WT) children differs in order to identify individual proteins useful for component-resolved diagnostics. MethodsSera of 106 children with suspected wheat allergy, of whom 44 children had clinical relevant wheat allergy and 62 were tolerant upon oral food challenge, were analyzed for wheat-specific IgE using the ImmunoCap system as well as immunoblots against water and salt soluble, and water-insoluble protein fractions. 40 randomly selected sera were analyzed for specific IgE to 5-gliadin. ResultsSixty-three percent of the WT and 86% of the WA children were sensitized to wheat with >0.35 kU(A)/l in ImmunoCAP analysis. We could confirm the role of -, ss-, -, and -gliadins, and LMW glutenin subunits as major allergens and found also IgE binding to a broad spectrum of water- and salt-soluble protein bands. It is of great importance that wheat allergic and tolerant patients showed IgE binding to the same protein bands. WT and WA did not significantly differ in levels of 5-gliadin-specific IgE. Conclusions & Clinical RelevanceChildren with challenge proven clinical relevant food allergy and tolerant ones had a similar spectrum of IgE binding to the same protein bands. These findings imply that component-resolved diagnostics might not be helpful in the diagnostic work-up of wheat allergy.
Countries processing raw coffee beans are burdened with low economical incomes to fight the serious environmental problems caused by the by-products and wastewater that is generated during the wet-coffee processing. The aim of this work was to develop alternative methods of improving the waste by-product quality and thus making the process economically more attractive with valorization options that can be brought to the coffee producers.
The type of processing influences not only the constitution of green coffee but also of by-products and wastewater. Therefore, coffee bean samples as well as by-products and wastewater collected at different production steps of were analyzed. Results show that the composition of wastewater is dependent on how much and how often the wastewater is recycled in the processing. Considering the coffee beans, results indicate that the proteins might be affected during processing and a positive effect of the fermentation on the solubility and accessibility of proteins seems to be probable. The steps of coffee processing influence the different constituents of green coffee beans which, during roasting, give rise to aroma compounds and express the characteristics of roasted coffee beans. Knowing that this group of compounds is involved in the Maillard reaction during roasting, this possibility could be utilized for the coffee producers to improve the quality of green coffee beans and finally the coffee cup quality.
The valorization of coffee wastes through modification to activated carbon has been considered as a low-cost option creating an adsorbent with prospective to compete with commercial carbons. Activation protocol using spent coffee and parchment was developed and prepared to assess their adsorption capacity for organic compounds. Spent coffee grounds and parchment proved to have similar adsorption efficiency to commercial activated carbon.
The results of this study document a significant information originating from the processing of the de-pulped to green coffee beans. Furthermore, it showed that coffee parchment and spent coffee grounds can be valorized as low-cost option to produce activated carbons. Further work needs to be directed to the optimization of the activation methods to improve the quality of the materials produced and the viability of applying such experiments in-situ to bring the coffee producer further valorization opportunities with environmental perspectives.
Coffee producers would profit in establishing appropriate simple technologies to improve green coffee quality, re-use coffee by-products, and wastewater valorization.
Substanzen der pharmazeutischen und chemischen Industrie müssen nach internationalen Richtlinien auf deren Toxizität gegenüber Mensch und Umwelt geprüft werden. Dazu gehören u. a. Prüfungen zur Vorhersage des embryotoxischen Potentials, die am lebenden Organismus durchgeführt werden. Mit dem Ziel die Anzahl der Tierversuche zu verringern, die notwendig sind um das toxikologische Profil einer Prüfsubstanz zu bestimmen, wurde der Embryonale Stammzelltest (EST) entwickelt. Als Grundlage des EST dienen embryonale Stammzellen (ES-Zellen) einer Zelllinie. ES-Zellen sind Zellen, die sich in der frühen embryonalen Entwicklung in die Zellen der Keimblätter entwickeln können. Daraus wiederum differenzieren die vielen verschiedenen, unterschiedlich spezialisierten Zelltypen des komplexen Organismus. Im EST wird die Konzentration einer Prüfsubstanz bestimmt, bei der die Differenzierung von ES-Zellen zu Herzmuskelzellen zu 50 % inhibiert wird. Zusätzlich wird die Konzentration der Prüfsubstanz bestimm°t, bei der 50 % der ES-Zellen (IC50D3) bzw. Fibroblastenzellen (IC503T3) absterben. Die allgemeine Toxizität ist damit von der spezifischen Toxizität der Prüfsubstanz auf die ES-Zellen und deren Differenzierung unterscheidbar. Die Parameter fliessen in ein biostatistisches Modell zur Prädiktion des embryotoxischen Potentials der Prüfsubstanzen ein. Es wurde ein Versuchsprotokoll entwickelt, wonach die ES-Zellen sich verstärkt zu Endothelzellen differenzieren. Die Endothelzellen, die im lebenden Organismus die Wand der späteren Blutgefässe, wie Venen und Arterien bilden, wurden mittels molekularbiologischer Methoden auf der RNA- und der Protein-Ebene nachgewiesen und quantifiziert. Verschiedene Zellkulturmethoden, Wachstumsfaktoren, als auch Wachstumsfaktorkonzentrationen wurden auf deren Vermögen die Differenzierung der ES-Zellen zu Endothelzellen zu induzieren, untersucht. Nach der Etablierung des Differenzierungsprotokolls wurden sieben Substanzen auf deren Vermögen geprüft, die Differenzierung von ES-Zellen zu Endothelzellen zu inhibieren. Die Endothelzellen wurden dabei über die Expression der RNA von zwei endothelzellspezifischen Genen quantifiziert. Im Vergleich dazu wurden die IC50D3 und die IC503T3 der Prüfsubstanz bestimmt, um eine Abschätzung des embryotoxischen Potentials der Prüfsubstanz zu ermöglichen. Die Ergebnisse zeigten, dass eine Abschätzung des embryotoxischen Potentials der sieben Prüfsubstanzen in nicht-, schwach- oder stark embryotoxisch vorgenommen werden konnte. Es ist zu schlussfolgern, dass der weiterentwickelte in vitro Embryotoxizitätsassay sensitiv und reproduzierbar ist. Mit der Verwendung von verschiedenen Differenzierungsendpunkten kann die Prädiktionskraft des Assays deutlich verbessert, und die Anzahl von Tierversuchen verringert werden. Durch die Verwendung von molekularbiologischen Markern kann der Assay einem Hochdurchsatzscreening zugängig gemacht werden und damit die Anzahl von Prüfsubstanzen deutlich erhöht werden.
Obesity is a risk factor for several major cancers. Associations of weight change in middle adulthood with cancer risk, however, are less clear. We examined the association of change in weight and body mass index (BMI) category during middle adulthood with 42 cancers, using multivariable Cox proportional hazards models in the European Prospective Investigation into Cancer and Nutrition cohort. Of 241 323 participants (31% men), 20% lost and 32% gained weight (>0.4 to 5.0 kg/year) during 6.9 years (average). During 8.0 years of follow-up after the second weight assessment, 20 960 incident cancers were ascertained. Independent of baseline BMI, weight gain (per one kg/year increment) was positively associated with cancer of the corpus uteri (hazard ratio [HR] = 1.14; 95% confidence interval: 1.05-1.23). Compared to stable weight (+/- 0.4 kg/year), weight gain (>0.4 to 5.0 kg/year) was positively associated with cancers of the gallbladder and bile ducts (HR = 1.41; 1.01-1.96), postmenopausal breast (HR = 1.08; 1.00-1.16) and thyroid (HR = 1.40; 1.04-1.90). Compared to maintaining normal weight, maintaining overweight or obese BMI (World Health Organisation categories) was positively associated with most obesity-related cancers. Compared to maintaining the baseline BMI category, weight gain to a higher BMI category was positively associated with cancers of the postmenopausal breast (HR = 1.19; 1.06-1.33), ovary (HR = 1.40; 1.04-1.91), corpus uteri (HR = 1.42; 1.06-1.91), kidney (HR = 1.80; 1.20-2.68) and pancreas in men (HR = 1.81; 1.11-2.95). Losing weight to a lower BMI category, however, was inversely associated with cancers of the corpus uteri (HR = 0.40; 0.23-0.69) and colon (HR = 0.69; 0.52-0.92). Our findings support avoiding weight gain and encouraging weight loss in middle adulthood.
Obesity is a risk factor for several major cancers. Associations of weight change in middle adulthood with cancer risk, however, are less clear. We examined the association of change in weight and body mass index (BMI) category during middle adulthood with 42 cancers, using multivariable Cox proportional hazards models in the European Prospective Investigation into Cancer and Nutrition cohort. Of 241 323 participants (31% men), 20% lost and 32% gained weight (>0.4 to 5.0 kg/year) during 6.9 years (average). During 8.0 years of follow-up after the second weight assessment, 20 960 incident cancers were ascertained. Independent of baseline BMI, weight gain (per one kg/year increment) was positively associated with cancer of the corpus uteri (hazard ratio [HR] = 1.14; 95% confidence interval: 1.05-1.23). Compared to stable weight (+/- 0.4 kg/year), weight gain (>0.4 to 5.0 kg/year) was positively associated with cancers of the gallbladder and bile ducts (HR = 1.41; 1.01-1.96), postmenopausal breast (HR = 1.08; 1.00-1.16) and thyroid (HR = 1.40; 1.04-1.90). Compared to maintaining normal weight, maintaining overweight or obese BMI (World Health Organisation categories) was positively associated with most obesity-related cancers. Compared to maintaining the baseline BMI category, weight gain to a higher BMI category was positively associated with cancers of the postmenopausal breast (HR = 1.19; 1.06-1.33), ovary (HR = 1.40; 1.04-1.91), corpus uteri (HR = 1.42; 1.06-1.91), kidney (HR = 1.80; 1.20-2.68) and pancreas in men (HR = 1.81; 1.11-2.95). Losing weight to a lower BMI category, however, was inversely associated with cancers of the corpus uteri (HR = 0.40; 0.23-0.69) and colon (HR = 0.69; 0.52-0.92). Our findings support avoiding weight gain and encouraging weight loss in middle adulthood.
Nahrungsinhaltsstoffe sind im Organismus an Steuerungsprozessen und Stoffwechselvorgängen beteiligt, wobei die Mechanismen ihrer Wirkung noch nicht völlig aufgeklärt sind. Wie Vitamin E zeigen auch sekundäre Pflanzeninhaltsstoffe in Zellsystemen sowie in vivo eine Reihe biologischer Wirkungen, deren Erklärung jedoch häufig auf ihre antioxidative Eigenschaft reduziert wird. Ziel der Dissertation war es, den Einfluss von Vitamin E und anderen Pflanzeninhaltsstoffen (in Form von Pflanzenextrakten oder isolierten sekundären Pflanzeninhaltsstoffen, z.B. Polyphenole), die bisher alle hauptsächlich als Antioxidanz klassifiziert wurden, auf die transkriptionelle Regulation von Phase I- und Phase II-Enzymen zu untersuchen. Dazu wurde die Aktivierung des PXR (pregnane X receptor) und des Nrf2 (NF-E2-related factor-2) als zentrale Transkriptionsfaktoren der Phase I- bzw. Phase II-Enzyme getestet. Der Einfluss von verschiedenen Vitamin E-Formen und antioxidativen Pflanzeninhaltsstoffen in Form von Reinsubstanzen (Curcumin, EGCG, Medox, Quercetin, Resveratrol und Sulforaphan) oder Pflanzenextrakten (aus Blaubeeren, Gewürznelken, Himbeeren, Nelkenpfeffer, Thymian oder Walnüssen) auf die Aktivierung von PXR und Nrf2 sowie des Promotors eines jeweiligen Zielgens (CYP3A4 bzw. GI-GPx) wurde in vitro mit Reportergenplasmiden untersucht. Es zeigte sich, dass sowohl Vitamin E-Formen als auch verschiedene sekundäre Pflanzeninhaltsstoffe PXR und/oder Nrf2 sowie die Promotoren der jeweiligen Zielgene CYP3A4 bzw. GI-GPx aktivieren. In einem Tierexperiment konnte diese genregulatorische Wirkung von Vitamin E auf die in vivo-Situation übertragen werden. In Lebern von Mäusen, deren Futter unterschiedliche Mengen von Vitamin E enthielt (Mangel-, Normal- und Überflussdiät), wurde eine direkte Korrelation zwischen der alpha-Tocopherol-Konzentration und der Cyp3a11 mRNA-Expression nachgewiesen (Cyp3a11 ist das murine Homolog zum humanen CYP3A4). Entgegen der in vitro-Situation hatte gamma-Tocotrienol in vivo einen nur kaum nachweisbaren Effekt auf die Expression der Cyp3a11 mRNA, induzierte aber die Expression der alpha-TTP mRNA. Es konnte gezeigt werden, dass Vitamin E und sekundäre Pflanzeninhaltsstoffe Phase I- und Phase II-Enzyme transkriptionell regulieren können. Die Wirkungen des Vitamin E können sich allerdings nur entfalten, wenn die Vitamin E-Formen ausreichend vom Körper aufgenommen werden. Gegenstand der Dissertation waren daher auch Untersuchungen zur Bioverfügbarkeit (zelluläre Akkumulation und Metabolismus) verschiedener Vitamin E-Formen. Es konnte gezeigt werden, dass Unterschiede in der chemischen Struktur der Vitamin E-Formen deren zelluläre Akkumulation und Metabolisierung beeinflussen. Unter Berücksichtigung der Ergebnisse der Dissertation lassen sich protektive Wirkungen von antioxidativen Nahrungsinhaltsstoffen auch unabhängig von ihren antioxidativen Eigenschaften über die Induktion zelleigener Schutzsysteme, einschließlich der Phase I- und Phase II-Enzyme, erklären. Die Induktion der zelleigenen Abwehr lässt sich auch als adaptive Antwort (sog. "adaptive response") des Organismus gegenüber zellschädigenden Ereignissen betrachten.
Vitamine
(2000)
Vitamin E wird immer noch als das wichtigste lipophile Antioxidanz in biologischen Membranen betrachtet. In den letzten Jahren hat sich jedoch der Schwerpunkt der Vitamin E-Forschung hin zu den nicht-antioxidativen Funktionen verlagert. Besonderes Interesse gilt dabei dem α-Tocopherol, der häufigsten Vitamin E-Form im Gewebe von Säugetieren, und seiner Rolle bei der Regulation der Genexpression. Das Ziel dieser Dissertation war die Untersuchung der genregulatorischen Funktionen von α-Tocoperol und die Identifizierung α-Tocopherol-sensitiver Gene in vivo. Zu diesem Zweck wurden Mäuse mit verschiedenen Mengen α-Tocopherol gefüttert. Die Analyse der hepatischen Genexpression mit Hilfe von DNA-Microarrays identifizierte 387 α-Tocopherol-sensitive Gene. Funktionelle Clusteranalysen der differentiell exprimierten Gene zeigten einen Einfluss von α-Tocooherol auf zelluläre Transportprozesse. Besonders solche Gene, die an vesikulären Transportvorgängen beteiligt sind, wurden größtenteils durch α-Tocopherol hochreguliert. Für Syntaxin 1C, Vesicle-associated membrane protein 1, N-ethylmaleimide-sensitive factor and Syntaxin binding protein 1 konnte eine erhöhte Expression mittels real time PCR bestätigt werden. Ein funktioneller Einfluss von α-Tocopherol auf vesikuläre Transportprozesse konnte mit Hilfe des in vitro β-Hexosaminidase Assays in der sekretorischen Mastzelllinie RBL-2H3 gezeigt werden. Die Inkubation der Zellen mit α-Tocopherol resultierte in einer konzentrationsabhängigen Erhöhung der PMA/Ionomycin-stimulierten Sekretion der β-Hexosaminidase. Eine erhöhte Expression ausgewählter Gene, die an der Degranulation beteiligt sind, konnte nicht beobachtet werden. Damit schien ein direkter genregulatorischer Effekt von α-Tocopherol eher unwahrscheinlich. Da eine erhöhte Sekretion auch mit β-Tocopherol aber nicht mit Trolox, einem hydrophilen Vitamin E-Analogon, gefunden wurde, wurde vermutet, dass α-Tocopherol die Degranulation möglicherweise durch seine membranständige Lokalisation beeinflussen könnte. Die Inkubation der Zellen mit α-Tocopherol resultierte in einer veränderten Verteilung des Gangliosids GM1, einem Lipid raft Marker. Es wird angenommen, dass diese Membranmikrodomänen als Plattformen für Signaltransduktionsvorgänge fungieren. Ein möglicher Einfluss von Vitamin E auf die Rekrutierung/Translokation von Signalproteinen in Membranmikrodomänen könnte die beobachteten Effekte erklären. Eine Rolle von α-Tocopherol im vesikulären Transport könnte nicht nur seine eigene Absorption und seinen Transport beeinflussen, sondern auch eine Erklärung für die bei schwerer Vitamin E-Defizienz auftretenden neuronalen Dysfunktionen bieten. Im zweiten Teil der Arbeit wurde die α-Tocopheroltransferprotein (Ttpa) Knockout-Maus als genetisches Modell für Vitamin E-Defizienz verwendet, um den Effekt von Ttpa auf die Genexpression und die Gewebeverteilung von α-Tocopherol zu analysieren. Ttpa ist ein cytosolisches Protein, das für die selektive Retention von α-Tocopherol in der Leber verantwortlich ist. Die Ttpa-Defizienz resultierte in sehr geringen α-Tocopherol-Konzentrationen im Plasma und den extrahepatischen Geweben. Die Analyse der α-Tocopherol-Gehalte im Gehirn wies auf eine Rolle von Ttpa bei der α-Tocopherol-Aufnahme ins Gehirn hin.
Vitamin E : elucidation of the mechanism of side chain degradation and gene regulatory functions
(2005)
For more than 80 years vitamin E has been in the focus of scientific research. Most of the progress concerning non-antioxidant functions, nevertheless, has only arisen from publications during the last decade. Most recently, the metabolic pathway of vitamin E has been almost completely elucidated. Vitamin E is metabolized by truncation of its side chain. The initial step of an omega-hydroxylation is carried out by cytochromes P450 (CYPs). This was evidenced by the inhibition of the metabolism of alpha-tocopherol by ketoconozole, an inhibitor of CYP3A expression, whereas rifampicin, an inducer of CYP3A expression increased the metabolism of alpha-tocopherol. Although the degradation pathway is identical for all tocopherols and tocotrienols, there is a marked difference in the amount of the release of metabolites from the individual vitamin E forms in cell culture as well as in experimental animals and in humans. Recent findings not only proposed an CYP3A4-mediated degradation of vitamin E but also suggested an induction of the metabolizing enzymes by vitamin E itself. In order to investigate how vitamin E is able to influence the expression of metabolizing enzymes like CYP3A4, a pregnane X receptor (PXR)-based reporter gene assay was chosen. PXR is a nuclear receptor which regulates the transcription of genes, e.g., CYP3A4, by binding to specific DNA response elements. And indeed, as shown here, vitamin E is able to influence the expression of CYP3A via PXR in an in vitro reporter gene assay. Tocotrienols showed the highest activity followed by delta- and alpha-tocopherol. An up-regulation of Cyp3a11 mRNA, the murine homolog of the human CYP3A4, could also be confirmed in an animal experiment. The PXR-mediated change in gene expression displayed the first evidence of a direct transcriptional activity of vitamin E. PXR regulates the expression of genes involved in xenobiotic detoxification, including oxidation, conjugation, and transport. CYP3A, e.g., is involved in the oxidative metabolism of numerous currently used drugs. This opens a discussion of possible side effects of vitamin E, but the extent to which supranutritional doses of vitamin E modulate these pathways in humans has yet to be determined. Additionally, as there is arising evidence that vitamin E's essentiality is more likely to be based on gene regulation than on antioxidant functions, it appeared necessary to further investigate the ability of vitamin E to influence gene expression. Mice were divided in three groups with diets (i) deficient in alpha-tocopherol, (ii) adequate in alpha-tocopherol supply and (iii) with a supranutritional dosage of alpha-tocopherol. After three months, half of each group was supplemented via a gastric tube with a supranutritional dosage of gamma-tocotrienol per day for 7 days. Livers were analyzed for vitamin E content and liver RNA was prepared for hybridization using cDNA array and oligonucleotide array technology. A significant change in gene expression was observed by alpha-tocopherol but not by gamma-tocotrienol and only using the oligonucleotide array but not using the cDNA array. The latter effect is most probably due to the limited number of genes represented on a cDNA array, the lacking gamma-tocotrienol effect is obviously caused by a rapid degradation, which might prevent bioefficacy of gamma-tocotrienol. Alpha-tocopherol changed the expression of various genes. The most striking observation was an up-regulation of genes, which code for proteins involved in synaptic transmitter release and calcium signal transduction. Synapsin, synaptotagmin, synaptophysin, synaptobrevin, RAB3A, complexin 1, Snap25, ionotropic glutamate receptors (alpha 2 and zeta 1) were shown to be up-regulated in the supranutritional group compared to the deficient group. The up-regulation of synaptic genes shown in this work are not only supported by the strong concentration of genes which all are involved in the process of vesicular transport of neurotransmitters, but were also confirmed by a recent publication. However, a confirmation by real time PCR in neuronal tissue like brain is now required to explain the effect of vitamin E on neurological functionality. The change in expression of genes coding for synaptic proteins by vitamin E is of principal interest thus far, since the only human disease directly originating from an inadequate vitamin E status is ataxia with isolated vitamin E deficiency. Therefore, with the results of this work, an explanation for the observed neurological symptoms associated with vitamin E deficiency can be presented for the first time.
Aim: To investigate the relationship of vitamin D-binding protein (GC) and genetic variation of GC (rs4588, rs7041 and rs2282679) with metabolic syndrome (MetS) in the Thai population. Materials & methods: GCglobulin concentrations were measured by quantitative western blot analysis in 401 adults. All participants were genotyped using TaqMan allelic discrimination assays. Results: GC-globulin levels were significatly lower in MetS subjects than in control subjects, in which significant negative correlations of GC-globulin levels with systolic blood pressure, glucose and age were found. Male participants who carried the GT genotype for rs4588 showed an increased risk of MetS compared with the GG wild-type (odds ratio: 3.25; p = 0.004). Conclusion: GC-globulin concentrations and variation in GC rs4588 were supported as a risk factor for MetS in Thais.
Background: Given the huge impact of vitamin D deficiency on a broad spectrum of diseases such as rickets, osteoporosis, mineral bone disease-vascular calcification syndrome, infectious diseases, but also several types of cancer and CNS diseases, reliable and simple methods to analyze the vitamin D status are urgently needed.
Methods: We developed an easy technique to determine the 25-OH vitamin D status from dried blood samples on filter paper. This allows determination of the 25-OH vitamin D status independently of venous blood taking, since only sampling of capillary blood is required for this new method. We compared the results of vitamin D measurements from venous blood of 96 healthy blood donors with those from capillary blood taken from the same patients at the same time. The capillary blood was dried on filter paper using the D-Vital ID dry-blood collection system.
Results: 25-OH vitamin D concentration data from extracted dried capillary blood filters correlated very well with data obtained after direct measurement of venous blood samples of the same blood donor (R: 0.7936; p<0.0001). The correlation was linear over the whole range of 25-OH vitamin D concentrations seen in this study. A Bland-Altman plot revealed good agreement between both tests.
Conclusions: The D-Vital ID dry-blood collection system showed an excellent performance as compared to the classical way of 25-OH vitamin D measurement from venous blood. This new technique will facilitate easy and reliable measurement for vitamin D status, in particular, in rural or isolated areas, developing countries, and field studies.
Preclinical work indicates that calcitriol restores vascular function by normalizing the endothelial expression of cyclooxygenase-2 and thromboxane-prostanoid receptors in conditions of estrogen deficiency and thus prevents the thromboxane-prostanoid receptor activation-induced inhibition of nitric oxide synthase. Since endothelial dysfunction is a key factor in the pathogenesis of cardiovascular diseases, this finding may have an important translational impact. It provides a clear rationale to use endothelial function in clinical trials aiming to find the optimal dose of vitamin D for the prevention of cardiovascular events in postmenopausal women.
Mutations in the enzyme isocitrate dehydrogenase 1 (IDH1) lead to metabolic alterations and a sustained formation of 2-hydroxyglutarate (2-HG). 2-HG is an oncometabolite as it inhibits the activity of alpha-ketoglutarate-dependent dioxygenases such as ten-eleven translocation (TET) enzymes. Inhibitors of mutant IDH enzymes, like ML309, are currently tested in order to lower the levels of 2-HG. Vitamin C (VC) is an inducer of TET enzymes. To test a new therapeutic avenue of synergistic effects, the anti-neoplastic activity of inhibition of mutant IDH1 via ML309 in the presence of VC was investigated in the colon cancer cell line HCT116 IDH1(R132H/+) (harbouring a mutated IDH1 allele) and the parental cells HCT116 IDH1(+/+) (wild type IDH1). Measurement of the oncometabolite indicated a 56-fold higher content of 2-HG in mutated cells compared to wild type cells. A significant reduction of 2-HG was observed in mutated cells after treatment with ML 309, whereas VC produced only minimally changes of the oncometabolite. However, combinatorial treatment with both, ML309 and VC, in mutated cells induced pronounced reduction of 2-HG leading to levels comparable to those in wild type cells. The decreased level of 2-HG in mutated cells after combinatorial treatment was accompanied by an enhanced global DNA hydroxymethylation and an increased gene expression of certain tumour suppressors. Moreover, mutated cells showed an increased percentage of apoptotic cells after treatment with non-cytotoxic concentrations of ML309 and VC. These results suggest that combinatorial therapy is of interest for further investigation to rescue TET activity and treatment of IDH1/2 mutated cancers.
Background: Sub-Saharan Africa is facing a double burden of malnutrition: vitamin A deficiency (VAD) prevails, whereas the nutrition-related chronic conditions type 2 diabetes (T2D) and hypertension are emerging. Serum retinol a VAD marker increases in kidney disease and decreases in inflammation, which can partly be attributed to alterations in the vitamin A transport proteins retinol-binding protein 4 (RBP4) and prealbumin. Kidney dysfunction and inflammation commonly accompany T2D and hypertension.
Objective: Among urban Ghanaians, we investigated the associations of T2D and hypertension with serum retinol as well as the importance of kidney function and inflammation in this regard.
Design: A hospital-based, case-control study in individuals for risk factors of T2D, hypertension, or both was conducted in Kumasi, Ghana (328 controls, 197 with T2D, 354 with hypertension, and 340 with T2D plus hypertension). In 1219 blood samples, serum retinol, RBP4, and prealbumin were measured. Urinary albumin and estimated glomerular filtration rate (eGFR) defined kidney function. C-reactive protein (CRP) >5 mg/L indicated inflammation. We identified associations of T2D and hypertension with retinol by linear regression and calculated the contribution of RBP4, prealbumin, urinary albumin, eGFR, and CRP to these associations as the percentages of the explained variance of retinol.
Results: VAD (retinol <1.05 mu mol/L) was present in 10% of this predominantly female, middle-aged, overweight, and deprived population. Hypertension, but not T2D, was positively associated with retinol (beta: 0.12; 95% CI: 0.08, 0,17), adjusted for age, sex, socioeconomic factors, anthropometric measurements, and lifestyle. In addition to RBP4 (72%) and prealbumin (22%), the effect of increased retinol on individuals with hypertension was mainly attributed to impaired kidney function (eGFR: 30%; urinary albumin: 5%) but not to inflammation.
Conclusions: In patients with hypertension, VAD might be underestimated because of increased serum retinol in the context of kidney dysfunction. Thus, the interpretation of serum retinol in sub-Saharan Africa should account for hypertension status.
Vitamin A metabolism is changed in donors after living-kidney transplantation an observational study
(2011)
Background: The kidneys are essential for the metabolism of vitamin A (retinol) and its transport proteins retinol-binding protein 4 (RBP4) and transthyretin. Little is known about changes in serum concentration after living donor kidney transplantation (LDKT) as a consequence of unilateral nephrectomy; although an association of these parameters with the risk of cardiovascular diseases and insulin resistance has been suggested. Therefore we analyzed the concentration of retinol, RBP4, apoRBP4 and transthyretin in serum of 20 living-kidney donors and respective recipients at baseline as well as 6 weeks and 6 months after LDKT.
Results: As a consequence of LDKT, the kidney function of recipients was improved while the kidney function of donors was moderately reduced within 6 weeks after LDKT. With regard to vitamin A metabolism, the recipients revealed higher levels of retinol, RBP4, transthyretin and apoRBP4 before LDKT in comparison to donors. After LDKT, the levels of all four parameters decreased in serum of the recipients, while retinol, RBP4 as well as apoRBP4 serum levels of donors increased and remained increased during the follow-up period of 6 months.
Conclusion: LDKT is generally regarded as beneficial for allograft recipients and not particularly detrimental for the donors. However, it could be demonstrated in this study that a moderate reduction of kidney function by unilateral nephrectomy, resulted in an imbalance of components of vitamin A metabolism with a significant increase of retinol and RBP4 and apoRBP4 concentration in serum of donors.
Background
The kidneys are essential for the metabolism of vitamin A (retinol) and its transport proteins retinol-binding protein 4 (RBP4) and transthyretin. Little is known about changes in serum concentration after living donor kidney transplantation (LDKT) as a consequence of unilateral nephrectomy; although an association of these parameters with the risk of cardiovascular diseases and insulin resistance has been suggested. Therefore we analyzed the concentration of retinol, RBP4, apoRBP4 and transthyretin in serum of 20 living-kidney donors and respective recipients at baseline as well as 6 weeks and 6 months after LDKT.
Results
As a consequence of LDKT, the kidney function of recipients was improved while the kidney function of donors was moderately reduced within 6 weeks after LDKT. With regard to vitamin A metabolism, the recipients revealed higher levels of retinol, RBP4, transthyretin and apoRBP4 before LDKT in comparison to donors. After LDKT, the levels of all four parameters decreased in serum of the recipients, while retinol, RBP4 as well as apoRBP4 serum levels of donors increased and remained increased during the follow-up period of 6 months.
Conclusion
LDKT is generally regarded as beneficial for allograft recipients and not particularly detrimental for the donors. However, it could be demonstrated in this study that a moderate reduction of kidney function by unilateral nephrectomy, resulted in an imbalance of components of vitamin A metabolism with a significant increase of retinol and RBP4 and apoRBP4 concentration in serum of donors.
Vitamin A excreted in the urine of canines is associated with a Tamm-Horsfall-like Glycoprotein
(1998)
Veränderung der Carotinoidkonzentration im Serum und in der Milch im Verlauf der Laktation der Frau
(2000)
Verteilung von Vitamin A und Retinol-Bindungs-Protein (RBP) in verschiedenen Geweben von Caniden
(1997)
Respiratorische Erkrankungen stellen zunehmend eine relevante globale Problematik dar. Die Erweiterung bzw. Modifizierung von Applikationswegen möglicher Arzneimittel für gezielte topische Anwendungen ist dabei von größter Bedeutung. Die Variation eines bekannten Applikationsweges durch unterschiedliche technologische Umsetzungen kann die Vielfalt der Anwendungsmöglichkeiten, aber auch die Patienten-Compliance erhöhen. Die einfache und flexible Verfahrensweise durch schnelle Verfügbarkeit und eine handliche Technologie sind heutzutage wichtige Eigenschaften im Entwicklungsprozess eines Produktes. Eine direkte topische Behandlung von Atemwegserkrankungen am Wirkort in Form einer inhalativen Applikation bietet dabei viele Vorteile gegenüber einer systemischen Therapie. Die medizinische Inhalation von Wirkstoffen über die Lunge ist jedoch eine komplexe Herausforderung. Inhalatoren gehören zu den erklärungsbedürftigen Applikationsformen, die zur Erhöhung der konsequenten Einhaltung der Verordnung so einfach, wie möglich gestaltet werden müssen. Parallel besitzen und nutzen weltweit annähernd 68 Millionen Menschen die Technologie eines inhalativen Applikators zur bewussten Schädigung ihrer Gesundheit in Form einer elektronischen Zigarette. Diese bekannte Anwendung bietet die potentielle Möglichkeit einer verfügbaren, kostengünstigen und qualitätsgeprüften Gesundheitsmaßnahme zur Kontrolle, Prävention und Heilung von Atemwegserkrankungen. Sie erzeugt ein Aerosol durch elektrothermische Erwärmung eines sogenannten Liquids, das durch Kapillarkräfte eines Trägermaterials an ein Heizelement gelangt und verdampft. Ihr Bekanntheitsgrad zeigt, dass eine beabsichtigte Wirkung in den Atemwegen eintritt. Diese Wirkung könnte jedoch auch auf potentielle pharmazeutische Einsatzgebiete übertragbar sein. Die Vorteile der pulmonalen Verabreichung sind dabei vielfältig. Im Vergleich zur peroralen Applikation gelangt der Wirkstoff gezielt zum Wirkort. Wenn eine systemische Applikation zu Arzneimittelkonzentrationen unterhalb der therapeutischen Wirksamkeit in der Lunge führt, könnte eine inhalative Darreichung bereits bei niedriger Dosierung die gewünschten höheren Konzentrationen am Wirkort hervorrufen. Aufgrund der großen Resorptionsfläche der Lunge sind eine höhere Bioverfügbarkeit und ein schnellerer Wirkungseintritt infolge des fehlenden First-Pass-Effektes möglich. Es kommt ebenfalls zu minimalen systemischen Nebenwirkungen. Die elektronische Zigarette erzeugt wie die medizinischen Inhalatoren lungengängige Partikel. Die atemzuggesteuerte Technik ermöglicht eine unkomplizierte und intuitive Anwendung. Der prinzipielle Aufbau besteht aus einer elektrisch beheizten Wendel und einem Akku. Die Heizwendel ist von einem sogenannten Liquid in einem Tank umgeben und erzeugt das Aerosol. Das Liquid beinhaltet eine Basismischung bestehend aus Propylenglycol, Glycerin und reinem Wasser in unterschiedlichen prozentualen Anteilen. Es besteht die Annahme, dass das Basisliquid auch mit pharmazeutischen Wirkstoffen für die pulmonale Applikation beladen werden kann. Aufgrund der thermischen Belastung durch die e-Zigarette müssen potentielle Wirkstoffe sowie das Vehikel eine thermische Stabilität aufweisen.
Die potentielle medizinische Anwendung der Technologie einer handelsüblichen e-Zigarette wurde anhand von drei Schwerpunkten an vier Wirkstoffen untersucht. Die drei ätherischen Öle Eucalyptusöl, Minzöl und Nelkenöl wurden aufgrund ihrer leichten Flüchtigkeit und der historischen pharmazeutischen Anwendung anhand von Inhalationen bei Erkältungssymptomen bzw. im zahnmedizinischen Bereich gewählt. Das eingesetzte Cannabinoid Cannabidiol (CBD) hat einen aktuellen Bezug zu dem pharmazeutischen Markt Deutschlands zur Legalisierung von cannabishaltigen Produkten und der medizinischen Forschung zum inhalativen Konsum. Es wurden relevante wirkstoffhaltige Flüssigformulierungen entwickelt und hinsichtlich ihrer Verdampfbarkeit zu Aerosolen bewertet. In den quantitativen und qualitativen chromatographischen Untersuchungen konnten spezifische Verdampfungsprofile der Wirkstoffe erfasst und bewertet werden. Dabei stieg die verdampfte Masse der Leitsubstanzen 1,8-Cineol (Eucalyptusöl), Menthol (Minzöl) und Eugenol (Nelkenöl) zwischen 33,6 µg und 156,2 µg pro Zug proportional zur Konzentration im Liquid im Bereich zwischen 0,5% und 1,5% bei einer Leistung von 20 Watt. Die Freisetzungsrate von Cannabidiol hingegen schien unabhängig von der Konzentration im Liquid im Mittelwert bei 13,3 µg pro Zug zu liegen. Dieses konnte an fünf CBD-haltigen Liquids im Konzentrationsbereich zwischen 31 µg/g und 5120 µg/g Liquid gezeigt werden. Außerdem konnte eine Steigerung der verdampften Massen mit Zunahme der Leistung der e-Zigarette festgestellt werden. Die Interaktion der Liquids bzw. Aerosole mit den Bestandteilen des Speichels sowie weiterer gastrointestinaler Flüssigkeiten wurde über die Anwendung von zugehörigen in vitro Modellen und Einsatz von Enzymaktivitäts-Assays geprüft. In den Untersuchungen wurden Änderungen von Enzymaktivitäten anhand des oralen Schlüsselenzyms α-Amylase sowie von Proteasen ermittelt. Damit sollte exemplarisch ein möglicher Einfluss auf physiologische bzw. metabolische Prozesse im humanen Organismus geprüft werden. Das Bedampfen von biologischen Suspensionen führte bei niedriger Leistung der e-Zigarette (20 Watt) zu keiner bzw. einer leichten Änderung der Enzymaktivität. Die Anwendung einer hohen Leistung (80 Watt) bewirkte tendenziell das Herabsetzen der Enzymaktivitäten. Die Erhöhung der Enzymaktivitäten könnte zu einem enzymatischen Abbau von Schleimstoffen wie Mucinen führen, was wiederum die effektive, mechanische Abwehr gegenüber bakteriellen Infektionen zur Folge hätte. Da eine Anwendung der Applikation insbesondere bei bakteriellen Atemwegserkrankungen denkbar wäre, folgten abschließend Untersuchungen der antibakteriellen Eigenschaften der Liquids bzw. Aerosole in vitro. Es wurden sechs klinisch relevante bakterielle Krankheitserreger ausgewählt, die nach zwei Charakteristika gruppiert werden können. Die drei multiresistenten Bakterien Pseudomonas aeruginosa, Klebsiella pneumoniae und Methicillin-resistenter Staphylococcus aureus können mithilfe von üblichen Therapien mit Antibiotika nicht abgetötet werden und haben vor allem eine nosokomiale Relevanz. Die zweite Gruppe weist Eigenschaften auf, die vordergründig assoziiert sind mit respiratorischen Erkrankungen. Die Bakterien Streptococcus pneumoniae, Moraxella catarrhalis und Haemophilus influenzae sind repräsentativ beteiligt an Atemwegserkrankungen mit diverser Symptomatik. Die Bakterienarten wurden mit den jeweiligen Liquids behandelt bzw. bedampft und deren grundlegende Dosis-Wirkungsbeziehung charakterisiert. Dabei konnte eine antibakterielle Aktivität der Formulierungen ermittelt werden, die durch Zugabe eines Wirkstoffes die bereits antibakterielle Wirkung der Bestandteile Glycerin und Propylenglycol verstärkte. Die hygroskopischen Eigenschaften dieser Substanzen sind vermutlich für eine Wirkung in aerosolierter Form verantwortlich. Sie entziehen die Feuchtigkeit aus der Luft und haben einen austrocknenden Effekt auf die Bakterien. Das Bedampfen der Bakterienarten Streptococcus pneumoniae, Moraxella catarrhalis und Haemophilus influenzae hatte einen antibakteriellen Effekt, der zeitlich abhängig von der Leistung der e-Zigarette war.
Die Ergebnisse der Untersuchungen führen zu dem Schluss, dass jeder Wirkstoff bzw. jede Substanzklasse individuell zu bewerten ist und somit Inhalator und Formulierung aufeinander abgestimmt werden müssen. Der Einsatz der e-Zigarette als Medizinprodukt zur Applikation von Arzneimitteln setzt stets Prüfungen nach Europäischem Arzneibuch voraus. Durch Modifizierungen könnte eine Dosierung gut kontrollierbar gemacht werden, aber auch die Partikelgrößenverteilung kann insoweit reguliert werden, dass die Wirkstoffe je nach Partikelgröße zu einem geeigneten Applikationsort wie Mund, Rachen oder Bronchien transportiert werden. Der Vergleich mit den Eigenschaften anderer medizinischer Inhalatoren führt zu dem Schluss, dass die Technologie der e-Zigarette durchaus eine gleichartige oder bessere Performance für thermisch stabile Wirkstoffe bieten könnte. Dieses fiktive Medizinprodukt könnte aus einer hersteller-unspezifisch produzierten, wieder aufladbaren Energiequelle mit Universalgewinde zum mehrfachen Gebrauch und einer hersteller- und wirkstoffspezifisch produzierten Einheit aus Verdampfer und Arzneimittel bestehen. Das Arzneimittel, ein medizinisches Liquid (Vehikel und Wirkstoff) kann in dem Tank des Verdampfers mit konstanten, nicht variablen Parametern patientenindividuell produziert werden. Inhalative Anwendungen werden perspektivisch wohl nicht zuletzt aufgrund der aktuellen COVID-19-Pandemie eine zunehmende Rolle spielen. Der Bedarf nach alternativen Therapieoptionen wird weiter ansteigen. Diese Arbeit liefert einen Beitrag zum Einsatz der Technologie der elektronischen Zigarette als electronic nicotin delivery system (ENDS) nach Modifizierung zu einem potentiellen pulmonalen Applikationssystem als electronic drug delivery system (EDDS) von inhalativen, thermisch stabilen Arzneimitteln in Form eines Medizinproduktes.
Mit dem Alter kann eine Zunahme leichtgradiger Entzündungsprozesse beobachtet werden, von denen angenommen wird, dass sie den typischen, altersbedingten Verlust an Muskelmasse, -kraft und -funktion „befeuern“. Diese als Inflammaging bezeichneten Prozesse können auf ein komplexes Zusammenspiel aus einem dysfunktionalen (viszeralen) Fettgewebe, einer Dysbiose und damit einhergehender mikrobiellen Translokation und geringeren Abwehrfähigkeit sowie einer insgesamt zunehmenden Immunseneszenz zurückgeführt werden. In Summa begünstigt ein pro-inflammatorisches Milieu metabolische Störungen und chronische, altersassoziierte Erkrankungen, die das Entzündungsgeschehen aufrechterhalten oder vorantreiben. Neben einem essenziellen Bewegungsmangel trägt auch eine westlich geprägte, industrialisierte Ernährungsweise zum Entzündungsgeschehen und zur Entwicklung chronischer Erkrankungen bei. Daher liegt die Vermutung nahe, dem Entzündungsgeschehen mit ausreichend Bewegung und einer anti-inflammatorischen Ernährung entgegenzuwirken. In dieser Hinsicht werden insbesondere Omega-3-Fettsäuren (Omega-3) mit anti-inflammatorischen Eigenschaften verbunden. Obwohl ein Zusammenhang zwischen dem ernährungsbedingten Inflammationspotenzial bzw. der Zufuhr von Omega-3 und dem Inflammationsprofil bereits untersucht wurde, fehlen bislang Untersuchungen insbesondere bei älteren Erwachsenen, die den Link zwischen dem Inflammationspotenzial der Ernährung und Sarkopenie-relevanten Muskelparametern herstellen.
Aufgrund des Proteinmehrbedarfs zum Erhalt der funktionellen Muskulatur im Alter wurde bereits eine Vielzahl an Sport- und Ernährungsinterventionen durchgeführt, die eine Verbesserung des Muskelstatus mit Hilfe von strukturiertem Krafttraining und einer proteinreichen Ernährung zeigen. Es gibt zudem Hinweise, dass Omega-3 auch die Proteinsynthese verstärken könnten. Unklar ist jedoch, inwiefern eine anti-inflammatorische Ernährung mit Fokus auf Omega-3 sowohl die Entzündungsprozesse als auch den Muskelproteinmetabolismus und die neuromuskuläre Funktionalität im Alter günstig unterstützen kann. Dies vor allem im Hinblick auf die Muskelleistung, die eng mit der Sturzneigung und der Autonomie im Alltag verknüpft ist, aber in Interventionsstudien mit älteren Erwachsenen bisher wenig Berücksichtigung erhielt. Darüber hinaus werden häufig progressive Trainingselemente genutzt, die nach Studienabschluss oftmals wenig Anschluss im Lebensalltag der Betroffenen finden und somit wenig nachhaltig sind. Ziel dieser Arbeit war demnach die Evaluierung einer proteinreichen und zusätzlich mit Omega-3 supplementierten Ernährung in Kombination mit einem wöchentlichen Vibrationstraining und altersgemäßen Bewegungsprogramm auf Inflammation und neuromuskuläre Funktion bei älteren, selbständig lebenden Erwachsenen.
Hierzu wurden zunächst mögliche Zusammenhänge zwischen dem ernährungsbedingten Inflammationspotenzial, ermittelt anhand des Dietary Inflammatory Index, und dem Muskelstatus sowie dem Inflammationsprofil im Alter eruiert. Dazu dienten die Ausgangswerte von älteren, selbständig lebenden Erwachsenen einer postprandialen Interventionsstudie (POST-Studie), die im Querschnitt analysiert wurden. Die Ergebnisse bestätigten, dass eine pro-inflammatorische Ernährung sich einerseits in einem stärkeren Entzündungsgeschehen widerspiegelt und andererseits mit Sarkopenie-relevanten Parametern, wie einer geringeren Muskelmasse und Gehgeschwindigkeit, ungünstig assoziiert ist. Darüber hinaus zeigten sich diese Zusammenhänge auch in Bezug auf die Handgreifkraft bei den inaktiven, älteren Erwachsenen der Studie.
Anschließend wurde in einer explorativ ausgerichteten Pilot-Interventionsstudie (AIDA-Studie) in einem dreiarmigen Design untersucht, inwieweit sich eine Supplementierung mit Omega-3 unter Voraussetzung einer optimierten Proteinzufuhr und altersgemäßen Sportintervention mit Vibrationstraining auf die neuromuskuläre Funktion und Inflammation bei selbständig lebenden, älteren Erwachsenen auswirkt. Nach acht Wochen Intervention zeigte sich, dass eine mit Omega-3 supplementierte, proteinreiche Ernährung die Muskelleistung insbesondere bei den älteren Männern steigerte. Während sich die Kontrollgruppe nach acht Wochen Sportintervention nicht verbesserte, bestätigte sich zusätzlich eine Verbesserung der Beinkraft und der Testzeit beim Stuhl-Aufsteh-Test der älteren Erwachsenen mit einer proteinreichen Ernährung in Kombination mit der Sportintervention.
Darüber hinaus wurde deutlich, dass die zusätzliche Omega-3-Supplementierung insbesondere bei den Männern eine Reduktion der pro-inflammatorischen Zytokine im Serum zur Folge hatte. Allerdings spiegelten sich diese Beobachtungen nicht auf Genexpressionsebene in mononukleären Immunzellen oder in der LPS-induzierten Sekretion der Zytokine und Chemokine in Vollblutzellkulturen wider. Dies erfordert weitere Untersuchungen.
Background: Plasma concentration of retinol is an accepted indicator to assess the vitamin A (retinol) status in cattle. However, the determination of vitamin A requires a time consuming multi-step procedure, which needs specific equipment to perform extraction, centrifugation or saponification prior to high-performance liquid chromatography (HPLC).
Methods: The concentrations of retinol in whole blood (n = 10), plasma (n = 132) and serum (n = 61) were measured by a new rapid cow-side test (iCheck™ FLUORO) and compared with those by HPLC in two independent laboratories in Germany (DE) and Japan (JP).
Results: Retinol concentrations in plasma ranged from 0.033 to 0.532 mg/L, and in serum from 0.043 to 0.360 mg/L (HPLC method). No significant differences in retinol levels were observed between the new rapid cow-side test and HPLC performed in different laboratories (HPLC vs. iCheck™ FLUORO: 0.320 ± 0.047 mg/L vs. 0.333 ± 0.044 mg/L, and 0.240 ± 0.096 mg/L vs. 0.241 ± 0.069 mg/L, lab DE and lab JP, respectively). A similar comparability was observed when whole blood was used (HPLC vs. iCheck™ FLUORO: 0.353 ± 0.084 mg/L vs. 0.341 ± 0.064 mg/L). Results showed a good agreement between both methods based on correlation coefficients of r2 = 0.87 (P < 0.001) and Bland-Altman blots revealed no significant bias for all comparison.
Conclusions: With the new rapid cow-side test (iCheck™ FLUORO) retinol concentrations in cattle can be reliably assessed within a few minutes and directly in the barn using even whole blood without the necessity of prior centrifugation. The ease of the application of the new rapid cow-side test and its portability can improve the diagnostic of vitamin A status and will help to control vitamin A supplementation in specific vitamin A feeding regimes such as used to optimize health status in calves or meat marbling in Japanese Black cattle.
Background: Plasma concentration of retinol is an accepted indicator to assess the vitamin A (retinol) status in cattle. However, the determination of vitamin A requires a time consuming multi-step procedure, which needs specific equipment to perform extraction, centrifugation or saponification prior to high-performance liquid chromatography (HPLC).
Methods: The concentrations of retinol in whole blood (n = 10), plasma (n = 132) and serum (n = 61) were measured by a new rapid cow-side test (iCheck™ FLUORO) and compared with those by HPLC in two independent laboratories in Germany (DE) and Japan (JP).
Results: Retinol concentrations in plasma ranged from 0.033 to 0.532 mg/L, and in serum from 0.043 to 0.360 mg/L (HPLC method). No significant differences in retinol levels were observed between the new rapid cow-side test and HPLC performed in different laboratories (HPLC vs. iCheck™ FLUORO: 0.320 ± 0.047 mg/L vs. 0.333 ± 0.044 mg/L, and 0.240 ± 0.096 mg/L vs. 0.241 ± 0.069 mg/L, lab DE and lab JP, respectively). A similar comparability was observed when whole blood was used (HPLC vs. iCheck™ FLUORO: 0.353 ± 0.084 mg/L vs. 0.341 ± 0.064 mg/L). Results showed a good agreement between both methods based on correlation coefficients of r2 = 0.87 (P < 0.001) and Bland-Altman blots revealed no significant bias for all comparison.
Conclusions: With the new rapid cow-side test (iCheck™ FLUORO) retinol concentrations in cattle can be reliably assessed within a few minutes and directly in the barn using even whole blood without the necessity of prior centrifugation. The ease of the application of the new rapid cow-side test and its portability can improve the diagnostic of vitamin A status and will help to control vitamin A supplementation in specific vitamin A feeding regimes such as used to optimize health status in calves or meat marbling in Japanese Black cattle.
Background. Despite considerable progress made in the past decade through salt iodization programs, over 2 billion people worldwide still have inadequate iodine intake, with devastating consequences for brain development and intellectual capacity. To optimize these programs with regard to salt iodine content, careful monitoring of salt iodine content is essential, but few methods are available to quantitatively measure iodine concentration in a simple, fast, and safe way.
Objective. We have validated a newly developed device that quantitatively measures the content of potassium iodate in salt in a simple, safe, and rapid way.
Methods. The linearity, determination and detection limit, and inter- and intra-assay variability of this colorimetric method were assessed and the method was compared with iodometric titration, using salt samples from several countries.
Results. Linearity of analysis ranged from 5 to 75 mg/kg iodine, with I mg/kg being the determination limit; the intra- and interassay imprecision was 0.9%, 0.5%, and 0.7% and 1.5%, 1.7%, and 2.5% for salt samples with iodine contents of 17, 30, and 55 mg/kg, respectively; the interoperator imprecision for the same samples was 1.2%, 4.9%, and 4.7%, respectively. Comparison with the iodometric method showed high agreement between the methods (R-2 = 0.978; limits of agreement, -10.5 to 10.0 mg/kg).
Conclusions. The device offers a field- and user-friendly solution to quantifying potassium iodate salt content reliably. For countries that use potassium iodide in salt iodization programs, further validation is required.
INTRODUCTION: For obtaining reliable information about physical activity in epidemiological studies, validated and easy-to-use instruments are required. Therefore, a new simplified physical activity record based on 15-min recording intervals was developed and validated. SUBJECTS: Nonobese volunteers (n = 31). MEASUREMENTS: Physical activity was recorded over a 7-day period without detailed instructions. Energy expenditure was calculated (EEsPAR) and compared to energy expenditure measured by doubly labelled water technique (EEDLW). RESULTS: A good agreement between EEsPAR (12.1 +/ 3.0) and EEDLW (11.7 +/- 3.3) with a mean difference of 0.33 +/- 1.55 MJ (r = 0.880, P < 0.001) was observed. The absolute difference between EEsPAR and EEDLW was <10% in 65% of the subjects. The difference between EEsPAR and EEDLW was independent of gender, age, body weight, and body mass index. A weak positive association between the difference and total body fat was observed (r = 0.618, P < 0.001), suggesting a slight tendency to overestimate EEsPAR with increasing total body fat. CONCLUSION: The new simplified physical activity protocol needs no detailed instructions, provides valid estimates of physical activity in nonobese free-living adults and can be used in epidemiological studies to assess total daily energy expenditure and physical activity level
In order to improve a recently established cell-based assay to assess the potency of botulinum neurotoxin, neuroblastoma-derived SiMa cells and induced pluripotent stem-cells (iPSC) were modified to incorporate the coding sequence of a reporter luciferase into a genetic safe harbor utilizing CRISPR/Cas9. A novel method, the double-control quantitative copy number PCR (dc-qcnPCR), was developed to detect off-target integrations of donor DNA. The donor DNA insertion success rate and targeted insertion success rate were analyzed in clones of each cell type. The dc-qcnPCR reliably quantified the copy number in both cell lines. The probability of incorrect donor DNA integration was significantly increased in SiMa cells in comparison to the iPSCs. This can possibly be explained by the lower bundled relative gene expression of a number of double-strand repair genes (BRCA1, DNA2, EXO1, MCPH1, MRE11, and RAD51) in SiMa clones than in iPSC clones. The dc-qcnPCR offers an efficient and cost-effective method to detect off-target CRISPR/Cas9-induced donor DNA integrations.
In order to improve a recently established cell-based assay to assess the potency of botulinum neurotoxin, neuroblastoma-derived SiMa cells and induced pluripotent stem-cells (iPSC) were modified to incorporate the coding sequence of a reporter luciferase into a genetic safe harbor utilizing CRISPR/Cas9. A novel method, the double-control quantitative copy number PCR (dc-qcnPCR), was developed to detect off-target integrations of donor DNA. The donor DNA insertion success rate and targeted insertion success rate were analyzed in clones of each cell type. The dc-qcnPCR reliably quantified the copy number in both cell lines. The probability of incorrect donor DNA integration was significantly increased in SiMa cells in comparison to the iPSCs. This can possibly be explained by the lower bundled relative gene expression of a number of double-strand repair genes (BRCA1, DNA2, EXO1, MCPH1, MRE11, and RAD51) in SiMa clones than in iPSC clones. The dc-qcnPCR offers an efficient and cost-effective method to detect off-target CRISPR/Cas9-induced donor DNA integrations.
Background: beta-Carotene is an important precursor of vitamin A, and is associated with bovine fertility. beta-Carotene concentrations in plasma are used to optimize beta-carotene supplementation in cattle, but measurement requires specialized equipment to separate plasma and extract and measure beta-carotene, either using spectrophotometry or high performance liquid chromatography (HPLC).
Objective: The objective of this study was to validate a new 2-step point-of-care (POC) assay for measuring beta-carotene in whole blood and plasma.
Methods: beta-carotene concentrations in plasma from 166 cows were measured using HPLC and compared with results obtained using a POC assay, the iCheck-iEx-Carotene test kit. Whole blood samples from 23 of these cattle were also evaluated using the POC assay and compared with HPLC-plasma results from the same 23 animals. The POC assay includes an extraction vial (iEx Carotene) and hand-held photometer (iCheck Carotene).
Results: Concentrations of beta-carotene in plasma measured using the POC assay ranged from 0.40 to 15.84 mg/L (n = 166). No differences were observed between methods for assay of plasma (mean +/- SD; n = 166): HPLC-plasma 4.23 +/- 2.35 mg/L; POC-plasma 4.49 +/- 2.36 mg/L. Similar good agreement was found when plasma analyzed using HPLC was compared with whole blood analyzed using the POC system (n = 23): HPLC-plasma 3.46 +/- 2.12 mg/L; POC-whole blood 3.67 +/- 2.29 mg/L.
Conclusions: Concentrations of beta-carotene can be measured in blood and plasma from cattle easily and rapidly using a POC assay, and results are comparable to those obtained by the highly sophisticated HPLC method. Immediate feedback regarding beta-carotene deficiency facilitates rapid and appropriate optimization of beta-carotene supplementation in feed.
Scaling agriculture to the globally rising population demands new approaches for future crop production such as multilayer and multitrophic indoor farming. Moreover, there is a current trend towards sustainable local solutions for aquaculture and saline agriculture. In this context, halophytes are becoming increasingly important for research and the food industry. As Salicornia europaea is a highly salt-tolerant obligate halophyte that can be used as a food crop, indoor cultivation with saline water is of particular interest. Therefore, finding a sustainable alternative to the use of seawater in non-coastal regions is crucial. Our goal was to determine whether natural brines, which are widely distributed and often available in inland areas, provide an alternative water source for the cultivation of saline organisms. This case study investigated the potential use of natural brines for the production of S. europaea. In the control group, which reflects the optimal growth conditions, fresh weight was increased, but there was no significant difference between the treatment groups comparing natural brines with artificial sea water. A similar pattern was observed for carotenoids and chlorophylls. Individual components showed significant differences. However, within treatments, there were mostly no changes. In summary, we showed that the influence of the different chloride concentrations was higher than the salt composition. Moreover, nutrient-enriched natural brine was demonstrated to be a suitable alternative for cultivation of S. europaea in terms of yield and nutritional quality. Thus, the present study provides the first evidence for the future potential of natural brine waters for the further development of aquaculture systems and saline agriculture in inland regions.
Reporter gene assays are widely used for the assessment of transcription factor activation following xenobiotic exposure of cells. A critical issue with such assays is the possibility of interference of test compounds with the test system, for example, by direct inhibition of the reporter enzyme. Here we show that the pyrrolizidine alkaloid heliotrine interferes with reporter signals derived from GAL4-based nuclear receptor transactivation assays by a mechanism independent of luciferase enzyme inhibition. These data highlight the necessity to conduct proper control experiments in order to avoid perturbation of reporter assays by test chemicals. (C) 2015 Elsevier Inc. All rights reserved.
Background There is a high mortality rate in patients with systemic inflammatory response syndrome (SIRS) or sepsis. Therefore, an early diagnosis and prognostic assessment is important for optimal therapeutic intervention. The objective of the study was to evaluate if baseline values and changes in serum C-reactive protein (CRP) might predict survival in dogs with SIRS and sepsis. Design Prospective study; July 2004 to July 2005. Setting Small Animal Clinic, Berlin, Clinic of Small Animal Medicine, Munich. Animals Sixty-one dogs. Measurements and Main Results For the CRP analysis blood was drawn on day 0, 1, and 2; CRP was measured using a commercial ELISA test kit. Thirteen dogs suffered from nonseptic SIRS and 48 dogs from sepsis. The 14-day survival rate was 61% (69% nonseptic SIRS, 58% sepsis). Serum CRP was higher in sick dogs compared with controls (P < 0.001). Over the 3-day period surviving dogs (n=31) displayed a significantly greater decrease in CRP than nonsurvivors (n=10) (P=0.001). No correlation was found between the initial CRP concentrations and the survival rate. The changes in CRP corresponded to the survival rate (P=0.01). Conclusion There was no significant relationship between the survival rate in dogs with nonseptic SIRS or sepsis and the initial serum CRP concentrations. There was a correlation between decreasing CRP concentrations and recovery from disease. However, the changes in CRP concentrations over a 3-day period correctly predicted survival in 94% of dogs and death in 30% of the dogs (false positive rate 22%).
Der Fettsäurestoffwechsel unterliegt vielfältigen Kontrollmechanismen. So wird der Fettsäureabbau über die Induktion und Aktivität spezifischer Enzyme reguliert. Ein zentraler Regulator ist dabei der nukleäre Rezeptor Peroxisomenproliferator-aktivierter-Rezeptor-α (PPARα). PPARα wird durch freie Fettsäuren in der Zelle aktiviert und fördert über die Induktion von Zielgenen den Fettsäuretransport und -abbau sowie die Gluconeogenese und Ketogenese. Der Anstieg an freien Fettsäuren beim Fasten, aber auch im Diabetes aktiviert PPARα. Unabhängig davon wurde in beiden Stoffwechsellagen auch eine erhöhte Expression des nukleären Rezeptors Constitutiver-Androstan-Rezeptor (CAR) und einiger CAR-Zielgene, vorrangig Enzyme des Fremdstoffmetabolismus wie Cytochrom P450 2B (CYP2B), festgestellt. Bei der Adaption an eine Fastensituation scheinen PPARα- und CAR-Signalwege über einen bisher unbekannten Mechanismus miteinander verschaltet zu sein. In der vorliegenden Arbeit sollte der der Verschaltung zugrunde liegende Mechanismus anhand eines Modelsystems, der PPARα-Agonisten-vermittelten Verstärkung der Phenobarbital (PB)-abhängigen Induktion des CAR-Zielgens CYP2B, in vitro untersucht werden. Zudem sollte die physiologische Relevanz einer durch PPARα-Agonisten vermittelten Modulierung der CYP2B-Aktivität in einer Ganztierstudie in vivo belegt werden. Die verwendeten synthetischen PPARα-Agonisten steigerten in primären Hepatozyten der Ratte signifikant die Phenobarbital (PB)-abhängige mRNA- und Protein-Expression sowie die Aktivität von CYP2B. Ohne vorherige PB-Behandlung induzierten PPARα-Agonisten CYP2B nicht. In Gegenwart von PB war die Steigerung der CYP2B-Aktivität durch PPARα-Agonisten dosisabhängig. In einem Luciferase-Reportergenassay wurde gezeigt, dass die Induktion durch PB unter der Kontrolle des CYP2B1-Promotors von einem distalen PBREM (PB-responsive-enhancer-module), an welches CAR binden kann, abhängig war. PPARα-Agonisten steigerten diese PB- und PBREM-abhängige Reportergentranskription und induzierten die CAR-mRNA und CAR-Proteinexpression. Sie aktivierten die Transkription eines Reportergens unter der Kontrolle eines Promotorfragments von bis zu 4,4 kb oberhalb des mutmaßlichen CAR-Transkriptionsstarts. Mit Hilfe von Deletionskonstrukten konnte ein potentielles Peroxisomenproliferator-aktivierter-Rezeptor-responsives Element (PPRE) im CAR-Promotorbereich von -942 bp bis -930 bp identifiziert werden, welches essentiell für die Initiation der Transkription durch PPARα-Agonisten ist. In band shift Experimenten akkumulierte verstärkt Kernprotein mit diesem PPRE. Ein Überschuss an unmarkiertem Wildtyp-CAR-Reportergenvektor, nicht aber an CAR-Reportergenvektor mit PPRE-Deletion, konnte mit dem markierten PPRE um die Bindung von Kernprotein konkurrieren. Nach Chromatin-Immunpräzipitation mit einem PPARα-Antikörper wiederum wurde das betreffende PPRE amplifiziert. Bei in vivo Experimenten an männlichen Ratten resultierte die Behandlung mit PPARα-Agonisten in einer signifikanten Induktion der CAR-mRNA-Expression und signifikant erhöhter PB-abhängiger CYP2B-Aktivität. Die physiologisch Relevanz wurde durch weiterführenden Experimente unterstrichen, in denen gezeigt wurde, dass die Fasten-abhängige Induktion von CAR in PPARα-defizienten Mäusen unterdrückt war. Diese Experimente legen nahe, dass durch PPARα-Agonisten aktiviertes PPARα an das PPRE im CAR-Promotorbereich von -942 bp bis -930 bp bindet und dadurch die CAR-Transkription induziert. Somit kann CAR als PPARα-Zielgen betrachtet werden, was die Schlussfolgerung zulässt, dass die PPARα- und CAR-Signalwege über die direkte Bindung von PPARα an den CAR-Promotor unmittelbar miteinander verknüpft sind. Allerdings ist davon unabhängig eine Aktivierung von CAR, etwa durch PB, für die vermehrte Induktion von CAR-Zielgenen notwendig . Die physiologische Relevanz der PPARα-abhängige CAR-Expression zeigt sich in den Ganztierexperimenten, bei denen die Wirksamkeit der PPARα-Agonisten bestätigt werden konnte. CAR-abhängig induzierte Enzyme sind nicht nur in großem Umfang am Fremdstoffmetabolismus beteiligt, sondern auch am Abbau von Schilddrüsenhormonen und Glucocorticoiden. Sie können damit direkt Einfluss auf den Kohlenhydrat- und Energiestoffwechsel sowie die Regulation der Nahrungsaufnahme nehmen. Über eine PPARα-abhängige Induktion von CAR im Rahmen der Fastenadaption könnten die CAR-Zielgene UDP-Glucuronyltransferase 1A1 und Sulfotransferase N beispielsweise verstärkt Schilddrüsenhormone abbauen und in der Folge den Grundumsatz senken. Der in dieser Arbeit erstmals beschriebene Mechanismus ist dafür von zentraler Bedeutung.
Background Vitamin-D-binding protein (VDBP) is a low molecular weight protein that is filtered through the glomerulus as a 25-(OH) vitamin D 3/VDBP complex. In the normal kidney VDBP is reabsorbed and catabolized by proximal tubule epithelial cells reducing the urinary excretion to trace amounts. Acute tubular injury is expected to result in urinary VDBP loss. The purpose of our study was to explore the potential role of urinary VDBP as a biomarker of an acute renal damage. Method We included 314 patients with diabetes mellitus or mild renal impairment undergoing coronary angiography and collected blood and urine before and 24 hours after the CM application. Patients were followed for 90 days for the composite endpoint major adverse renal events (MARE: need for dialysis, doubling of serum creatinine after 90 days, unplanned emergency rehospitalization or death). Results Increased urine VDBP concentration 24 hours after contrast media exposure was predictive for dialysis need (no dialysis: 113.06 +/- 299.61ng/ml, n = 303; need for dialysis: 613.07 +/- 700.45 ng/ml, n = 11, Mean +/- SD, p < 0.001), death (no death during follow-up: 121.41 +/- 324.45 ng/ml, n = 306; death during follow-up: 522.01 +/- 521.86 ng/ml, n = 8; Mean +/- SD, p < 0.003) and MARE (no MARE: 112.08 +/- 302.00ng/ml, n = 298; MARE: 506.16 +/- 624.61 ng/ml, n = 16, Mean +/- SD, p < 0.001) during the follow-up of 90 days after contrast media exposure. Correction of urine VDBP concentrations for creatinine excretion confirmed its predictive value and was consistent with increased levels of urinary Kidney Injury Molecule1 (KIM-1) and baseline plasma creatinine in patients with above mentioned complications. The impact of urinary VDBP and KIM-1 on MARE was independent of known CIN risk factors such as anemia, preexisting renal failure, preexisting heart failure, and diabetes. Conclusions Urinary VDBP is a promising novel biomarker of major contrast induced nephropathy-associated events 90 days after contrast media exposure.
Vitamin A (VA) deficiency in very low birth weight (VLBW) infants is associated with an increased risk for disorders related to kidney and lung maturation and function. VA losses through increased urinary retinol (ROH) excretion might contribute to this deficiency risk. The mechanism accounting for ROH loss in the urine has not yet been clarified. The aim of this study was to assess the excretion of ROH, retinol-binding protein 4 (RBP4) and transthyretin (TTR) in urine from VLBW infants in comparison with that in term infants in relation to kidney function. Urine specimens were collected from 15 VLBW infants (birth weight < 1,500 g) as well as from 20 term infants during the first 2 days after birth. ROH in urine was detectable in 14 of the 15 VLBW infants at a median concentration of 234 nmol/g creatinine. In the group of term infants, 17 of the 20 excreted ROH, but at an approximately five-times lower concentration (P<0.001). Excretion of RBP4 and TTR was also much higher in VLBW infants (both P<0.001). The urinary ROH excretion in VLBW infants may be related to the impaired tubular handling of its carrier proteins RBP4 and TTR. Thus, ROH excretion might contribute to an increased risk of VA deficiency, especially in VLBW infants.
Aims: Contrast media-induced nephropathy (CIN) is associated with increased morbidity and mortality. The renal endothelin system has been associated with disease progression of various acute and chronic renal diseases. However, robust data coming from adequately powered prospective clinical studies analyzing the short and long-term impacts of the renal ET system in patients with CIN are missing so far. We thus performed a prospective study addressing this topic.
Main methods: We included 327 patients with diabetes or renal impairment undergoing coronary angiography. Blood and spot urine were collected before and 24 h after contrast media (CM) application. Patients were followed for 90 days for major clinical events like need for dialysis, unplanned rehospitalization or death.
Key findings: The concentration of ET-1 and the urinary ET-1/creatinine ratio decreased in spot urine after CM application (ET-1 concentration: 0.91 +/- 1.23pg/ml versus 0.63 +/- 1.03pg/ml, p<0.001; ET-1/creatinine ratio: 0.14 +/- 0.23 versus 0.09 +/- 0.19, p<0.001). The urinary ET-1 concentrations in patients with CIN decreased significantly more than in patients without CIN (-0.26 +/- 1.42pg/ml vs. -0.79 +/- 1.69pg/ml, p=0.041), whereas the decrease of the urinary ET-1/creatinine ratio was not significantly different (non-CIN patients: -0.05 +/- 0.30; CIN patients: -0.11 +/- 0.21, p=0.223). Urinary ET-1 concentrations as well as the urinary ET-1/creatinine ratio were not associated with clinical events (need for dialysis, rehospitalization or death) during the 90day follow-up after contrast media exposure. However, the urinary ET-1 concentration and the urinary ET-1/creatinine ratio after CM application were higher in those patients who had a decrease of GFR of at least 25% after 90days of follow-up.
Significance: In general the ET-1 system in the kidney seems to be down-regulated after contrast media application in patients with moderate CIN risk. Major long-term complications of CIN (need for dialysis, rehospitalization or death) are not associated with the renal ET system. (C) 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license.
Background The use of iodine-based contrast agents entails the risk of contrast induced nephropathy (CIN). Radiocontrast agents elicit the third most common cause of nephropathy among hospitalized patients, accounting for 11-12% of cases. CIN is connected with clinically significant consequences, including increased morbidity, prolonged hospitalization, increased risk of complications, potential need for dialysis, and increased mortality rate. The number of in hospital examinations using iodine-based contrast media has been significantly increasing over the last decade. In order to protect patients from possible complications of such examinations, new biomarkers are needed that are able to predict a risk of contrast-induced nephropathy. Urinary and plasma cyclic guanosine monophosphate (cGMP) concentrations are influenced by renal function. Urinary cGMP is primarily of renal cellular origin. Therefore, we assessed if urinary cGMP concentration may predict major adverse renal events (MARE) after contrast media exposure during coronary angiography. Methods Urine samples were prospectively collected from non-randomized consecutive patients with either diabetes or preexisting impaired kidney function receiving intra-arterial contrast medium (CM) for emergent or elective coronary angiography at the Charite Campus Mitte, University Hospital Berlin. Urinary cGMP concentration in spot urine was analyzed 24 hours after CM exposure. Patients were followed up over 90 days for occurrence of death, initiation of dialysis, doubling of plasma creatinine concentration or MARE. Results In total, 289 consecutive patients were included into the study. Urine cGMP/creatinine ratio 24 hours before CM exposure expressed as mean +/- SD was predictive for the need of dialysis (no dialysis: 89.77 +/- 92.85 mu M/mM, n = 277; need for dialysis: 140.3 +/- 82.90 mu M/mM, n = 12, p = 0.008), death (no death during follow-up: 90.60 +/- 92.50 mu M/mM, n = 280; death during follow-up: 169.88 +/- 81.52 mu M/mM, n = 9; p = 0.002), and the composite endpoint MARE (no MARE: 86.02 +/- 93.17 mu M/mM, n = 271; MARE: 146.64 +/- 74.68 mu M/mM, n = 18, p<0.001) during the follow-up of 90 days after contrast media application. cGMP/creatinine ratio stayed significantly increased at values exceeding 120 pM/mM in patients who developed MARE, required dialysis or died. Conclusions Urinary cGMP/creatinine ratio >= 120 mu M/mM before CM exposure is a promising biomarker for the need of dialysis and all-cause mortality 90 days after CM exposure in patients with preexisting renal impairment or diabetes.
Der Embryonale Stammzelltest (EST) ist ein validierter In-vitro-Embryotoxizitätstest, der zur Untersuchung embryotoxischer Wirkungen von Chemikalien eingesetzt werden kann. Während des zehntägigen Differenzierungsassays differenzieren sich die pluripotenten murinen embryonalen Stammzellen (ES-Zellen) der Linie D3 in vitro in spontan kontrahierende Herzmuskelzellen. Dabei rekapitulieren sie Prozesse der frühen Embryogenese in vivo. Ein Zytotoxizitätsassay mit D3-Zellen und ausdifferenzierten, adulten 3T3-Maus-Fibroblasten dient der Ermittlung allgemeiner zytotoxischer Effekte und unterschiedlicher Sensitivitäten beider Zelllinien. Somit basiert der EST auf den beiden wichtigsten Mechanismen pränataler Toxizität, der Störung der Differenzierung und der Zytotoxizität. Ziel dieser Arbeit war es, mit Hilfe des EST das embryotoxische Potential der vier Chemikalien Trichostatin A (TSA), Methylazoxymethanolacetat (MAMac), Natriumdodecylsulfat (SDS) und Benzoesäure (BA) abzuschätzen. Dazu wurde mikroskopisch ermittelt, bei welcher Testsubstanzkonzentration in 50 % der während der In-vitro-Differenzierung gebildeten Embryonalkörperchen die Kardiomyozytendifferenzierung inhibiert wird (ID50). Außerdem wurde die halbmaximale Hemmkonzentration des Zellwachstums auf die beiden Zelllinien bestimmt (IC50D3 bzw. IC503T3). Als Erweiterung dieses konventionellen EST wurden mittels quantitativer Real Time-PCR an den Tagen 5, 7 und 10 der Differenzierung zusätzlich Genexpressionsanalysen etablierter herzmuskelspezifischer Markergene (Mesoderm Posterior 1, Tag 5; Myosin light chain 1, Tag 7 und 10) durchgeführt. Deren Expression korreliert in den ES-Zellen mit der embryonalen Herzdifferenzierung in vivo und kann zur Ermittlung der von der Prüfsubstanz hervorgerufenen halbmaximalen Hemmung der Genexpression in den Kardiomyozyten (IC50 Exp) herangezogen werden. Um letztlich embryotoxische Effekte in vivo auf Grundlage der ermittelten In-vitro-Daten abschätzen zu können, wurden die ermittelten Parameter mittels eines für den EST empirisch abgeleiteten mathematischen Prädiktionsmodells (PM) zur Klassifizierung der Testsubstanzen als nicht, schwach oder stark embryotoxisch herangezogen. Für jede der Substanzen waren die ermittelten Halbhemmkonzentrationen in den überwiegenden Fällen vergleichbar und führten unter Verwendung des PMs im konventionellen und im molekularen EST zu deren identischer Klassifizierung. TSA wurde als „stark embryotoxisch“ klassifiziert und beeinflusste insbesondere das Differenzierungspotential der ES-Zellen. Das als „schwach embryotoxisch“ klassifizierte SDS wirkte auf die D3-Zellen stärker differenzierungsinhibierend als zytotoxisch, hemmte jedoch das Wachstum der 3T3-Zellen bereits in deutlich niedrigeren Konzentrationen. MAMac und BA wurden als „nicht embryotoxisch“ klassifiziert. Bei ihnen stand die zytotoxische Wirkung deutlich im Vordergrund. Diese Prädiktionen stimmten mit In-vivo-Befunden überein, was von der Stabilität und der Brauchbarkeit der im konventionellen und molekularen EST ermittelten Parameter zeugte. Einzige Ausnahme war das als Entwicklungsneurotoxin in vivo bekannte MAMac. Da der EST auf mesodermaler Differenzierung basiert, können spezifische Effekte auf neuronale Entwicklungsprozesse offenbar nicht vollständig erfasst werden. Substanzkonzentrationen, die sich als differenzierungsinhibierend auf die morphologische Kardiomyozytendifferenzierung erwiesen haben, führten auch zu einer messbaren Repression der herzmuskelspezifischen Genexpression. Dabei erwies sich die IC50 Exp als ebenso sensitiv wie die konventionellen Parameter und als nutzbringende Ergänzung zu diesen, da sie bereits nach 5 bzw. 7 Tagen der In-vitro-Differenzierung eine mit dem mikroskopischen Parameter übereinstimmende Einschätzung des embryotoxischen Potentials der Chemikalien in vivo ermöglichte. Genexpressionsanalysen weiterer differenzierungsspezifischer Gene können zusätzlich zur Aufklärung zu Grunde liegender Mechanismen der Embryotoxizität von Testsubstanzen dienen. Somit kann der EST durch die Vorteile der Stammzelltechnologie und der Genexpressionsanalyse als neues prädiktives Screening-Instrument zur frühzeitigen Detektion embryotoxischer Substanzeffekte in der pharmazeutischen und chemischen Industrie genutzt werden.
Die Zahl der Kolonkarzinome in den westlichen Industrieländern steigt in den letzten Jahren stetig an. Zu den Verbindungen, die mit der Zubereitung der Nahrung entstehen, mit ihr aufgenommen werden und die Kolonkanzerogenese möglicherweise begünstigen, gehört das heterozyklische aromatische PhIP, das bei der Erhitzung proteinreicher Nahrungsmittel entsteht. Neben zahlreichen Fütterungsversuchen an Nagern existieren auch Zellkulturmodelle zur Untersuchung der molekularen Mechanismen der PhIP-induzierten Kolonkanzerogenese. Die chemische Transformation von Zellen sollte durch wiederholte Exposition gegenüber dem hydroxylierten Metaboliten des Kanzerogens (N2-OH-PhIP) erzielt werden. Es wurden IEC-18-Zellen der Ratte und HCEC-Zellen des Menschen zur Untersuchung verwendet. Die Behandlung der IEC-18-Zellen führt nach 25 Behandlungszyklen mit Konzentrationen von 5 bis 20 µM nicht zur Transformation der Zellen. Die Anwesenheit von N2-OH-PhIP führt zu einer zehnfach erhöhten Induktion der GST-Aktivität, insbesondere der Untereinheiten GST-A1, -A3, -Pi und -T2, die für die effiziente Detoxifizierung des N-Acetoxy-Metaboliten vom N2-OH-PhIP verantwortlich sind. Bereits nach drei Behandlungen mit 1,5 µM N2-OH-PhIP konnte eine maligne Transformation der HCEC-Zellen erzielt werden. Die Zellen zeigten die charakteristischen Zeichen der Transformation: veränderte Wachstumseigenschaften wie klonales dreidimensionales Zellwachstum („pilling up“), Hemmung der Zell-Zell-Kontaktinhibierung, verkürzte Populationsverdopplungszeiten und tumorigene und metastasierende Eigenschaften. Außerdem exprimierten die N2-OH-PhIP-exponierten humanen Kolonzellen mit steigender Anzahl der Behandlungen größere Mengen des trunkierten APC-Proteins. Die bekannten PhIP-spezifischen Mutationen im APC-Gen resultieren in der Expression eines trunkierten Proteinproduktes und werden als frühe Ereignisse in der Kolonkanzerogenese betrachtet. Die zusammenfassende Betrachtung aller Ergebnisse zeigt, dass die IEC-18-Zelllinie zur chemischen Transformation durch N2-OH-PhIP ungeeignet ist. Dagegen wurde erstmalig eine vollständige chemische Transformation von Humandickdarmepithelzellen in vitro durch Exposition der humanen Kolonepithelzelllinie HCEC gegenüber dem Kolonkarzinogen N2-OH-PhIP erzielt.
Untersuchungen zum Transfer von Carotinoiden aus dem Plasma in die Follikelflüssigkeit der Frau
(2000)
Am Beispiel der Wiederkäuer wurde unter Zuhilfenahme von biochemischen und molekularbiologischen Methoden die Adaptation von Pflanzenfressern (Herbivoren) an pflanzliche Sekundärmetabolite wie z.B. Tannine untersucht. Tannine können in nicht an ihren Verzehr adaptierten Spezies durch ihr Proteinbindungsvermögen die Nahrungsverwertung und damit Wachstum und Gesundheit des Pflanzenfressers beeinträchtigen (antinutritive Wirkung). Einige Wiederkäuerarten wie z.B. das Reh (Capreolus capreolus) haben in ihrem Nahrungsspektrum viele stark tanninhaltige Pflanzen, leiden aber nicht unter den erwähnten postdigestiven Konsequenzen. Eine Möglichkeit, die antinutritive Wirkung von Tanninen zu neutralisieren, besteht in der Produktion tanninbindender Speichelproteine. Der Speichel verschiedener Wiederkäuerarten wurde auf das Vorhandensein tanninbindender Proteine untersucht. Diese Arten wurden so ausgewählt, dass alle drei Ernährungstypen (Konzentratselektierer, Intermediärtyp, Gras- und Rauhfutterfresser) in den Vergleich eingeschlossen werden konnten. Als Referenzspezies wurde der Konzentratselektierer Reh herangezogen. Die Speichelproteine des Rehs und die der Intermediärtypen (Rentier, Rangifer tarandus; Damhirsch, Cervus dama; Moschusochse, Ovibos moschatus) banden ungefähr doppelt so effektiv an hydrolysierbare Tannine (Tanninsäure), wie die der untersuchten Gras- und Rauhfutterfresser (Rind, Bos taurus; und Mufflon, Ovis orientalis musimon). Diese Abstufung zeigte sich auch bei der Untersuchung der Bindung an kondensierte Tannine (Quebracho). Eine Ausnahme stellte Mufflonspeichel dar, dieser band ebenso gut an Quebracho wie die Speichelproteine der anderen Ernährungstypen. Über eine Aminosäuretotalanalyse konnte festgestellt werden, dass der Speichel einiger untersuchter Wiederkäuerarten prolinreiche Proteine (PRPs) enthielt. Unter Ausnutzung ihrer Trichloressigsäure (TCA)-Löslichkeit wurden diese angereichert und genauer untersucht. Die Analyse der TCA-löslichen Speichelproteine der Konzentratselektierer (Reh, Elch) ergab einen relativen Prolingehalt von über 35 %, während beim Moschusochsen noch 29 % gemessen wurden. In Damhirsch- und Rinderspeichel wurden keine prolinreichen Proteine gefunden. Für die TCA-löslichen Speichelproteine des Rehs konnte eine hohe Tanninbindungskapazität nachgewiesen werden. Diese banden 24 - 30 x effektiver an Tannine als die TCA-löslichen Speichelproteine des Rindes. Die Tanninbindungskapazitäten der TCA-löslichen Speichelproteine von Moschusochse und Damhirsch waren ebenfalls höher als die des Rindes, aber niedriger als die des Rehs. Die Kohlenhydrat-Analyse der TCA-löslichen Speichelproteine des Rehs erbrachte, dass es sich bei ihnen um Glykoproteine handelt. Mittels Gelfiltration und zweidimensionaler Polyacrylamidgelektrophorese konnten fünf Proteingruppen mit Molekulargewichten zwischen 15 und 50 kd sowie isoelektrischen Punkten zwischen 4,0 und 8,2 detektiert werden. Von 15 dieser Proteine konnten die N-terminalen Aminosäuresequenzen ermittelt werden. Ausgehend von diesen Informationen wurden Reh-PRP spezifische mRNAs isoliert und partiell sequenziert. Die meisten dieser Fragmente hatten eine gemeinsame 18 Aminosäuren lange C-terminale Sequenz PPPEEQPEE/QSPDEE/DSPSE. Die Suche nach Übereinstimmungen der analysierten Sequenzen mit anderen Säugetier-PRPs in der Genbank ergab keine sinnvollen Ähnlichkeiten. Die Ergebnisse können zu Informationen über tanninbindende Proteine anderer Wiederkäuer führen. Die Sequenzinformationen stellen einen Ausgangspunkt bei der Analyse der evolutiven Zusammenhänge der Cerviden dar.
"Untersuchung kardioprotektiver Wirkungen des Olivenöles und seiner phenolischen Komponenten in einer Gruppe gesunder deutscher Männer" EINLEITUNG: Epidemiologische Daten belegen, dass die mediterrane Ernährung mit einer niedrigen Inzidenz an mit oxidativen Stress assoziierten kardiovaskulären Erkrankungen einhergeht. Dabei wird vor allem dem Olivenöl, als Hauptfettlieferant in der mediterranen Ernährung, eine kardioprotektive Wirkung zugesprochen. Olivenöl zeichnet sich neben dem hohen Gehalt an einfach ungesättigten Fettsäuren (MUFA) durch ein reichhaltiges Spektrum an phenolischen Verbindungen aus, deren antioxidative Wirkung bereits zahlreichen in in vitro Studien beschrieben wurde. Demnach könnte der Verzehr von phenolreichem Olivenöl auch in vivo vor oxidativen Schädigungen schützen und somit das Risiko für kardiovaskuläre Erkrankungen senken. ZIELSTELLUNG: Untersuchung der kardioprotektiven Wirkung von Olivenöl und seiner phenolischen Komponenten in einer Gruppe gesunder deutscher Männer. METHODE: Dazu wurde eine randomisierte cross-over doppelt-verblindete Interventionsstudie an 70 gesunden Männern zwischen 20 - 60 Jahren im Raum Berlin-Brandenburg durchgeführt. In jeweils drei dreiwöchigen Interventionsphasen konsumierten die Probanden täglich 25 ml natives (phenolreich), gemischtes (mittlerer Phenolgehalt) und raffiniertes (annähernd phenolfrei) Olivenöl, was sich ausschließlich im Gehalt an phenolischen Verbindungen unterschied. Das Olivenöl sollte dabei die gewöhnlich verzehrten Fette ersetzen. Die Interventionsphasen waren durch zweiwöchige Wash out-Phasen unterbrochen. Die Erhebung der Blutlipide, Biomarker der Lipidperoxidation und endogene Antioxidantien erfolgte zu Studienbeginn sowie zu Beginn und Ende jeder Verzehrsperiode.ERGEBNISSE: Bei den Blutlipiden sowie den Biomarkern der Lipidperoxidation und den endogenen Antioxidantien konnte keine signifikante Veränderung in Abhängigkeit vom Phenolgehalt der applizierten Olivenöle nachgewiesen werden. Einzig die Glutathion-Reduktase-Aktivität stieg mit zunehmendem Gehalt an phenolischen Verbindungen (pTrend = 0,041). Unabhängig von der Konzentration der Phenole im Olivenöl wurde bei den Probanden durch den Olivenölverzehr eine Senkung von Gesamtcholesterol (p = 0,007) und Triglyzeride (p = 0,013) im Serum erzielt. Diese Wirkung geht einher mit einem gestiegenen MUFA-Anteil in der Ernährung aufgrund des Olivenölkonsums (p < 0,001). SCHLUSSFOLGERUNG: Die Hypothese, dass die Phenole im Olivenöl aufgrund ihrer in in vitro und Tierstudien beschriebenen antioxidativen Wirkung dem Olivenöl neben dem einzigartigen Fettsäureprofil eine zusätzliche kardioprotektive Wirkung bescheren, konnte in der vorliegenden Studie nicht gezeigt werden. Dennoch konnte durch den Olivenölverzehr und der damit einhergehenden Erhöhung des MUFA-Anteils in der Ernährung eine vorteilhafte Beeinflussung der Blutlipide erzielt werden. Obgleich Olivenöl nicht das vorwiegend verzehrte Fett in Deutschland darstellt, zeigten die befragten Probanden eine hohe Akzeptanz. Folglich könnte die Integration von Olivenöl in die habituelle Ernährung einen Beitrag zur Senkung des kardiovaskulären Erkrankungsrisikos leisten.
Untersuchung des Recyclings Kaede-fusionierter Corticotropin-Releasing-Factor Rezeptoren Typ 1
(2009)
Aktivierte G-Protein-gekoppelte Rezeptoren (GPCR) werden schnell desensitisiert, internalisiert und anschließend entweder lysosomal degradiert oder zur Plasmamembran (PM) recycelt. Zur Resensitisierung der Zellen tragen neben recycelten auch neusynthetisierte Rezeptoren bei. Die Überlagerung beider Prozesse erschwert die Untersuchung des Rezeptorrecyclings. In dieser Arbeit sollte mit Hilfe des photokonvertierbaren Fluoreszenzproteins Kaede eine Technik entwickelt werden, mit der es möglich ist Recycling- von Neusyntheseprozessen zu trennen und das Recycling von GPCR mikroskopisch in Echtzeit zu beobachten. Als Modellproteine wurden der Vasopressin-1a-Rezeptor V1aR (recycelnder Rezeptor), der Vasopressin-2-Rezeptor V2R (degradierter Rezeptor) und der Corticotropin-Releasing Factor-Rezeptor Typ 1 (CRF1R) verwendet, wobei bei Letzterem untersucht werden sollte, ob er nach Stimulation zur PM zurücktransportiert wird. Da Kaede als fluoreszierendes Protein mit den GPCR fusioniert wird, wurde zunächst überprüft, ob es die Eigenschaften der Rezeptoren verändert und generell für Transportstudien geeignet ist. Eventuell könnte die bereits publizierte Tetramerisierung von Kaede seine Anwendung verhindern oder erschweren. Mittels Fluoreszenz-Korrelationsspektroskopie konnte gezeigt werden, dass Kaede nicht tetramerisiert, wenn es an ein Membranprotein fusioniert ist. Außerdem konnte in in vitro- und Zellkulturexperimenten belegt werden, dass die native und die photokonvertierte Form von Kaede gleichermaßen stabil sind. Darüber hinaus zeigten Kaede-fusionierte GPCR sowohl in Kolokalisationsstudien als auch in Agonistbindungs- und Rezeptoraktivierungsexperimenten die gleichen Eigenschaften wie CFP- bzw. die unfusionierte Rezeptoren. Lediglich die Expression der Kaede-fusionierten Rezeptoren war geringer. Parallel wurde anhand der bereits publizierten Kaede-Struktur versucht, die Tetramerisierung des Proteins durch den Austausch interagierender Aminosäuren zu unterbinden. Die eingeführten Mutationen bewirkten aber eine Fehlfaltung des Proteins und damit den Verlust der Fluoreszenz. Da zuvor gezeigt werden konnte, dass Kaede-fusionierte Membranproteine nicht tetramerisieren und nicht die Eigenschaften der fusionierten Proteine verändern, war monomerisiertes Kaede zur Untersuchung des Rezeptorrecyclings nicht notwendig. Im zweiten Teil der Arbeit wurde mit Hilfe von Kaede-Fusionsproteinen und mikroskopischer Testsysteme das noch unbekannte Recyclingverhalten des CRF1R untersucht. Hierfür wurden die Kaede-fusionierten Rezeptoren in eukaryotischen Zellen exprimiert und mit Agonisten internalisiert. Die internalisierten Rezeptoren wurden in Endosomen selektiv mit UV-Strahlung photokonvertiert. Anschließend wurde der Transport der photokonvertierten Form verfolgt. Sowohl beim CRF1R als auch beim V1aR wurden Signale in der PM detektiert, beim V2R hingegen nicht. Dies zeigt, dass es sich beim CRF1R um einen recycelnden Rezeptor handelt. Die als Kontrolle eingesetzten Rezeptoren verhielten sich in diesem Experiment wie erwartet: Der V1aR wurde zur PM zurücktransportiert, der V2R nicht. Diese Ergebnisse konnten mit Hilfe biochemischer und durchflusscytometrischer Experimente bestätigt werden. Die Internalisierung des CRF1R verläuft Clathrin-vermittelt in Anwesenheit von β-Arrestin. Je nach Stabilität der β Arrestin-Interaktion unterscheidet man zwei Klassen von Rezeptoren: Klasse A-Rezeptoren interagieren transient mit β Arrestin und können recyceln. Im Gegensatz dazu gehen Klasse B-Rezeptoren eine stabile Interaktion mit β Arrestin ein und werden nach Internalisierung degradiert. In mikroskopischen Untersuchungen konnte für die aktivierten CRF1R und V1aR eine Rekrutierung von β Arrestin zur PM und eine transiente Interaktion mit β Arrestin gezeigt werden (Klasse A-Rezeptoren). Für den V2R wurde dagegen eine stabile Interaktion mit β Arrestin beobachtet (Klasse B-Rezeptor). Diese Daten stützen die Ergebnisse des Kaede-basierten Recyclingversuchs und zeigen, dass der CRF1R ein recycelnder Rezeptor ist. Ferner wurde untersucht, ob der CRF1R zu den schnell oder langsam recycelnden Rezeptoren zählt. Schnell recycelnde Rezeptoren werden direkt aus frühen Endosomen, langsam recycelnde hingegen über das Trans-Golgi-Netzwerk (TGN) bzw. über Recycling-Endosomen zur PM transportiert. Als Marker für das TGN oder die Recycling-Endosomen wurde Rab11 verwendet. In Kolokalisationsstudien konnte gezeigt werden, dass der CRF1R den langsam recycelnden Rezeptoren zugeordnet werden kann. Zusammenfassend konnte in dieser Arbeit belegt werden, dass Kaede als Fusionspartner für Membranproteine genutzt werden kann um deren Transport in Echtzeit zu studieren. Damit wurde erstmals eine mikroskopische Methode etabliert, die es erlaubt recycelnde von neusynthetisierten Rezeptoren zu unterscheiden. Mit Hilfe dieser Methode war es möglich zu zeigen, dass der CRF1R ein recycelnder Rezeptor ist.
Manganese (Mn) is an essential micronutrient for development and function of the nervous system. Deficiencies in Mn transport have been implicated in the pathogenesis of Huntington's disease (HD), an autosomal dominant neurodegenerative disorder characterized by loss of medium spiny neurons of the striatum. Brain Mn levels are highest in striatum and other basal ganglia structures, the most sensitive brain regions to Mn neurotoxicity. Mouse models of HD exhibit decreased striatal Mn accumulation and HD striatal neuron models are resistant to Mn cytotoxicity. We hypothesized that the observed modulation of Mn cellular transport is associated with compensatory metabolic responses to HD pathology. Here we use an untargeted metabolomics approach by performing ultraperformance liquid chromatography-ion mobility-mass spectrometry (UPLC-IM-MS) on control and HD immortalized mouse striatal neurons to identify metabolic disruptions under three Mn exposure conditions, low (vehicle), moderate (non-cytotoxic) and high (cytotoxic). Our analysis revealed lower metabolite levels of pantothenic acid, and glutathione (GSH) in HD striatal cells relative to control cells. HD striatal cells also exhibited lower abundance and impaired induction of isobutyryl carnitine in response to increasing Mn exposure. In addition, we observed induction of metabolites in the pentose shunt pathway in HD striatal cells after high Mn exposure. These findings provide metabolic evidence of an interaction between the HD genotype and biologically relevant levels of Mn in a striatal cell model with known HD by Mn exposure interactions. The metabolic phenotypes detected support existing hypotheses that changes in energetic processes underlie the pathobiology of both HD and Mn neurotoxicity.
Manganese (Mn) is an essential micronutrient for development and function of the nervous system. Deficiencies in Mn transport have been implicated in the pathogenesis of Huntington's disease (HD), an autosomal dominant neurodegenerative disorder characterized by loss of medium spiny neurons of the striatum. Brain Mn levels are highest in striatum and other basal ganglia structures, the most sensitive brain regions to Mn neurotoxicity. Mouse models of HD exhibit decreased striatal Mn accumulation and HD striatal neuron models are resistant to Mn cytotoxicity. We hypothesized that the observed modulation of Mn cellular transport is associated with compensatory metabolic responses to HD pathology. Here we use an untargeted metabolomics approach by performing ultraperformance liquid chromatography-ion mobility-mass spectrometry (UPLC-IM-MS) on control and HD immortalized mouse striatal neurons to identify metabolic disruptions under three Mn exposure conditions, low (vehicle), moderate (non-cytotoxic) and high (cytotoxic). Our analysis revealed lower metabolite levels of pantothenic acid, and glutathione (GSH) in HD striatal cells relative to control cells. HD striatal cells also exhibited lower abundance and impaired induction of isobutyryl carnitine in response to increasing Mn exposure. In addition, we observed induction of metabolites in the pentose shunt pathway in HD striatal cells after high Mn exposure. These findings provide metabolic evidence of an interaction between the HD genotype and biologically relevant levels of Mn in a striatal cell model with known HD by Mn exposure interactions. The metabolic phenotypes detected support existing hypotheses that changes in energetic processes underlie the pathobiology of both HD and Mn neurotoxicity.
The regulation of energy homeostasis is controlled by the brain and, besides requiring high amounts of energy, it relies on functional insulin/insulin-like growth factor (IGF)-1 signalling in the central nervous system. This energy is mainly provided by mitochondria in form of ATP. Thus, there is an intricate interplay between mitochondrial function and insulin/IGF-1 action to enable functional brain signalling and, accordingly, propagate a healthy metabolism. To adapt to different nutritional conditions, the brain is able to sense the current energy status via mitochondrial and insulin signalling-dependent pathways and exerts an appropriate metabolic response. However, regional, cell type and receptor-specific consequences of this interaction occur and are linked to diverse outcomes such as altered nutrient sensing, body weight regulation or even cognitive function. Impairments of this cross-talk can lead to obesity and glucose intolerance and are linked to neurodegenerative diseases, yet they also induce a self-sustainable, dysfunctional 'metabolic triangle' characterised by insulin resistance, mitochondrial dysfunction and inflammation in the brain. The identification of causal factors deteriorating insulin action, mitochondrial function and concomitantly a signature of metabolic stress in the brain is of utter importance to offer novel mechanistic insights into development of the continuously rising prevalence of non-communicable diseases such as type 2 diabetes and neurodegeneration. This review aims to determine the effect of insulin action on brain mitochondrial function and energy metabolism. It precisely outlines the interaction and differences between insulin action, insulin-like growth factor (IGF)-1 signalling and mitochondrial function; distinguishes between causality and association; and reveals its consequences for metabolism and cognition. We hypothesise that an improvement of at least one signalling pathway can overcome the vicious cycle of a self-perpetuating metabolic dysfunction in the brain present in metabolic and neurodegenerative diseases.
Analyzing mixture toxicity requires an in-depth understanding of the mechanisms of action of its individual components. Substances with the same target organ, same toxic effect and same mode of action (MoA) are believed to cause additive effects, whereas substances with different MoAs are assumed to act independently. Here, we tested 2 triazole fungicides, propiconazole, and tebuconazole (Te), for individual and combined effects on liver toxicity-related endpoints. Both triazoles are proposed to belong to the same cumulative assessment group and are therefore thought to display similar and additive behavior. Our data show that Te is an antagonist of the constitutive androstane receptor (CAR) in rats and humans, while propiconazole is an agonist of this receptor. Both substances activate the pregnane X-receptor (PXR) and further induce mRNA expression of CYP3A4. CYP3A4 enzyme activity, however, is inhibited by propiconazole. For common targets of PXR and CAR, the activation of PXR by Te overrides CAR inhibition. In summary, propiconazole and Te affect different hepatotoxicity-relevant cellular targets and, depending on the individual endpoint analyzed, act via similar or dissimilar mechanisms. The use of molecular data based on research in human cell systems extends the picture to refine cumulative assessment group grouping and substantially contributes to the understanding of mixture effects of chemicals in biological systems.
Ultrasound evaluation of the patellar tendon cross-sectional area and its relation to maximum force
(2012)
Detection of cancer precursors contributes to cancer prevention, for example, in the case of colorectal cancer. To record more patients early, ultrasensitive methods are required for the purpose of noninvasive precursor detection in body fluids. Our aim was to develop a method for enrichment and detection of known as well as unknown driver mutations in the Adenomatous polyposis coli (APC) gene. By coupled wild-type blocking (WTB) PCR and high-resolution melting (HRM), referred to as WTB-HRM, a minimum detection limit of 0.01% mutant in excess wild-type was achieved according to as little as 1 pg mutated DNA in the assay. The technique was applied to 80 tissue samples from patients with colorectal cancer (n = 17), adenomas (n = 50), serrated lesions (n = 8), and normal mucosa (n = 5). Any kind of known and unknown APC mutations (deletions, insertions, and base exchanges) being situated inside the mutation cluster region was distinguishable from wild-type DNA. Furthermore, by WTB-HRM, nearly twice as many carcinomas and 1.5 times more precursor lesions were identified to be mutated in APC, as compared with direct sequencing. By analyzing 31 associated stool DNA specimens all but one of the APC mutations could be recovered. Transferability of the WTB-HRM method to other genes was proven using the example of KRAS mutation analysis. In summary, WTB-HRM is a new approach for ultrasensitive detection of cancer-initiating mutations. In this sense, it appears especially applicable for noninvasive detection of colon cancer precursors in body fluids with excess wild-type DNA like stool. Cancer Prev Res; 6(9); 898-907. (C) 2013 AACR.
The Saxon granulites, the type granulite locality, were deeply buried, extremely heated and then rapidly exhumed during the Variscan Orogeny; thus their evolution differs from many granulites elsewhere. The peak-metamorphic assemblages of layered felsic-mafic granulites from a 500 m deep borehole consist of garnet, kyanite, rutile, ternary feldspar and quartz in felsic granulite, and garnet, omphacite, titanite, ternary feldspar and quartz in mafic granulite. A minimum temperature of 1000-1020degreesC, calculated from reintegrated hypersolvus feldspar in felsic and mafic granulites, is consistent with the highest temperature estimates from garnet-clinopyroxene equilibria. Various equilibria in felsic and mafic granulites record a peak pressure of about 23 kbar. Diffusion zoning and local homogenisation of minerals reflect near-isothermal decompression that preceded cooling and partial hydration at medium- to low-pressure. U-Pb dating of titanite yields an age of peak metamorphism at 340.7+/-0.8 Ma (2sigma). However, chemical inheritance from precursor rutile and post-peak Pb loss are also evident, suggesting a protolith age of 499+/-2 Ma (2sigma) and partial resetting down to an age of 333+/-2 Ma (2sigma). Rb-Sr mica ages of 333.2+/-3.3 Ma (2sigma) are interpreted as dating cooling through about 620degreesC. Hence the Saxon granulites were exhumed to the upper crust during the short period of 6-11 Ma, which corresponds to average exhumation and cooling rates of 10 mm/year and 50degreesC/Ma, respectively. Such rapid exhumation is inconsistent with recent numerical models that assume foreland- directed transport of the Saxon granulites in the lower crust followed by extensional unroofing. Instead, high-pressure rocks of the Saxon Granulite Massif and the nearby Erzgebirge experienced a buoyant rise to the middle crust and subsequent juxtaposition with structurally higher units along a series of medium- to low-pressure detachment faults
A randomized, placebo-controlled, double-blind clinical study was performed to investigate the dose-dependent response of serum cholesterol after consuming an ultra-heat-treated milk containing a soy protein preparation. Eighty hypercholesterolemic subjects were assigned to one of four study groups receiving 12.5 or 25 g soy protein (active treatment) or casein (placebo) daily over a period of 4 weeks. The trial substances were provided as ready-made, ultra-heated milk preparations. Before and after the treatment, serum concentrations of total, low-density lipoprotein, and high-density lipoprotein cholesterol were determined. Unexpectedly, at the end of the study, low-density lipoprotein cholesterol concentrations were significantly increased compared with baseline in all study groups. The magnitude of this increase (17 - 19%) was similar in all active and placebo study groups. Soy protein supplements previously shown to be effective in reducing serum cholesterol had in this study no such lipid-lowering effect after ultra heat treatment.
Mutations in the gene encoding for filaggrin (FLG) are major predisposing factors for atopic dermatitis (AD). Besides genetic predisposition, immunological dysregulations considerably contribute to its pathophysiology. For example, thymic stromal lymphopoietin (TSLP) is highly expressed in lesional atopic skin and significantly contributes to the pathogenesis of AD by activating dendritic cells that then initiate downstream effects on, for example, T cells. However, little is known about the direct interplay between TSLP, filaggrin-deficient skin and other immune cells such as T lymphocytes. In the present study, FLG knockdown skin equivalents, characterised by intrinsically high TSLP levels, were exposed to activated CD4(+) T cells. T cell exposure resulted in an inflammatory phenotype of the skin equivalents. Furthermore, a distinct shift from a Th1/Th17 to a Th2/Th22 profile was observed following exposure of T cells to filaggrin-deficient skin equivalents. Interestingly, TSLP directly stimulated T cell migration exclusively in filaggrin-deficient skin equivalents even in the absence of dendritic cells, indicating a hitherto unknown role of TSLP in the pathogenesis of AD.
Treatment of caenorhabditis elegans with small selenium species enhances antioxidant defense systems
(2019)
ScopeSmall selenium (Se) species play a key role in Se metabolism and act as dietary sources of the essential trace element. However, they are redox-active and trigger pro- and antioxidant responses. As health outcomes are strongly species-dependent, species-specific characteristics of Se compounds are tested in vivo. Methods and resultsIn the model organism Caenorhabditis elegans (C. elegans), immediate and sustained effects of selenite, selenomethionine (SeMet), and Se-methylselenocysteine (MeSeCys) are studied regarding their bioavailability, incorporation into proteins, as well as modulation of the cellular redox status. While all tested Se compounds are bioavailable, only SeMet persistently accumulates and is non-specifically incorporated into proteins. However, the protection toward chemically-induced formation of reactive species is independent of the applied Se compound. Increased thioredoxin reductase (TXNRD) activity and changes in mRNA expression levels of antioxidant proteins indicate the activation of cellular defense mechanisms. However, in txnrd-1 deletion mutants, no protective effects of the Se species are observed anymore, which is also reflected by differential gene expression data. ConclusionSe species protect against chemically-induced reactive species formation. The identified immediate and sustained systemic effects of Se species give rise to speculations on possible benefits facing subsequent periods of inadequate Se intake.
OBJECTIVE-BMI and albumin are commonly accepted parameters to recognize wasting in dialysis patients and are powerful predictors of morbidity and mortality. However, both parameters reveal limitations and may not cover the entire range of patients with wasting. The visceral protein transthyretin (TTR) may be helpful in overcoming the diagnostic and prognostic gap. Therefore, the aim of this study was to assess the association of TTR with morbidity and mortality in hemodialysis patients.
RESEARCH DESIGN AND METHODS-The TTR concentration was determined in plasma samples of 1,177 hemodialysis patients with type 2 diabetes. Cox regression analyses were used to determine hazard ratios (HRs) for the risk of cardiovascular end points (CVEs) and mortality according to quartiles of TTR concentration for the total study cohort and the subgroups BMI >= 23 kg/m(2), albumin concentration >= 3.8 g/dL, and a combination of both.
RESULTS-A low TTR concentration was associated with an increased risk for CVE for the total study cohort (HR 1.65 [95% CI 1.27-2.14]), patients with BMI >= 23 kg/m(2) (1.70 [1.22-2.37]), albumin >= 3.8 g/dL (1.68 [1.17-2.42]), and the combination of both (1.69 [1.13-2.53]). Additionally, a low TTR concentration predicted mortality for the total study cohort (1.79 [1.43-2.24]) and patients with BMI >= 23 kg/m(2) (1.46 [1.09-1.95]).
CONCLUSIONS-The current study demonstrated that TTR is a useful predictor for cardiovascular outcome and mortality in diabetic hemodialysis patients. TTR was particularly useful in patients who were not identified to be at risk by BMI or albumin status.
Objective:
We address two questions relevant to infants' exposure to potentially toxic arsenolipids, namely, are the arsenolipids naturally present in fish transported intact to a mother's milk, and what is the efficiency of this transport.
Methods:
We investigated the transport of arsenolipids and other arsenic species present in fish to mother's milk by analyzing the milk of a single nursing mother at 15 sampling times over a 3-day period after she had consumed a meal of salmon. Total arsenic values were obtained by elemental mass spectrometry, and arsenic species were measured by HPLC coupled to both elemental and molecular mass spectrometry.
Results:
Total arsenic increased from background levels (0.1 mu g As kg(-1)) to a peak value of 1.72 lig As kg(-1) eight hours after the fish meal. The pattern for arsenolipids was similar to that of total arsenic, increasing from undetectable background levels (< 0.01 mu g As kg(-1)) to a peak after eight hours of 0.45 mu g As kg(-1). Most of the remaining total arsenic in the milk was accounted for by arsenobetaine. The major arsenolipids in the salmon were arsenic hydrocarbons (AsHCs; 55 % of total arsenolipids), and these compounds were also the dominant arsenolipids in the milk where they contributed over 90 % of the total arsenolipids.
Conclusions:
Our study has shown that ca 2-3 % of arsenic hydrocarbons, natural constituents of fish, can be directly transferred unchanged to the milk of a nursing mother. In view of the potential neurotoxicity of AsHCs, the effects of these compounds on the brain developmental stage of infants need to be investigated.
Methicillin resistant Staphylococcus aureus (MRSA) is one of the most important antibiotic-resistant pathogens in hospitals and the community. Recently, a new generation of MRSA, the so called livestock associated (LA) MRSA, has emerged occupying food producing animals as a new niche. LA-MRSA can be regularly isolated from economically important live-stock species including corresponding meats. The present thesis takes a methodological approach to confirm the hypothesis that LA-MRSA are transmitted along the pork, poultry and beef production chain from animals at farm to meat on consumers` table. Therefore two new concepts were developed, adapted to differing data sets.
A mathematical model of the pig slaughter process was developed which simulates the change in MRSA carcass prevalence during slaughter with special emphasis on identifying critical process steps for MRSA transmission. Based on prevalences as sole input variables the model framework is able to estimate the average value range of both the MRSA elimination and contamination rate of each of the slaughter steps. These rates are then used to set up a Monte Carlo simulation of the slaughter process chain. The model concludes that regardless of the initial extent of MRSA contamination low outcome prevalences ranging between 0.15 and 1.15 % can be achieved among carcasses at the end of slaughter. Thus, the model demonstrates that the standard procedure of pig slaughtering in principle includes process steps with the capacity to limit MRSA cross contamination. Scalding and singeing were identified as critical process steps for a significant reduction of superficial MRSA contamination.
In the course of the German national monitoring program for zoonotic agents MRSA prevalence and typing data are regularly collected covering the key steps of different food production chains. A new statistical approach has been proposed for analyzing this cross sectional set of MRSA data with regard to show potential farm to fork transmission. For this purpose, chi squared statistics was combined with the calculation of the Czekanowski similarity index to compare the distributions of strain specific characteristics between the samples from farm, carcasses after slaughter and meat at retail. The method was implemented on the turkey and veal production chains and the consistently high degrees of similarity which have been revealed between all sample pairs indicate MRSA transmission along the chain.
As the proposed methods are not specific to process chains or pathogens they offer a broad field of application and extend the spectrum of methods for bacterial transmission assessment.
Background Cardiovascular disease risk among individuals across different categories of BMI might depend on their metabolic health. It remains unclear to what extent metabolic health status changes over time and whether this affects cardiovascular disease risk. In this study, we aimed to examine the association between metabolic health and its change over time and cardiovascular disease risk across BMI categories. Findings During 2 127 391 person-years of follow-up with a median follow-up of 24 years, we documented 6306 cases of cardiovascular disease including 3304 myocardial infarction cases and 3080 strokes. Cardiovascular disease risk of women with metabolically healthy obesity was increased compared with women with metabolically healthy normal weight (HR 1.39, 95% CI 1.15-1.68), but risk was considerably higher in women with metabolically unhealthy normal weight (2.43, 2.19-2.68), overweight (2.61, 2.36-2.89) and obesity (3.15, 2.83-3.50). The majority of metabolically healthy women converted to unhealthy phenotypes (2555 [84%] of 3027 women with obesity, 22 215 [68%] of 32 882 women with normal-weight after 20 years). Women who maintained metabolically healthy obesity during follow-up were still at a higher cardiovascular disease risk compared with women with stable healthy normal weight (HR 1.57, 1.03-2.38), yet this risk was lower than for initially metabolically healthy women who converted to an unhealthy phenotype (normal-weight 1.90, 1.66-2.17 vs obesity 2.74, 2.30-3.27). Particularly incident diabetes and hypertension increased the risk among women with initial metabolic health. Interpretation Even when metabolic health is maintained during long periods of time, obesity remains a risk factor for cardiovascular disease. However, risks are highest for metabolically unhealthy women across all BMI categories. A large proportion of metabolically healthy women converted to an unhealthy phenotype over time across all BMI categories, which is associated with an increased cardiovascular disease risk. Copyright (C) 2018 Elsevier Ltd. All rights reserved.
Transfer of carotenoids, alfa-tocopherol and retinol from plasma into follicular fluid in women
(2000)
Cholesterol uptake and efflux are key metabolic processes associated with macrophage physiology and atherosclerosis. Peroxisome proliferator-activated receptor gamma (PPARgamma) and liver X receptor alpha (LXRalpha) have been linked to the regulation of these processes. It remains to be identified how activation of these receptors is connected and regulated by endogenous lipid molecules. We identified CYP27, a p450 enzyme, as a link between retinoid, PPARgamma, and LXR signaling. We show that the human CYP27 gene is under coupled regulation by retinoids and ligands of PPARs via a PPAR-retinoic acid receptor response element in its promoter. Induction of the enzyme's expression results in an increased level of 27-hydroxycholesterol and upregulation of LXR-mediated processes. Upregulated CYP27 activity also leads to LXR-independent elimination of CYP27 metabolites as an alternative means of cholesterol efflux. Moreover, human macrophage-rich atherosclerotic lesions have an increased level of retinoid-, PPARgamma-, and LXR- regulated gene expression and also enhanced CYP27 levels. Our findings suggest that nuclear receptor-regulated CYP27 expression is likely to be a key integrator of retinoic acid receptor-PPARgamma-LXR signaling, relying on natural ligands and contributing to lipid metabolism in macrophages
Small selenium (Se) species play a major role in the metabolism, excretion and dietary supply of the essential trace element selenium. Human cells provide a valuable tool for investigating currently unresolved issues on the cellular mechanisms of Se toxicity and metabolism. In this study, we developed two isotope dilution inductively coupled plasma tandem-mass spectrometry based methods and applied them to human hepatoma cells (HepG2) in order to quantitatively elucidate total cellular Se concentrations and cellular Se species transformations in relation to the cytotoxic effects of four small organic Se species. Species-and incubation time-dependent results were obtained: the two major urinary excretion metabolites trimethylselenonium (TMSe) and methyl-2-acetamido-2-deoxy-1-seleno-beta- D-galactopyranoside (SeSugar 1) were taken up by the HepG2 cells in an unmodified manner and did not considerably contribute to the Se pool. In contrast, Se-methylselenocysteine (MeSeCys) and selenomethionine (SeMet) were taken up in higher amounts, they were largely incorporated by the cells (most likely into proteins) and metabolized to other small Se species. Two new metabolites of MeSeCys, namely gamma-glutamyl-Se-methylselenocysteine and Se-methylselenoglutathione, were identified by means of HPLC-electrospray-ionization-Orbitrap-MS. They are certainly involved in the (de-) toxification modes of Se metabolism and require further investigation.
The trace elements copper, iron, manganese, selenium and zinc are essential micronutrients involved in various cellular processes, all with different responsibilities. Based on that importance, their concentrations are tightly regulated in mammalian organisms. The maintenance of those levels is termed trace element homeostasis and mediated by a combination of processes regulating absorption, cellular and systemic transport mechanisms, storage and effector proteins as well as excretion. Due to their chemical properties, some functions of trace elements overlap, as seen in antioxidative defence, for example, comprising an expansive spectrum of antioxidative proteins and molecules. Simultaneously, the same is true for regulatory mechanisms, causing trace elements to influence each other’s homeostases. To mimic physiological conditions, trace elements should therefore not be evaluated separately but considered in parallel. While many of these homeostatic mechanisms are well-studied, for some elements new pathways are still discovered. Additionally, the connections between dietary trace element intake, trace element status and health are not fully unraveled, yet. With current demographic developments, also the influence of ageing as well as of certain pathological conditions is of increasing interest. Here, the TraceAge research unit was initiated, aiming to elucidate the homeostases of and interactions between essential trace elements in healthy and diseased elderly. While human cohort studies can offer insights into trace element profiles, also in vivo model organisms are used to identify underlying molecular mechanisms. This is achieved by a set of feeding studies including mice of various age groups receiving diets of reduced trace element content. To account for cognitive deterioration observed with ageing, neurodegenerative diseases, as well as genetic mutations triggering imbalances in cerebral trace element concentrations, one TraceAge work package focuses on trace elements in the murine brain, specifically the cerebellum. In that context, concentrations of the five essential trace elements of interest, copper, iron, manganese, selenium and zinc, were quantified via inductively coupled plasma-tandem mass spectrometry, revealing differences in priority of trace element homeostases between brain and liver. Upon moderate reduction of dietary trace element supply, cerebellar concentrations of copper and manganese deviated from those in adequately supplied animals. By further reduction of dietary trace element contents, also concentrations of cerebellar iron and selenium were affected, but not as strong as observed in liver tissue. In contrast, zinc concentrations remained stable. Investigation of aged mice revealed cerebellar accumulation of copper and iron, possibly contributing to oxidative stress on account of their redox properties. Oxidative stress affects a multitude of cellular components and processes, among them, next to proteins and lipids, also the DNA. Direct insults impairing its integrity are of relevance here, but also indirect effects, mediated by the machinery ensuring genomic stability and its functionality. The system includes the DNA damage response, comprising detection of endogenous and exogenous DNA lesions, decision on subsequent cell fate and enabling DNA repair, which presents another pillar of genomic stability maintenance. Also in proteins of this machinery, trace elements act as cofactors, shaping the hypothesis of impaired genomic stability maintenance under conditions of disturbed trace element homeostasis. To investigate this hypothesis, a variety of approaches was used, applying OECD guidelines Organisation for Economic Co-operation and Development, adapting existing protocols for use in cerebellum tissue and establishing new methods. In order to assess the impact of age and dietary trace element depletion on selected endpoints estimating genomic instability, DNA damage and DNA repair were investigated. DNA damage analysis, in particular of DNA strand breaks and oxidatively modified DNA bases, revealed stable physiological levels which were neither affected by age nor trace element supply. To examine whether this is a result of increased repair rates, two steps characteristic for base excision repair, namely DNA incision and ligation activity, were studied. DNA glycosylases and DNA ligases were not reduced in their activity by age or trace element depletion, either. Also on the level of gene expression, major proteins involved in genomic stability maintenance were analysed, mirroring results obtained from protein studies. To conclude, the present work describes homeostatic regulation of trace elements in the brain, which, in absence of genetic mutations, is able to retain physiological levels even under conditions of reduced trace element supply to a certain extent. This is reflected by functionality of genomic stability maintenance mechanisms, illuminating the prioritization of the brain as vital organ.
The trace elements zinc and manganese are essential for human health, especially due to their enzymatic and protein stabilizing functions. If these elements are ingested in amounts exceeding the requirements, regulatory processes for maintaining their physiological concentrations (homeostasis) can be disturbed. Those homeostatic dysregulations can cause severe health effects including the emergence of neurodegenerative disorders such as Parkinson’s disease (PD). The concentrations of essential trace elements also change during the aging process. However, the relations of cause and consequence between increased manganese and zinc uptake and its influence on the aging process and the emergence of the aging-associated PD are still rarely understood. This doctoral thesis therefore aimed to investigate the influence of a nutritive zinc and/or manganese oversupply on the metal homeostasis during the aging process. For that, the model organism Caenorhabditis elegans (C. elegans) was applied. This nematode suits well as an aging and PD model due to properties such as its short life cycle and its completely sequenced, genetically amenable genome. Different protocols for the propagation of zinc- and/or manganese-supplemented young, middle-aged and aged C. elegans were established. Therefore, wildtypes, as well as genetically modified worm strains modeling inheritable forms of parkinsonism were applied. To identify homeostatic and neurological alterations, the nematodes were investigated with different methods including the analysis of total metal contents via inductively-coupled plasma tandem mass spectrometry, a specific probe-based method for quantifying labile zinc, survival assays, gene expression analysis as well as fluorescence microscopy for the identification and quantification of dopaminergic neurodegeneration.. During aging, the levels of iron, as well as zinc and manganese increased.. Furthermore, the simultaneous oversupply with zinc and manganese increased the total zinc and manganese contents to a higher extend than the single metal supplementation. In this relation the C. elegans metallothionein 1 (MTL-1) was identified as an important regulator of metal homeostasis. The total zinc content and the concentration of labile zinc were age-dependently, but differently regulated. This elucidates the importance of distinguishing these parameters as two independent biomarkers for the zinc status. Not the metal oversupply, but aging increased the levels of dopaminergic neurodegeneration. Additionally, nearly all these results yielded differences in the aging-dependent regulation of trace element homeostasis between wildtypes and PD models. This confirms that an increased zinc and manganese intake can influence the aging process as well as parkinsonism by altering homeostasis although the underlying mechanisms need to be clarified in further studies.